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Abstract 
Liquid extraction surface analysis (LESA) mass spectrometry is an emerging 
direct surface sampling technique. In this thesis, LESA has been coupled to an 
Orbitrap Velos ETD (Thermo), a TSQ Vantage (Thermo) and a Synapt G2-S 
(Waters) mass spectrometers, for the analysis of lipids and proteins from 
human liver. The aim was to develop analytical methods that would ultimately 
be used in the study of non-alcoholic liver disease. Initial investigations 
assessed the capabilities of using LESA for imaging and optimised sampling 
protocol for lipids and proteins. Analysis of the fatty acid binding protein was 
explored further, in particular to the identification of a single amino acid 
substitution that is associated with non-alcoholic steatohepatitis, a potentially 
fatal liver disease. Both top-down and bottom-up proteomics techniques were 
employed. Bottom-up resulted in over 300 proteins being detected and 
identified, including several other known biomarkers for liver disease, however 
failed to distinguish between two proteins with a single amino acid substitution. 
Top-down approach was employed to identify these two proteins. Field 
asymmetric ion mobility spectrometry (FAIMS) analysis was coupled with 
LESA to enhanced the quality of intact protein mass spectra and doubled the 
number of proteins detected. FAIMS analysis was able to separated lipids and 
proteins that are extracted simultaneously as well as removing background 
noise from large unresolvable ions. To fully appreciate that data that was 
 acquired using the FAIMS visualisation software was developed. In addition to 
FAIMS, traveling wave ion mobility spectrometry (TWIMS) was also coupled to 
LESA via the Synapt G2-S. In addition to the separation of lipids from proteins, 
several lipids also showed a separation in drift. MS/MS of one of these lipids 
revealed that the composition of the two drift peaks differed. The ability to 
separate isobaric lipids made this technique particularly useful for imaging. 
MALDI imaging was performed on the Synapt G2-S with TWIMS, to show the 
isolation of specific lipid species using MS/MS imaging and TWIMS imaging. 
The MALDI gives a complementary approach to LESA for tissue analysis. 
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Chapter 1:  Introduction 
1.1 Origins of Mass spectrometry 
In 1803, a theory put forward by John Dalton that described matter as a 
composition of various different atoms was one of the first steps in bringing 
understanding to molecular compositions. Dalton’s theory was based on four 
assumptions:  
• Matter is composed of elements consisting of solid indivisible atoms. 
• The elements are indestructible. 
• The number of different types of atoms corresponds exactly to the 
number of chemical elements.  
• Each element has fixed and measurable properties.  
This theory started the process of the development of mass spectrometry as an 
instrument to measure atoms and elements. [1, 2] 
The discovery of cathode rays in the late 19th century started the development 
of the first mass spectrometer. It was noticed that this ray was made of particles 
that could be deflected by strong magnetic or electrical fields, and that the 
degree of the deflection was related to their charge to mass ratio, which was 
measured at 1/1800th of a hydrogen atom. This was the discovery of the 
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electron for which J.J. Thomson and G.J. Stoney were awarded the Noble prize 
for physics in 1906. [1, 2] 
Meanwhile Eugen Goldstein hypothesised that if negatively charged particles 
were traveling in one direction then positively charged particles must be 
traveling in the opposite direction. He was able to prove these particles were 
indeed traveling in the opposite direction but could not prove that they were 
positively charged as this would require stronger magnetic fields than were 
available to Goldstein. It was Weilhelm Wien, a student of Goldstein’s, who 
was able to demonstrate the production of positive ions. He used a combination 
of magnetic and electrical fields to deflect ions. These deflections were detected 
on a photographic plate and characteristic parabolas were observed with lighter 
ions being deflected more than heavier ions. Wien used this equipment to 
calculate the mass to charge ratio of a proton by calculating the degree of 
deflection. Larger ions that were analysed were difficult to interpret because the 
resolution was very poor. Thompson and Francis W. Aston developed the 
technique to enhance the clarity of the results by removing the air that was 
causing interference. The first mass spectrometer produced images of parabolas 
the width and height of which were specific to an ion. J. J. Thomson further 
developed methods for ion detection: Instead of all ions being detected at the 
same time, single ion types were detected in turn by tuning the magnetic field 
so that ions sequentially passed through a parabola shaped slit in a metal sheet, 
producing a spectrum. 
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Mass spectrometers and mass spectrometry have progressed since the work of J. 
J. Thomson. Several Nobel prizes have been won for contributing to the design 
and methodology that have enabled mass spectrometry to become an 
instrument that is used in several scientific disciplines. The individuals that 
have won or shared the Nobel prize are [3]; 
• In 1922 Francis W. Aston won the Nobel prize for chemistry by 
identifying 212 natural occurring isotopes using Thomson’s mass 
spectrometer [4] 
• In 1939 Ernest O. Laurence was awarded the Nobel prize for physics for 
the Invention of the Cyclotron [5] 
• Wolfgang Paul and Hans Dehmelt (quarter each) shared the Nobel prize 
in physics in 1989 for the invention of the ion trap techniques [6, 7] 
• In 2002 John Bennett Fenn and Koichi Tanaka shared (quarter each) the 
Nobel Prize in chemistry for the development of soft ionisation 
techniques for the analysis of biological macromolecules. [8, 9] 
1.2 Modern mass spectrometers 
There are a wide variety of mass spectrometers available, each used for a 
different purpose. All mass spectrometers have a similar configuration as 
outlined in Figure 1.  
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Figure 1: Generalised schematic of mass spectrometers. Online separation is optional. 
 
The sample, sampling method, and ionisation techniques are directly related to 
each other, because the sample needs to be introduced to the instrument in a 
suitable manner. In addition, online separation techniques such as liquid 
chromatography or ion mobility (see section 1.4) are sometimes used to enhance 
the quality and quantity of the data. 
1.2.1. Ionisation Techniques 
Molecules are converted to ions in the ionisation source. The hardness of the 
ionisation technique is a measure of how fragmented the analytes are after 
ionisation. Hard ionisation techniques such as electron ionisation (EI), result in 
extensive fragmentation. The advantage of EI is that the fragmentation is very 
predictable and mass fingerprinting and quantification is possible [10, 11], 
however the intact mass of the precursor ion is sometimes lost. The intact mass 
can be obtained by using softer ionisation methods. Soft ionisation techniques 
produce less fragmentation and are able to ionise larger molecules. The softest 
ionisation technique is matrix-assisted laser desorption/ionisation (MALDI), 
and is capable of ionising large molecules of over 100,000 Da as a singly 
charged ion [12]. This characteristic is ideal for the simplicity of the mass 
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spectrum however only the time of flight mass analyser (see section 1.3.1) is 
capable of analysing ions of this size. Electrospray Ionisation (ESI) is also a soft 
technique. It can still analyse large molecular weight compounds however 
typically produces a series of multiply charged ions for each molecular species. 
[13] The advantage of multiply charged ions is that there is a reduction in the 
mass to charge (m/z) ratio of the detected ions and so a wider choice of mass 
analysers is available.  
Ionisation techniques can be split into two categories, low-pressure ionisation 
(in a vacuum) and atmospheric pressure ionisation. A sub category of 
atmospheric pressure ionisation is ambient ionisation, where ionisation occurs 
at room pressure. The most widely used ambient ionisation technique is 
electrospray ionisation, and is discussed in more detail in section 1.2.1.2. Low-
pressure ionisation MALDI (with the exception of atmospheric pressure 
MALDI [14]) is one of the main vacuum based ionisation technique. The 
research presented here uses the soft ionisation techniques of MALDI and ESI. 
A few examples of ionisation techniques in each of these categories are shown 
in Table 1-1. 
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Table 1-1: Catagories of ionisation techniques 
Technique Low pressure 
ionisation 
Atmospheric 
ionisation 
Ambient 
ionisation 
Secondary ion mass spectrometry [15] ✔   
Matrix assisted laser desorption ionisation [16] ✔   
Atmospheric pressure MALDI [14]  ✔  
Atmospheric pressure chemical ionisation [17]  ✔  
Atmospheric pressure photo ionisation [18]  ✔  
Electrospray ionisation [19]   ✔ ✔ 
Desorption electrospray ionisation [20]  ✔ ✔ 
Laser desorption ionisation [21]  ✔ ✔ 
 
1.2.1.1 Matrix-assisted laser desorption/ionisation 
MALDI is a combined sampling and ionisation technique that was first 
reported in 1987 for the ionisation of non-volatile compounds [16]. This method 
incorporates a matrix compound to coat or suspend the sample. The matrix 
then absorbs the energy from the laser causing desorption and ionisation. The 
matrix choice is very important and some important considerations: 
• A good absorbance at the wavelength of the laser; [22] 
• Be soluble in a solvent that is suitable for the sample (exception of dry 
coating techniques); [23-25] 
• Not cause too much interference of analyte peaks in the spectrum, 
• Be stable under a vacuum (except AP-MALDI), especially true for liquid 
matrices [26] 
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• Form smaller crystals than the spatial resolution required (specific to 
imaging); 
• Results in homogeneous analyte inclusion; 
• Be able to be dispensed evenly across a surface (specific to imaging); 
• Promote ion formation; 
The relationship between the matrix and the sample is very complex. The ratio 
between the number of matrix molecules and number of analyte molecules can 
affect the intensity and type of species detected [27]. This can be easily 
controlled when using pure standards however in complex samples where the 
composition of analytes changes through out the sample it can be more difficult 
to control. Some commonly used matrices are; 
Table 1-2: Examples of matrices and their uses. 
Matrix Used for* References  
2,5-Dihydrobenzoic acid Positive mode, Lipids and 
polymers. 
[28, 29] 
α-cyano-hydroxycinannic 
acid  
Positive mode Lipids, proteins and 
peptides 
[28, 30] 
Sinapinic acid  Positive mode, proteins [31, 32] 
2,4,6-
Trihydroxyacetophenone 
Positive and negative mode, 
Carbohydrates oligonucleotides, 
Lipids 
[33-35] 
9-Aminoacridine  Negative mode, Lipids and small 
molecules. 
[36-38] 
* This is not an exclusive nor exhaustive list. 
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Matrix application is important. Some factors that affect the quality of the data 
are:  
• Collection and Storage 
• Washing 
• Matrix 
• Matrix application 
Collection and Storage are critical aspects of MALDI sample preparation, some 
molecules will degrade quickly others will degrade slowly. [39] To prevent 
degradation 3 methods can be employed, Snap freezing, chemical treatment 
such as formalin fixation, and heat treatment. [40-42] 
Tissue washing is an important aspect of MALDI sample preparation. The 
advantages of tissue washing are that it removes salts and competitive 
molecules that could prevent the ionisation of the target molecules. However, 
there is the risk of delocalising the molecules that are being targeted, which for 
imaging, results in misleading images. It is possible to reduce the degree of 
delocalising during washing by choosing wash solutions that do not dissolve 
the target molecules. [43-45] 
There are two considerations when choosing a matrix for MALDI imaging, the 
compatibility of the matrix with the target molecules and the crystal size of the 
matrix when it dries. There are many matrices used in MALDI, 2,5-
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Dihydroxybenzoic acid, a-Cyano-4-hydroxycinnamic acid and 2,4,6-
Trihydroxyacetophenone, are common. [46] There are many more, the use of 
nano-particles and ionic compounds as matrices are expanding areas.[47, 48] 
The matrix needs to be applied in such a manor that there is a uniform 
distribution across the surface. There are a number of methods to do this. 
Spraying is possibly the most popular method. This can be done relatively 
cheaply by hand using an airbrush, but this is very user specific. To make the 
process more repeatable inkjet printers can be used, but plastic tubing often 
does not last long with some organic solvents. Specially designed automatic 
sprayers and spotters are available on the market. Other methods include 
sublimation, and dry coating. [49, 50] 
1.2.1.1.1 MALDI ionisation 
Ionisation occurs when a laser pulse impacts the sample. The exact mechanism 
is still unclear however there is a wide range of theories. These theories can be 
separated into primary and secondary ion formation models. Primary ion 
formation is the direct ionisation caused by the laser and is typically matrix or 
matrix related molecules. Where by a matrix molecule (M) looses and electron 
to become a radically charged ion (M+.) [51] 
M →(hv)→ M+. + e- 
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It has been proposed that when the matrix molecule (M) is excited by the laser 
(hv) the excited molecule exists for sufficient length of time to then further react 
with molecules within close proximity, possibly ionising with analyte 
molecules (A). This is known as the excited state proton transfer. 
M →(hv)→ M* + A →n(hv)→ [M-H]- +[A+H]+ 
Other primary ionisation processes include thermal ionisation are outlined in 
Zenobi and Knochenmuss [51] 
Secondary ionisation processes is the interaction between two ions where the 
charge is transferred from an ion to form another. [11, 51] For example,  
M →(hv)→ M* + M →n(hv)→ [M-H]- +[M+H]+ 
Followed by  
[M+H]+ + A → M + [A+H]+ 
Overall, desorption and ionisation occurs when the laser interacts with the 
sample. A plume of molecules and ions form over the sample prior to the 
extraction of either positive or negative ions this process is shown in Figure 2. 
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Figure 2: Schematic of MALDI sampling. Laser causing desorption and ionisation (orange 
matrix molecules in their charge state). Secondary ionisation processes occur to 
ionise analyte molecules (red, blue and green). Positive ions are then extracted for 
analysis.  
 
MALDI is currently used for a wide range of analytes and purposes in a 
biological context. MALDI is used for the analysis of lipids, [52] proteins, [53] 
metabolites, [54] drug molecules [55]and DNA [56], from tissue[57], urine 
[58]and bacteria [59] to name a few. For MALDI there is a large emphasis on 
sample preparation, which is key to the success of the results, especially within 
MALDI imaging [41]. 
1.2.1.1.2 MALDI Imaging 
MALDI images are maps of ion distribution across a surface. They are 
produced by the sequential MALDI analysis over a sample area. The spectra 
acquired retain the spatial location enabling the intensity of specific m/z to be 
plotted. (Figure 3) The laser is often focused to under 200 µm in diameter and 
can be down to a few µm. This means that the sampling is spatially localised 
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and recent advances are achieving subcellular resolution [60, 61]. The first mass 
spectrometry images were first reported in 1994 by Short [62] who imaged spots 
acetylcholine and its MS/MS product ions from dry filter paper. The first 
biological sample was analysed by Caprioli in 1997, [63] where a selection of 
peptides and small proteins were imaged from human buccal mucosa cells.  
 
 
Figure 3 Schematic of MALDI imaging. Laser ablates a localised position on the sample. The 
spectrum is collected and the intensity of a particular m/z is displayed as a map.  
 
The spatial resolution can be increased by over-sampling. Oversampling 
involves reducing the step size between pixels to smaller than the diameter of 
the laser. This is possible because when the laser ablates an area it ablates the 
matrix. When the laser is moved to the next pixel, only the region where matrix 
is present will induce ionisation. A consequence of this is the first row and 
column may be more intense than the all the remaining pixels. [64] 
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MALDI and MALDI imaging is not the only way to analyse biological 
molecules and to view their distribution on tissue. Electrospray ionisation is 
capable of ionising these molecules and a number of ambient 
sampling/ionisation methods have been developed that would be suitable for 
imaging.  
1.2.1.2 Electrospray ionisation 
Electrospray ionisation (ESI) is an atmospheric ionisation technique that was 
developed by Whitehouse et al. in 1985, in-order to couple liquid 
chromatography with mass spectrometry. [19] In ESI, a liquid sample is passed 
through a capillary and a voltage is applied between the end of the capillary 
and the entrance to the mass spectrometer, resulting in the production of 
charged droplets.  
Three models are proposed for the ionisation of species via ESI (Figure 4). [65, 
66] The first is the ion evaporation model (IEM), whereby as the charge density 
on the droplet increases individual ions are ejected. IEM is the suggested 
mechanism for small, low charge state ions. The second model is the charge 
residue model (CRM) in which a large biomolecule is encompassed in a droplet 
and as the solvent evaporates the charge is transferred to the analyte resulting 
in a highly charged ion. The third is the chain ejection model whereby as the 
droplet evaporates a polymer chain gradually detaches from the droplet. As the 
polymer detaches charged residues reduce the charge density in the droplet. 
[65] 
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Figure 4: Three models of ionisation for ESI. A) ion ejection model, B) chain residue model C) 
chain ejection model. Orange circles and lines are analyte molecule obtaining a 
postive chare.  
 
Factors that will affect the ability of ESI to be effective include, 
• The organic content of the solution 
• Solubility of the sample in the solution 
• Salt content of sample 
Organic solvents have a higher vapour pressure than water and evaporate more 
readily. A combination of organic solvent and water is typically used for 
biological samples. The one exception is analysis of proteins in their native state 
where organic solvents are not used as they denature the protein. [67] The 
sample needs to be a solution rather than a suspension; this includes any 
biological matter that might have been picked up during sampling. This is 
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because the electrospray nozzle can be very narrow especially for nano-ESI.[68] 
Nano-ESI follows the sample principles as ESI, however the flow rates at which 
the sample is introduced are in the region of nanoliters per minute rather than 
millilitres per minute for standard ESI. Salt content can also affect the 
ionisation: salts are naturally ionic and stabilise the charge of other molecules, 
including water, neutralising or reducing the charge of other species.  
1.2.1.3 Liquid	micro-junction	surface	analysis	
Liquid micro-junction (LMJ) surface analysis is a newly emerging technique 
where micro-litre liquid droplets connect to a surface and a sampling probe. 
There are two types of LMJ surface analysis platforms available commercially: 
the continuous flow (CF-) LMJ sampling platform, produced by Prosolia and 
known as the flowprobe, and a discrete position LMJ analysis platform 
produced by Advion called the NanoMate TriVersa which performs liquid 
extraction surface analysis (LESA).  
The CF-LMJ sampling technique was first reported by Wachs and Henion 
(2001) [69], who described a process whereby a solution was fed from a 
reservoir onto a sample and then the enriched solution was led away via an 
internal tube into an ESI source. The first instance of use of the liquid micro-
junction sampling technique was the CF-LMJ sampling of TLC plates in 2002. 
[70]. Since then this technique has been demonstrated on SPE cards [71], and 
drug tablets [72] and has been used to show a selection of analytes including 
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active pharmaceutical ingredients and dyes [70, 72-75]. The fluid dynamics has 
also been investigated using dyes and a transparent sampling probe [76, 77].  
The LESA approach, developed by Kertesz and Van Berkel (2009) [78], involves 
aspiration of a predetermined volume of electrospray solution from a reservoir 
into a probe, relocation to the required position above the substrate and 
lowering of the pipette to just above the surface. A set volume of the solution is 
dispensed so that there is contact between the probe and the surface, i.e., 
formation of a liquid-microjunction. A short pause allows molecules from the 
surface to diffuse into solution before the sample is re-aspirated into the probe. 
The sampling probe relocates and rotates 90º to makes contact with the nano-
ESI chip. This chip has 400, 10 µm (I.D.) capillaries through it, and becomes the 
ESI source. (Figure 5) 
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Figure 5: Schematic of LESA protocol. A and B) LESA tip decendes into solvent well and draws 
up some solution, C) LESA tip relocates over sample (orange), D) LESA tip 
descends to just above the sample and dispences some of the solution. E) Enriched 
solution is reasiprated. F) The tip relocates to the capillary chip for nano-ESI. 
 
The LESA approach has been used to analyse a wide range of tissue sections 
including arterial plaque [79], whole body rat [78, 80], porcine ear [81], rat liver 
[82] and formalin fixed mouse brain [45]. Other complex biological samples 
have been analysed such as dried blood spots[83-85], bacterial colonies [86]and 
single cells printed onto glass[87]. 
In most cases the tissue has been dosed with a drug and investigations have 
shown the detection of the drug or its metabolites. However Stegemann et al. 
demonstrated the possibility of detecting endogenous lipid species directly 
from tissue by LESA and compared the approach with the Folch extraction, a 
method of extracting and purifying total lipids from tissue sections [79, 88]. The 
first demonstration of the analysis of intact proteins by LESA coupled to mass 
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spectrometry was the detection of haemoglobin variants from dried blood spots 
[83, 84]. Intact endogenous proteins have also been detected in bacterial 
colonies [86]. The first example of intact proteins from tissue is presented here 
in chapter 3.  
Both these techniques have advantages and disadvantages. CF-LMJ is able to 
spray for a long time but because of the continual sampling the extraction is 
liable to change over the analysis time whereas in LESA, a specific volume is 
collected. This finite volume is homogenous and therefore long experiments can 
be conducted without the risk of the sample composition changing. In addition 
there is no contamination using the LESA system as every analysis uses a fresh 
probe and chip position whereas the CF-LMJ uses the same probe for all 
analyses meaning the approach is prone to contamination between samples.  
 
Figure 6: A) Photograph of the NanoMate TriVersa sampling from tissue using a liquid 
microjunction, B) Advion NanoMate TriVersa in the spray position. 
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1.2.1.3.1 Liquid micro-junction imaging 
Liquid microjunction sampling is also an imaging modality. The sampling is 
limited in both the x and y directions, therefore the results from a particular 
analysis are spatially localised. LESA imaging has been used demonstrated by 
Eikel et al who profiled terfenadine, a pharmaceutical drug from dosed mouse 
brain [80]. These images were produced using an SRM method and therefore 
targeted to a specific m/z. Other reported instances of LESA imaging are single 
line evaluations [81]. Although neither study displayed the data as what might 
be considered a typical image (one as a bar chart and the other as a line graph) 
both have conducted spatially sequential analysis of pharmaceuticals from 
tissue. A SRM study was conducted to show the distribution of drug 
metabolites over a section of rat kidney. The other study on porcine tissue used 
a QToF however only reported the intensity of product ions [81, 89].  
The spatial resolution of these two techniques is very similar. LESA reports a 
step size between pixels as 1-2 mm [82, 90]. Reported literature for CF-LMJ 
imaging via the FlowProbe uses discreet spot locations. That displayed the 
distribution of three m/z that registered with the three tissue types found in 
diseased rabbit lung tissue [91]. The flow probe has the capability for raster 
mode imaging however this has yet to be demonstrated. 
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1.2.2. Other ambient sampling and ionisation methods 
Ambient ionisation is often confused with atmospheric pressure ionisation. To 
be defined as ambient ionisation a techniques must adhere to the following four 
conditions [92]:  
1. Minimal sample pre-treatment, 
2. Ionisation conducted in open air. 
3. Not be specific to a particular mass analyser.  
4. Soft ionisation or sample must be between the ionisation source and the 
inlet. 
The first condition, minimal sample pre-treatment, puts an emphasis on direct 
ionisation from a sample and excludes on and off-line purification methods 
such as chromatographic methods or other purification/separation techniques.  
The second condition, ionisation is conducted in open air, is the key difference 
to atmospheric pressure ionisation, which is conducted in an enclosure at 
atmospheric pressure. This condition also means that ambient ionisation should 
be able to sample any object regardless of size and shape without need to 
section the object, as there would be no physical constraints. This is not strictly 
true in all cases as some manufacturers include sample holders that limit the 
size and shape of the sample, however, it is not the technique per se that is the 
limiting factor.  
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The third condition is that the ionisation source is independent from the mass 
analyser, i.e., the ionisation source should be interchangeable with other mass 
analysers that have an atmospheric pressure compatible inlet.  
The fourth condition is to enable the analysis of a wide range of molecules from 
complex samples. Soft ionisation can be hard to define: In this case, the limit is 
equal to or softer than ESI, i.e., able to ionise large molecules intact, with the 
potential to produce multiply charged species.  
Even taking into account these four points, there are still many ambient 
pressure techniques that have been reported in literature. There are over 40 
ambient ionisation methods, several of which are very similar, and recent 
reviews have further subdivided ambient ionisation into groups based on their 
method of sampling and ionisation. [92, 93] 
1. Solid-Liquid Extraction Based 
2. Plasma Based 
3. Two step Non-Laser, 
4. Acoustic Desorption 
5. Two Step Laser Desorption/Ablation 
6. Other and Multimodal 
Solid-Liquid extraction based sampling techniques is a group of two-step 
sampling –ionisation sources. It is in this group that liquid-micro junction 
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techniques such as LESA are located [78]. Other techniques in the group include 
the CF-LMJ [69], the SSSP [94], and nano-DESI [95] (see table for acronym 
description). 
Plasma based techniques are techniques that use plasma beams for the 
desorption/ablation and ionisation of the sample. [96-98] 
Two-step Non-Laser techniques are a mix of acoustic, thermal and mechanical 
extraction techniques. There are two acoustic methods that use vibrations 
created by either radio frequency (RADIO) [99] or a pulsed laser through foil 
(LAID-ESI) [100] to vibrate the sample from a surface. An ESI plume then picks 
up the vaporised sample where molecules are ionised. Thermal methods such 
as APTDI [101] or APTD-ESI [102] heat the sample causing volatile molecules to 
vaporise. The vaporised sample then meets the ESI spray and induces 
ionisation of the sample.  
Two-step Laser ablation/desorption techniques are all very similar. The main 
differences are the types of laser used, and a difference in the extraction 
mechanism, either desorption or ablation. LADESI [103] and LDESI [104] both 
use IR-lasers to desorbed/ablate the sample the former used Er:YAG and the 
latter CO2. Also in this category is MALDIESI [105] similar to the two previous 
techniques, MALDIESI uses a UV laser (Nd:YAG) and a matrix is applied to the 
sample. In all cases an electrospray source is positioned so that the ESI spray 
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and the plume created by the laser intermingle. The electrospray droplets pick 
up some of the desorbed/ablated molecules and ionisation occurs via ESI. 
The five subcategories listed contain most of the ambient techniques, the 
remaining few including swiFerr [106] and REIMS [107] are unique enough to 
not have any other technique similar to them and do not form a definable 
category by altogether, and so this category is defined as other techniques.  
 
Table 1-3: Ambient techniques in alphabetical order based on their abbreviation 
Technique Brief Description First reported 
Ambient micro-hollow 
cathode discharge 
ionisation (ambient 
MHCD) 
 
A plasma stream formed from a micro-
hollow cathode, was directed over the 
sample interacting at a 45°C angle causing 
desperation and ionisation.  
[108] 
Atmospheric pressure 
thermal desorption 
ionisation (APTDI) 
Heated nitrogen is directed onto a surface, 
desorbed ions are analysed 
[101] 
Atmospheric pressure 
thermal desorption-ESI 
(APTD-ESI) 
Sample is heated — emissions are then 
captured by ES resulting in ionisation.  
[102] 
Beta electron-assisted 
direct chemical ionisation 
(BADCI) 
b-emitting radioactive source ionises 
nitrogen gas stream that flows over sample 
[109] 
Desorption atmospheric 
pressure chemical 
ionisation (DAPCI) 
Plasma induces ionisation of atmospheric 
water molecules ionising the sample. 
[110] 
Desorption atmospheric 
pressure photo-ionisation 
(DAPPI) 
Jet of nebulised solvent desorbs sample, 
ultra-violet lamp is used to ionise the 
sample.  
[111] 
Direct analysis in real time 
(DART) 
A stream of a reagent gas (He or N) is 
excited and projected onto the sample at an 
angle causing desorption/ionisation.  
[112] 
Dielectric barrier 
discharge ionisation 
(DBDI) 
Alternating current between two electrodes 
separated by glass slide containing the 
sample produced plasma, for desorption 
and ionisation.  
[113] 
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Technique Brief Description First reported 
Desorption corona beam 
ionisation (DCBI) 
A coronal beam is created from a stream of 
helium gas. Beam is directed onto a surface 
causing desorption and ionisation 
[114] 
Desorption electro-flow 
focussing ionisation 
(DEFFI) 
A jet of solvent surrounded by a flow of 
nitrogen gas is directed at the sample. 
desorption then chemical induced 
metastable ionisation occurs. 
[115] 
Desorption 
electrospray/metastable-
induced ionisation (DEMI) 
A jet of solvent directed at the sample 
desorption occurs, desorbed molecules 
mingle with charged ions causing 
metastable – induced ionisation.  
[116] 
Desorption electrospray 
ionisation (DESI) 
A high velocity jet of electrospray solution 
aimed at sample extracts analyte molecules 
from a surface. Secondary droplets are 
formed from the impact of the original jet. 
Ionisation occurs similar to that of ESI.  
[20] 
Desorption ionisation by 
Charge exchange (DICE) 
Conducted in a similar manor to DESI using 
toluene as a spray solvent  
[117] 
Electrode-assisted DESI 
(EADESI) 
An electrode positioned on close to the 
outlet for the jet of electrospray, Charged 
droplets desorbed analytes from the surface 
and form secondary droplets. Ionisation 
occurs similar to ESI.  
[118] 
Easy ambient sonic-spray 
ionisation (EASI) also 
known as Desorption 
sonic spray ionisation 
(DeSSI) 
A supersonic nebulising gas carries a jet of 
solvent to the sample. Desorption and 
ionisation occur without heat or voltage 
applied. 
[119] 
Electrospray assisted laser 
desorption ionisation 
(ELDI) 
Pulsed nitrogen laser beam ablates sample, 
plume mingles with ES creating ions.  
[120] 
Flowing atmospheric 
pressure afterglow 
(FAPA) 
Ions formed by the collision of helium gas 
and electrons. This ion beam desorbs and 
ionises sample.  
[121, 122] 
Infrared laser ablation 
metastable induced 
chemical ionisation (IR-
LAMICI) 
IR-lasers ablate sample the plume is ionised 
by excited helium and nitrogen gas that 
flows to the MS inlet.  
[123] 
Laser ablation 
atmospheric pressure 
photoionisation (LAAPPI) 
IR laser ablates sample, the plume is caught 
by heated toluene from a nebuliser. At the 
intersect of plume and spray a UV lamp 
causes ionisation. 
[124] 
Laser assisted desorption 
electrospray ionisation 
(LADESI) 
Er:YAG IR laser desorbs the sampling the 
plume is caught and ionised using ESI. 
[103] 
Laser ablation 
electrospray ionisation 
(LAESI) 
Nd:YAG UV laser ablates the sample and 
the resulting plume is caught in the 
electrospray spray where the sample is 
ionised.  
[125] 
Laser desorption 
electrospray ionisation 
(LDESI) 
CO2 IR laser desorbs the sampling the 
plume is caught and ionised using ESI. 
Requires Aqueous based sample. 
[104] 
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Technique Brief Description First reported 
Laser desorption 
ionisation (LDI) 
CO2 or Nd:YAG lasers are used to desorbed 
the sample, tubing then transfers the ions 
from the sample to the instrument. 
[21] 
Laser induced acoustic 
desorption/atmospheric 
pressure chemical 
ionisation (LIAD/APCI) 
Laser is directed at the reverse side of 
aluminium foil containing the sample, 
causing desorption, desorbed species are 
ionised using chemical ionisation.  
[126] 
Laser induced acoustic 
desorption electrospray 
ionisation (LIAD-ESI) 
Laser desorbs sample from 
silica/aluminium foil substrate via 
vibrational energy. Desorbed species are 
then captured by the ESI spray. 
[100] 
Surface sealing sampling 
probe (SSSP) 
A sampling probe with blade around the 
tip. The probe makes contact with the 
sample forming a seal. Liquid is then 
dispensed into this sealed area and re-
aspirated to be ionised via ESI. 
[94] 
Low temperature plasma 
probe (LTP) 
Stable 30 ºC plasma discharge is focused 
onto a surface causing desorption and 
ionisation.  
[98] 
Laserspray ionisation (LSI) The spraying capillary is irradiated with an 
IR laser inducing ionisation. Later versions 
us a CO2 laser. 
[127] 
Matrix assisted laser 
desorption electrospray 
ionisation (MALDESI) 
Matrix is applied to a surface a laser induces 
desorption the ion plume is then picked up 
in an ESI spray.  
[105] 
Micro-fabricated glow 
discharge plasma 
(MFGDP) 
A glowing plasma discharge is produced at 
the end of a probe. Sample is introduced at 
close proximity to the probe and the MS 
inlet.  
[128] 
Neutral desorption 
extractive electrospray 
ionisation (ND-EESI) 
A nitrogen stream is directed onto a sample, 
the resulting aerosol is heated and combines 
with an ES for ionisation.  
[129] 
Plasma-assisted 
desorption ionisation 
(PADI) 
A low temperature plasma is desorbs and 
ionise a sample close to the mass 
spectrometry  
[96] 
Probe electrospray 
ionisation (PESI) 
A solid probe pricks the sample and then 
moved to point into the inlet, a voltage is 
then applied to the probe and ions are 
ejected. 
[130] 
Plasma assisted multi 
wavelength laser 
desorption ionisation 
(PAMLDI) 
PADI using a tuneable laser. [97] 
Paper spray ionisation 
(PSI) 
A liquid sample is dispensed onto paper, a 
voltage is applied to the paper and induces 
a ionising spray. 
[131] 
Radio-frequency acoustic 
desorption and ionisation 
(RADIO) 
Sample on a quartz crystal microbalance is 
subjected to and RF of 10.1Mhz. Plume is 
captured and directed into mass 
spectrometer by sprayed solvent stream. 
[99] 
Rapid evaporative 
ionisation mass 
A heated probe vaporises and ionises the 
sample. Ions transferred to mass 
[107] 
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Technique Brief Description First reported 
spectrometry (REIMS) spectrometer using nitrogen flow. 
Surface acoustic wave 
nebulization (SAWN) 
Acoustic wave propagates along the surface 
and into the sample nebulizing and ionising 
the sample. 
[132] 
Switched ferroelectric 
plasma ionizer (SwiFerr) 
A sample that is in aerosol form enters the 
ionisation chamber and passes over a 
ferroeletric material that emits plasma 
radiation.  
[106] 
Transmission mode DESI 
(TMDESI) 
A high velocity jet of electrospray solution 
is passed through a mesh holding the 
sample.  
[133] 
 
1.2.2.1 Ambient imaging techniques, 
Many of the techniques mentioned in the previous section have spatially 
localised sampling, making them suitable for imaging. The majority of these 
techniques are liquid micro-junction techniques and laser or plasma directed 
sampling such as DESI, LAESI or PESI. [134] To-date the resolution that is 
achievable via ambient imaging techniques does not yet match the subcellular 
resolution of vacuum-based techniques such as MALDI or SIMS. [60, 61, 135].  
Nano-DESI is a direct relative of LESA. This technique supports a droplet 
between a solvent delivery tube and an extraction tube, and this extraction tube 
is also the ESI capillary. Images of rat brain tissue were acquired in raster mode, 
with a y-axis resolution of 200um and an x-axis resolution of 20um. Images 
show lipids specific to different regions of the brain. [136]  
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1.3 Mass analysers 
There are a wide range of mass analysers, four are discussed here. A summary 
of the techniques are provided in Table 1-4 
Table 1-4: – Comparison between mass analysers, data taken from vendor websites[137, 138]  
Parameter Time of Flight (Synapt G2) 
Quadrupole 
(TSQ Vantage) Orbitrap Velos 
Mass 
resolution 
20,000 at m/z 
556 (in 
resolution 
mode) 
7,500 at m/z 
508 
100,000 at m/z 
400 
Mass Accuracy 
<1ppm using 
Lockmass 
between m/z 
150-800 
<5ppm 
between m/z 
168 -1224 
<3ppm external 
calibration, 
<1ppm internal 
calibration 
Mass range 
m/z 20-100,000 
(in resolution 
mode) 
m/z 10-1500 m/z 50-2000 or m/z 200-4000 
 
1.3.1. Time of Flight 
Time of flight instruments measure the time taken for an ion to travel from the 
source to the detector. Using known molecular mass standards the time of flight 
can be related to the m/z ratio of the ion.  
Packets of ions are accelerated using an electrical potential gradient. (Figure 7) 
Ions are held between potentials (1) which are both equal (i=ii), for the 
extraction and acceleration, a potential gradient is formed (i>ii) (2), the 
potential at (iii) is neutral and therefore the same as the detector, insuring no 
further acceleration occurs during the flight path. Differences in the energy of 
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the ions starting point will be counteracted by this method for acceleration. Ions 
closer to the ion gate receive a stronger acceleration force than those further 
away. [11] This ensures that ions of the same m/z arrive at the detector at the 
same time.  
 
Figure 7 (1) Ions are contained between he sample plate (i) and the first ion gate(ii). (2) Ions are 
extracted when a potential gradient is applied (i>ii). (3) Ions are accelerated, the 
third ion gate insure there is no potential gradient between the source and the 
detector. (iii=d) 
 
Ions of different mass to charge are separated because they have the same 
kinetic energy (KE) that they receive during acceleration (Vx). Therefore the 
velocity (v) of the ion is dependant on the mass (m) and charge (ze).  
Equation 1 !" = !"!2 = !"#! 
The velocity of an ion can be calculated by rearranging Equation 1. 
Equation 2 
! = (2!"!!! ) 
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Ions will travel at a constant velocity for the length of the flight tube (L) and 
therefore the time the ion detected (t) is dependent on the mass to charge (m/z) 
ratio of the ion.  A doubly charged ion will feel the accelerating force twice as 
strongly resulting in a velocity twice as fast, halving the time it would take a 
signally charged ion of the same mass to reach the detector.  
Equation 3 
!! = !! ( !!2!"!) 
The longer the flight path, the greater the separation in time, and the better the 
resolution. However the longer the flight path, the greater chance for ions to 
either be neutralised by hitting residual air molecules in the instrument or to be 
extracted by the vacuum pump this reduces the sensitivity of the approach. 
Longer flight paths also cause a broadening of the peaks caused by ions of the 
same m/z having subtlety different velocities. Even using pulsed extraction to 
accelerate the ions there can be subtle differences in the kinetic energy. The 
resolution can be improved by reflecting the ions using reflectrons, which 
reduces this variation. 
Ions entering the reflector of the same m/z but differing slightly in their 
velocities penetrate into the reflector to differing degrees (d). Therefore the path 
length that the ions take is proportional to the velocity of the incoming ion. The 
depth the ion penetrates into the reflector is dependant on the electrical field (E) 
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of the reflector, which is in turn calculated by depth of the reflector (D) and the 
electrical field (Vy). Therefore the depth an ion penetrates into a reflector is 
calculated using Equation 4 
Equation 4 ! = !"!" = !"!! !! ! = !!!!!  
This process refocuses ions so that they reach the detector at the same time. This 
narrows the peak width and improves the resolution. [11, 139] 
 
Figure 8: Reflectron are used to remove subtle difference in velocity between ions of the same 
mass. Two ions of the same m/z but have different energies (red and blue cross) (1) 
the higher energy red ion travels faster (2) the ion take different paths through the 
reflector, and ions refocus on the detector 
 
There are three configurations of time of flight instruments: 
• Linear: Straight line between source and detector (Figure 9 Green line) 
• V mode: there is a V shaped flight path using one reflector. (Figure 9 Red 
line) 
• W mode: there is a W shaped flight path using 3 reflectrons. (Figure 9 
Blue line) 
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Linear is the most sensitive but has the lowest mass resolution whereas W 
mode has the highest mass resolution but the lowest sensitivity. 
 
Figure 9: Schematic of the time of flight mass spectrometry illustrating 3 modes of use. Linear 
(green) detected at detector A. V mode (red) and W mode (blue) detected at 
detector B.  
 
1.3.2. Quadrupole 
The quadrupole is a mass filter as a low mass resolution mass analyser. 
Quadrupole mass analysers comprise four parallel rods to which oscillating 
electrical potentials are applied. Only ions that have stable trajectories are able 
to pass through the device; others are ejected out of the path (Figure 10). The 
arrangement is such that adjacent rods have opposite polarities. When ions pass 
through the quadrupole in each plane (vertical and horizontal) ions go through 
a cycle of focusing (when polarity is the same as charged particles) and 
defocusing (when the polarity is opposite to the charged particles). [11, 140, 
141] 
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Figure 10: Schematic of a quadrupole, illustrating the ion path of a stable ion (blue) and an 
unstable ion (red) 
 
In a single plane this causes ions to oscillate between the two poles; however, 
with two planes the motion is spiral. For any single ion there is a range of 
combinations of direct voltages and r.f voltages that can be used to stabilise the 
ions passage through the quadruple. To calculate the trajectory of an ion in a 
quadrupole, it is necessary to solve the following differential equations 
(Equation 5, Equation 6 and Equation 7) that relate to the x, y, and z planes of 
the quadrupole. [141] 
Equation 5: x-plane !!!!!! + 2!"#!"!! ! + !"#$ !" = 0 
Equation 6: y-plane !!!!!! − 2!"#!"!! ! + !"!" !" = 0 
Equation 7: z-plane !!!!!! = 0 
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Where V is the magnitude of the ac (RF waveform), U is the magnitude of the 
applied dc potential, t is time, r is the distance from the z axis to the surface of 
any electrode, ω is the angular frequency m is the mass of the ion and e is the 
charge. The solution can be represented an a-q stability diagram (Figure 11) 
where, 
Equation 8 ! = 8!"#!!!!! 
Equation 9 ! = 4!"#!!!!! 
It is these equations that dictate the mass resolution and sensitivity of the 
instrument. The dc and ac potentials are applied to the quadrupole that satisfy 
these equations for each point along the scan line. Effective transmission of an 
ion of particular m/z only occurs when the stability diagram and the scan line 
intersect. Each mass to charge ratio has a similar stability diagram the peak of 
larger m/z has a higher ‘a’ and q value. Reducing the gradient of the scan line 
increases sensitivity but reduces mass resolution. [140, 141] 
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Figure 11: Graphical representation of the stability of an m/z ion in a quadruple. Figure taken 
from Miller et al (1986) [141] 
 
The advantages of quadrupoles; 
• Do not require a high vacuum, and therefore it is not necessary to have 
expensive turbo vacuum pumps. 
• Can be used for transferring ions from atmospheric and ambient ion 
sources. 
• Can be used to isolate one or more ions 
•  Only detects the target ion(s) by jumping through the frequencies.  
Hexapoles are used in the Synapt G2-S (see section 1.6.2) and work on a similar 
principle to quadrupoles, however hexapoles have six parallel bars arranged in 
a hexagon pattern. Hexapoles are used to transport ions rather than analyse 
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them as they have a wider m/z transmission range and a lower focusing power. 
[11]  
1.3.3. Linear ion trap 
The linear ion trap (LIT) is similar to the quadrupole in that it comprises 4 
parallel rods. The difference is that instead of the ions passing through the 
device, the ions are trapped within the device by ion lenses at either end to 
repel the ions back into the mass analyser. Using the same principles as 
quadrupoles, instead of stabilising a narrow range of m/z values, a much wider 
range of m/z are stable in the ion trap. This is achived by using a and q values in 
Figure 11 that would be more central in the stable region (greyed area) which 
overlap with the stability diagrams of other m/z. To detect and differentiate 
between ions of different m/z, the r.f values and direct voltages are scanned 
such that ions are destabilised sequentially. Ions can be ejected either axially or 
radially towards the detector. For radial ejection slits in the quadrupoles allow 
unperturbed transmission. LIT are also used as collision cells: a narrow range of 
m/z are selected and held in the LIT, the ions are then collided with a neutral 
gas causing the ions to fragment (see Section 1.5.1 for more information on CID). 
[11, 142] 
1.3.4. Orbitrap 
In an Orbitrap mass analyser ions rotate around a central barrel-shaped 
electrode. Ions rotate around this electrode in a radial direction (r) and travel 
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along the electrode transverse direction (q). The potential energy (U) of this 
field can be expressed using Equation 10. [143, 144] 
Equation 10 
! !, ! =  !2 !! − !!2 + !2×(!!)!× ln !!! + ! 
Where (r,q) are the cylindrical co-ordinates, k is the field curvature Rm is the 
radius and C is a constant. It is important to note there is no cross terms with r 
and z so these species are independent of each other. The motion of ions in 
transverse direction is calculated in radians per second and is dependant on the 
energy characteristics of the transverse direction (Eq), the mass (m) and the 
charge (z) of the ion and can be calculated using Equation 11 and Equation 12. 
Equation 11 
! ! = !! cos !" + 2!!! sin (!") 
where 
Equation 12 ! = (!/!)! 
The motion of ions is determined by the mass to charge ratio and ions of similar 
m/z form a packet of ions. When these ions pass the detector they induce a 
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current. The amplitude of this current is representative to the number of ions in 
the packet.  
By using the transverse motion rather than the radial motion ions stay in a 
tighter packet for longer increasing the spectral resolution. (Figure 12). [143-
145] 
 
Figure 12: A) Obitrap mass analyser with the motion of ions idecated by the red line. Blue lines 
indicate Transverse and radial motion of ions. B and C) packets of ions (red green 
and blue crosses) degrading radially observed from the radial and transvers views.  
 
Ion packets are measured multiple times as they pass the detector resulting in a 
time domain spectrum in which the waveform is comprised of the interfering 
frequencies for each m/z.  The time domain spectrum can be converted to a 
frequency domain spectrum by means of Fourier transform. Subsequent 
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calibration of frequency for m/z results in a mass spectrum. If multiple ions are 
present the rate at which they rotate around the central electrode differs, 
inducing a detector response at different frequencies that when processed via 
Fourier transform, result in specific mass to charge ratios. In ion traps the 
direction of the motion that is detected is axial motion, i.e., the motion that 
rotate around control electrode. Developments of the ion trap reported by Alex 
Makarov, show that packets of ions of the same mass dissociate from each other 
axially very quickly, quicker than the decay of signal due to loss of ions and this 
limits the resolution that can be achieved with an ion-trap. Makarov goes on to 
show that packets of ions dissociate more slowly in the transverse direction and 
therefore significantly improve the resolution and sensitivity of the Orbitrap 
from other ion trap instruments. [144]  
1.4 Separation techniques 
Separation is used to enhance the quality of spectra and to reveal additional 
species and may be performed in the solution-phase or the gas-phase. Three 
separation techniques are used in this research, liquid chromatography (LC) 
and two forms of ion mobility. Ion mobility separation is a gas phase separation 
technique that there are several forms, two that will be discussed in this thesis 
are traveling wave ion mobility spectrometry (TWIMS)) and ultra-high field 
asymmetric ion mobility spectrometry (ultra-FAIMS).  
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1.4.1. Liquid Chromatography 
Liquid chromatography is used to separate molecules on the interface of a 
stationary and mobile phase. The stationary phase is functionalised silica, 
typically with a C18 chain, that is packed into a column [146]. Variations in the 
carbon chain are used to target different molecules. Shorter chains such as C4 
columns are used for intact proteins [147] and C30 columns used for small 
molecules. [148] The mobile phase is the solvent that carries the sample through 
the column. There are two forms: normal and reversed phase. Normal phase 
chromatography was developed first and comprises of a polar stationary phase 
and a non-polar mobile phase [149]. Reversed phase was developed second and 
uses a non-polar stationary phase and a polar mobile phase [150]. Proteomics 
typically uses reversed phase liquid chromatography because peptides have 
little affinity to a polar stationary phase, and peptides will not be retained or 
separated, in reverse phase the peptides have an affinity to the column enabling 
them to be separated. Occasionally normal phase chromatography is used for 
proteins because of the functionalised groups that they contain or if they are 
rich in hydrophilic amino acids, for this hydrophilic interaction liquid 
chromatography (HILIC) columns are used. [151]  
Separation of proteins and peptides by LC occurs because of the affinity of the 
molecule to both the stationary and mobile phases. As the molecules travels 
through the column, an equilibrium is formed between the molecules on the 
stationary phase and the molecules in the mobile phase (Figure 13). As the 
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mobile phase is constantly moving the equilibrium is never reached causing the 
molecules to progress down the column. The composition of the mobile phase 
is often changed through the run to encourage slow moving analytes to elute 
from the column. [152] 
 
Figure 13: A) Molecules (blue crosses) have a strong affinity to the stationary phase resulting in 
a slow progression down the column. B) Molecules have an equal affinity to both 
the stationary and mobile phase. C) Molecules have a strong affinity to the mobile 
phase resulting in a fast elution.  
 
The number of theoretical plates measures the efficiency of a column. The 
greater the number of theoretical plates, the greater the resolution. The number 
of theoretical plates can be calculated using Equation 13 
Equation 13  !"#$%& !" !"#$%& = 1!"#$% ℎ!"#ℎ!  × !"#$%& !"#$%ℎ 
 
 
To increase the number of plates either the column must be made longer or the 
plate height needs to be reduced. Increasing the pressure of the system can 
decrease the plate height, this is the strategy for high pressure and ultra-high 
pressure chromatography. [151] An alternative method for improving the 
separation is to conduct 2-dimentional liquid chromatography. Where LC is 
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conducted fractions of the eluent collected, then each fraction is run on an LC-
MS/MS system for identification. This is particularly useful for extremely 
complex samples where the LC-MS/MS cannot identify peptides at a suitable 
rate for the identification of all detectable proteins in the sample. [153] When 
liquid chromatography is coupled to mass spectrometry by electrospray 
ionisation. The eluent of the LC from low flow rate systems can be directly 
coupled to the mass spectrometer, otherwise a splitter is used to redirect some 
of the sample to prevent the overloading the mass spectrometer.[154, 155] 
1.4.2. Traveling wave ion mobility spectrometry 
Traveling wave ion mobility spectrometry (TWIMS) separates ions based on the 
collisional cross section. [156, 157] Electrical potential waves are created by 
sequentially pulsing ring electrodes down a drift tube as a pulse occurs ions 
move down the potential gradient. (Figure 14 A) The expression that describes 
the effective potential generated (V*), is; 
Equation 14 
!∗ !, ! = !!"# [!!! !, ! !"#! !, ! + !!! !, ! !"#! !, ! ]!!!(!, !)  
Where r and z describe the radial and axial co-ordinates, δ is the spacing 
between electrode. I0 and I1 are the zero and first order modified Bessel 
functions. Vmax is;  
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Equation 15 
!!"# = !"!"!4!"!!! 
Where q is the charge of the molecule and m is the mass; VRF is half the applied 
peak-to-peak voltage and  ω is the angular frequency.[157, 158] 
The wave is not completely efficient at driving the ions forward and 
occasionally an ion tumbles backwards rather than forward. The larger the ions 
the more likely this is to occur. This is because there is a relatively high pressure 
in the drift tube and larger molecules are more likely to collide with the gas 
molecules and tumble to the following wave. There is a direct relationship 
between the size of the ions and the rate in which they pass through the 
mobility chamber; this makes it possible to calculate the collisional cross section 
of a molecule. [159, 160]  
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Figure 14: A) representation of TWIMS waves and the motion of an ion being affected by the 
wave.  From Giles et al. 2004, [157], B) representation of sequentially pulsed ring 
electrodes that results in a wave. Black solid rings are the on with a high potential, 
grey dashed rings are in resting state with low potential.  
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1.4.3. Ultra-high field asymmetric ion mobility spectrometry 
 
Figure 15: Top: Schematic of the dispersion field RF frequency showing an asymmetric 
waveform where the positive and negative parts would sum to zero. Bottom: 
Schematic of the drift of three theoretical ions using the dispersion field.  
 
FAIMS separates ions on the basis of differences in their mobility in high and 
low electric fields. To disperse the ions a voltage is applied via a RF waveform. 
This attracts ions strongly to one plate for a short period of time and then the 
polarity switches and weakly attracts ions to the other plate for a longer period 
of time (Figure 15). The length of time each voltage is applied is such that the 
net field over one wave period is zero. If the mobilities in high and low electric 
field were equal, the displacement of an ion from its original trajectory is zero; 
however, this is not the case, a theory is that ions will change conformation in 
the high and low fields and therefore the mobility in each condition are 
different and as a result ions will drift away from their linear path.  
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The addition of a direct voltage (compensation voltage generating 
compensation field CF) between the two plates compensates for this drift. The 
compensation field (CF) is changed to allow specific ions to traverse the device. 
Until recently it has been believed that there is a limit to the resolving power 
(R). Exposing ions to the FAIMS field for longer is beneficial to a point. The 
relationship is proportional on the square root of time (t) the ions are subjected 
to the FAIMS field, therefore as time is extended the advantages gained get 
proportionally smaller. In addition FAIMS occurs in atmospheric conditions 
and therefore the longer ions are in the FAIMS device the weaker the ion signal 
will become. [161]  
Equation 16 ! ∝ ! 
Other factors that contribute to the resolution include the mobility (K0) of a 
particular ion at a standard gas density (N0), as this will affect the length of time 
an ion takes to pass through the drift tube. Another factor is the anisotropic 
diffusion (DΠ) that causes peaks to broaden over a time period. The final factor 
affecting the resolution is the compensation field (EC). 
Equation 17 
! = !!!!!!4! !!!!"2 
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A recent development in FAIMS has reduced the path length that is required 
for the separation to occur. Shvartsburg et al. describe that increasing the E/N 
term in Equation 17, (by increasing the dispersion field) increases the resolution 
of FAIMS. Increasing the field strength was shown to have an additional benefit, 
as the resolution is less dependent on the mobility of an ion. [162] A chip based 
FAIMS device was developed by Owlstone Ltd. [161] , where the path length 
was only 700 µm, and there was not just one channel where a field is applied 
but many arranged in stacks along a chip (Figure 16A). In Figure 16 (B-D) the 
FAIMS chip is mounted into an adapted cone for the ESI inlet. 
 
Figure 16: A) Photograph of the ultraFAIMS chip in the holder. B) Photograph of half of the 
ultraFAIMS cone, with the chip and electrodes visible C) Photograph of both 
halves of the ultraFAIMS cone not connected D) Photograph of the whole 
ultraFAIMS cone ready to be connected to the ESI inlet. 
 
The first demonstration of the FAIMS chip was not in conjunction with mass 
spectrometry. The power of this technique was demonstrated with three ions 
that were known to have the same mobility with tradition FAIMS devices that 
operated at lower field strengths. At higher field strengths these three ions can 
be isolated using different compensation fields. [161]  
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A report published by the same group was the first to report the coupling of the 
FAIMS to a mass spectrometry. Analysis of leucine mixed with lab wastewater 
containing amino acids and peptide digests demonstrated the potential for this 
analysis. Leucine was separated from the near by peaks by tuning the 
dispersion field and the compensation field. [163] It should be noted that the 
units for the field strength in the ultraFAIMS is Townsends (Td). This is the 
ratio between the electric field and the gas number that was increased when 
developing the ultraFAIMS (Equation 18). 
Equation 18 
Td=
!! = Vm-1m-3 =  Vm2 
Analysis of a standard peptide mix containing 5 peptides by Brown et al 
demonstrated that the ultraFAIMS device could separate peptides of the same 
m/z. [163] In a subsequent analysis singly and doubly charged peptides from a 
tryptic digest of alpha-1-acid-glycoprotein were separated using the 
ultraFAIMS. MS/MS analysis was conducted on the peptides demonstrating 
that this technique can be used for identification of small molecules. [163] Other 
work by the same group has looked at two isobaric species, polyethylene glycol 
(PEG) and 2-hydroxy-4-octyloxybenzophenone (HOBP). The ultraFAIMS 
separated these two compounds at different CV values. CID was also 
conducted on HOBP showing that there was a significant improvement in the 
MS/MS spectral quality when HOBP was isolated from PEG. [164] 
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In addition FAIMS coupled to in-source CID-MS was shown to improve the 
MS/MS spectra of HOBP due to the isolation of HOBP from PEG. [164]  
1.5 Tandem mass spectrometry 
Tandem mass spectrometry (MS/MS) enables structural characterisation of 
selected precursor ions. By fragmenting an intact ion it is possible to elucidate a 
structure, based on predictable bond cleavages. 
Glycerol based lipids, such as triglycerides and phospholipids (see section 1.7.1) 
break along the glycerol and for phospholipids the phosphate group also 
cleaves (Figure 17). In addition lipids analysed from tissue often form salt 
adducts with the naturally occurring sodium and potassium, which readily 
dissociate upon fragmentation. 
 
Figure 17: Phosphatidylcholine lipid. Where R1 and R2 represent an acyl chain. Red markers 
indicate common positions for fragmentation to occur 
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In contrast fragmentation of proteins typically occurs along the peptide 
backbone. (Figure 18) The fragments observed depend on the technique for 
fragmentation. CID and HCD fragmentation produces the b/y pair of product 
ions and an occasional a ion is also formed. With ETD fragmentation c/z pairs 
are produced and occasionally a,b or y ions  
 
Figure 18: four amino acid long peptide, showing possible fragmentation. The letter indicates 
which bond is broken, and the number the number of residues along the chain the 
fragmentation has occurred. The b1 ion is not labled because it cannot be formed. 
  
Three different fragmentation methods are used in this research: collision 
induced dissociation (CID), higher energy collision dissociation (HCD) and 
electron transfer dissociation. (ETD).  
The fragments observed are also dependant on the mass spectrometry used. If 
the fragmentation occurs in an ion trap then only ions down to 1/3rd of the 
mass of the precursor is stabled prior to mass analysis. However, if the 
fragmentation occurs in an quadrupole the full range if product ions can be 
detected. [165, 166] 
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1.5.1. Collision induced dissociation 
Collision induced dissociation (CID) involves the inelastic collision of an ion 
(mp+) with an inert neutral molecule (N) such as nitrogen gas. The kinetic 
energy of the neutral molecules is converted into internal energy of the 
precursor ion, a uni-molecular degradation follows forming a fragment ion 
(mf+) and a neutral loss molecule (mn). [11, 167] 
!!! + ! →  !!!∗ → !!! +!! 
It is not necessarily a single collision event that occurs with CID. Multiple 
collisions with the inert neutral molecules may be necessary for the precursor 
ion to be activated sufficiently for fragmentation to occur 
!!! + ! →  !!!∗ + ! → !!!∗∗ + ! → !!!∗∗∗  → !!! +!! 
Alternatively multiple fragmentation events may occur 
!!! + ! →  !!!∗ → !!!! +!! + ! →  !!!!∗ → !!!! +!! 
1.5.2. High energy collision induced dissociation 
HCD is the same principle as CID, the difference is that in CID ions held with a 
kinetic energy between 1-100 eV where as HCD the kinetic energy is several 
keV. [167] The larger kinetic energy involved means that there is more kinetic 
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energy to be transferred to internal energy, the internal energy for CID exhibits 
as rotational or vibrational where as for HCD it is electronic excitation. Ions 
with high internal energy give rise to fragmentation of stronger bonds, peptide 
side chains and fatty acid back bone fragments. [168] A reports suggest that 
HCD improves the fragmentation efficacy of peptides resulting in a higher 
score for identification. [169]  
1.5.3. Electron transfer dissociation 
ETD uses radical anions such as floranthene (C16H10·) to transfer electrons to 
cations. The resulting ion becomes excited with the addition of an electron, this 
causes an electron cascade and the formation of c and z ions in peptides see 
Figure 19. 
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Figure 19: Formation of c and z ions via eletron transfer dissociation from a 6+ ion. 
 
 It is important to note that this method will only work with multiply charged 
ion. [170] Occasionally fragmentation does not occur and a charge-reduced 
species is detected, this is the precursor ion in a lower charge state than was 
initially selected.  
1.6 Specific instrument set ups 
The work presented has been conducted on three instruments, a Thermo 
Orbitrap Velos ETD, a Waters Synapt G2S, and a Thermo TSQ Vantage triple 
quadrupole The Orbitrap and triple quadrupole have a ESI source only and can 
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becoupled to the LESA platform or to liquid chromatography. The Synapt has 
been used with the Advion Triversa to allow LESA sampling and nano-ESI, and 
the MALDI source. 
1.6.1. The Orbitrap Velos 
The Orbitrap Velos ETD has two mass analysers and is capable of three 
fragmentation methods. A series of ion optics including a s-lens, a quadrupole 
and octopole transmit ions down from atmospheric pressure to a high vacuum 
and also as remove neutral molecules and solvent droplets. For MS analysis via 
Oribtrap, the ions are transmitted through the linear ion trap to the C-Trap 
where they accumulate prior to being injected into the Orbitrap. For MS/MS 
analysis the route of the transmitted ions differs for each fragmentation method. 
All MS/MS methods use the linear ion trap to isolate ions of a specific m/z; 
For CID the ions are held in the LIT where they are bombarded with nitrogen. 
The product ions are then injected into the Orbitrap. Because the fragmentation 
occurs in the LIT product ions that are less than 1/3 of the precursor m/z are lost. 
For HCD the ions are transferred to the HCD collision cell, where they are 
fragmented using nitrogen. The product ions are then directed into the Orbitrap. 
This means that there are no restrictions on the lower m/z range enabling all 
ions to be detected. For ETD ions are held in the LIT and anions generated 
using the reagent ion source are injected causing fragmentation. Product ions 
are then analysed in the Orbitrap. 
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The Orbitrap can be operated in data-dependent mode. In this work a ‘top 7’ 
method was used: The method comprises a full scan survey spectrum is 
acquired followed by seven MS/MS events. The full scan spectra are acquired 
in the Orbitrap. Based on the survey spectrum, the seven most abundant 
precursor ions are sequentially isolated and fragmented in the ion trap. Product 
ions are detected in the Orbitrap. In this work CID induced fragmentation was 
used, however fragmentation via HCD and ETD are also possible with the 
instrumental set up. This configuration is used because it is fast and suitable for 
coupling with LC separation. The sample input is continuously changing 
therefore it is essential to increase the number of MS/MS events to maximise 
the number of identifications. Compared to direct infusion where the sample 
composition is constant and where more time can be taken for the MS/MS 
events. 
 
Figure 20: Schematic of an LTQ Orbitrap Velos ETD [171] 
 
55 
1.6.2. The Synapt G2-S 
In this work the Synapt has been used with both the ESI source and MALDI 
source. Figure 21 below shows the ESI source. The MALDI source is positioned 
inline with the first ion gate prior to the step wave. A hexapole is used to 
transfer ions from the source to the ion gate. The StepWave ion guide is a filter 
to remove neutral molecules by changing the direction of the flow of ions. A 
quadrupole is used to transfer ions as well as isolate ions prior to the Triwave 
device. The Triwave comprises three travelling wave ion guides (TWIGs). The 
central TWIG is the ion mobility cell for TWIMS. A trapping cell is used to hold 
ions before pulsing the ions through the drift tube. The drift tube contains 
helium, to aid in the separation of molecules. The transfer tube extracts ions 
that have passed through the drift tube in packets for the time of flight mass 
analyser. Both the trapping and transfer cells can be used for CID. This allows 
investigations of the drift of fragments as well as the fragmentation of 
molecules with a specific drift time.  
 
Figure 21: Schematic of an Synapt G2-S [172] 
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1.6.3. TSQ Vantage Triple Quadrupole. 
The TSQ triple quadrupole (QqQ) is an instrument comprises of three 
quadrupoles. The first and the third are used as mass analysers whereas the 
second quadrupole is used as a transfer quadrupole and for fragmentation 
where necessary. In this thesis this instrument is has been used as mass 
analyser for full scan spectra. 
 
Figure 22: Schematic of an TSQ Vantage Triple Quadrupole [173] 
 
1.7 The Human Liver 
The liver is an organ that is fed by the hepatic vein and the portal artery. The 
hepatic vein carries blood that has picked up nutrients from the gut, and the 
portal artery is blood from the heart that is oxygen rich. Visually the liver is a 
relatively homogeneous, with arteries and veins for blood flow and the removal 
of bile. The main function of the liver is for metabolic reactions. This includes 
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the formation of enzymes and metabolites and the removal of toxins. In 
addition the liver also stores nutrients to ensure that the blood content remains 
stable. This means that diseases of the liver are often serious and can lead to 
fatalities as the whole body is affected. 
One such disease is non-alcoholic steatohepatitis (NASH). NASH is an 
inflammatory condition of the liver that mimics the damage caused by alcohol 
without the consumption of large quantities of alcohol. Causes of the disease 
are not yet fully understood however both genetic predisposition and lifestyle 
choices are important [174].  
The diseases progresses via fatty liver diseases that causes fibrosis, a localised 
reduction in cell function caused by the build up of collagen. If fibrosis is 
allowed to continue, cirrhosis develops. Cirrhosis is scaring of the liver that 
destroys the cellular structure causing cell death and ultimately liver failure. 
[175].  
Serum biomarkers such as elevated amino transferases and a 
glutamyltransferase, are found in patients with NASH; however, these 
biomarkers are not specific to NASH. Furthermore, due to natural variation 
defining elevated levels of any protein or biomarker can be difficult. Initial 
reports suggest that the liver fatty acid binding protein (FABP1) [175-178] may 
be a suitable biomarker. The FABP1 comes from a family of fatty acid binding 
proteins that have three broad functions; 
58 
• Regulates specific enzymes of lipid metabolism 
• Maintains the fatty acid levels in cellular membranes 
• Regulates the expression of fatty acid-responsive genes 
The FABP1 protein, like all FABPs, primarily binds to unsaturated and singly 
saturated fatty acids but is also capable of binding to other hydrophobic ligands 
such as heme. [179, 180] 
Recent work by Peng et. al [181] has shown that two single nucleotide 
polymorphisms in the FABP1 gene are associated with increased risk of 
developing non-alcoholic fatty liver disease. The first results in substitution of 
threonine for alanine at position 94 in FABP1, while the second is intrinsic. 
Increased risk of disease is linked to the two single nucleotide polymorphisms 
both individually and cumulatively, however the mechanisms by which these 
polymorphisms contribute to the disease process are unknown.  
Potential biomarkers can present themselves in various forms. Here, lipids and 
proteins are investigated by mass spectrometry. 
1.7.1. Lipids 
Lipids are a class of small molecules that are not water-soluble, but instead are 
soluble in organic solvents. Lipids have a wide range of functions, these include 
• Energy storage know as dietary fats,  
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• Cell structure, particularly the cell membranes 
• Cell signalling. 
There are eight subclasses of lipids, [182] 
• Fatty acyls: hydrocarbon chain with an acyl group. 
o Used to functionalise proteins. [183] 
o Broken down during respiration. [184] 
• Glycerolipids: Glycerol molecule with up to 3 fatty acids bonded to the 
hydroxyl groups 
o Used as fat storage. [185] 
o Cell signalling. [186] 
• Glycerophospholipids: Glycerol molecule with a terminal hydroxyl 
group substituted for a phosphate group, with either one or two fatty 
acids on the remaining hydroxyl groups.  
o Used for to form cell membranes as they have hydrophobic and 
hydrophilic regions enabling them to self assemble into bilayers. 
[187] 
• Polyketides: large cyclic molecules which large variety of 
functionalization.  
o Often have antibiotic and antifungal qualities. [188] 
• Prenol Lipids: highly functionalised phenol molecules that is capable of 
polymerising. 
o Foundations of vitamins A, E and K. [189] 
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• Saccharolipids: sugar back bone with fatty acids functionalising the 
hydroxyl groups 
o Can form lipopolysaccharides chains found in gram negative 
bacteria, used for cell identification and communication [190] 
• Sphingolipids: acyl chain with an amide and two alcohol groups, often 
found with substitutions of the amide and alcohol groups.  
o Used for cell recognition and signalling in mammalian cells [186] 
• Sterol lipids: multi cyclic structures with typically a mix of cyclohexane 
and cyclopentane with a large verity of functional groups. 
o Used for cell signalling, specifically in the form of steroids to 
promote cell growth. [191] 
Mass spectrometry is used to detect these species. Lipids typically have a mass 
between 220-1000Da, although some lipids are observed at higher masses. 
They are also usually observed as a singly charged ion. A number of 
approaches have been used to identify lipids from complex samples.  
1.7.1.1 Analysis of lipids via mass spectrometry 
MALDI mass spectrometry has identified lipids from a number of complex 
surfaces. These include plant and animal tissue. [52, 192] 
In positive mode analysis the predominant species that have been detected is 
phosphatide choline. Other species have been detected using targeted 
approaches. Precurse ion scans enable the isolation of types of precursor ions 
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that produce a specific fragment and using optimised solvent extraction enables 
less detectable lipids to be identified including cholesterol esters, wax esters 
and ceramides. [87, 193] 
Another method used to detect lipids is ESI. ESI requires a liquid sample, liquid 
extraction surface analysis is a new method that links a solid sample with ESI.  
Electrospray analysis of lipids is common. A larger proportion of analysis is 
conducted on pre-prepared samples such that lipids are isolated and purified 
prior to analysis. A growing number of samples are now being analysed from 
the surface using techniques such as LESA. 
LESA has been used to analyse lipids from a number complex samples, 
including a used contact lens, [193] a single living murine cell, [87] and 
atherosclerotic plaques [79]. In these examples a solvent composition of 1/2/4 
chloroform:methanol:isopropyl alcohol with an ammonium acetate modifier 
was used (7.5 mM for atherosclerotic plaques and 20 mM for the contact lens 
and murine cell) with analysis being conducted on either a QqQ or a QTrap. 
The most wide spread detected lipids were phosphatidylcholines, 
sphingomyelin lipids and cholesterol esters with ceramide wax esters and 
phosphatidylethanolamines also being detected depending on sample type.  
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1.7.2. Proteins 
Proteins are long chains of amino acids that are able to self assemble into a wide 
range of structures. There are 4 levels of structure to a protein. The first level is 
the amino acid sequence, the second is simple folding to form beta-pleated 
sheets and alpha helices, the third level is the arrangement of the beta-pleated 
sheets and alpha helices into a 3D conformation, and the fourth level is when 2 
or more polypeptide chains come together to form a complex. The function of 
proteins is related to their structure.  
Mass spectrometry is primarily used to identify the primary structure of a 
protein. Recent developments in analysis are allowing the analysis of native 
state proteins, providing insights to higher levels of structure. [194] In this 
report only the amino acid sequence is investigated.  
1.7.2.1 Analysis of peptides and proteins 
Proteins provide a wealth of information about health and disease. Since the 
invention of matrix-assisted laser desorption/ionisation[16, 195] and 
electrospray ionisation it has been possible to analyse proteins by mass 
spectrometry. With the ability to detect proteins it becomes necessary to 
identify the proteins detected. Two methods of identification are top-down and 
bottom-up.  
Top-down describes the process of ionising the intact protein and then 
fragmenting the protein. The protein can be identified because the majority of 
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the product ions contain either the N-terminus or the C-terminus making it 
possible to search the measured m/z of the fragments against theoretical m/z of 
those from a proposed protein. This approach only works if there are proteins 
with which to compare the results. Generally, this means the genome has been 
sequenced. The measured masses are searched against protein databases using 
algorithms such as Prosight PTM, [196] and the output is a list of possible 
identifications. In some cases fragments between most or all the amino acid are 
observed, in theses cases it would be possible to construct the amino acid 
sequence using the mass difference between the fragments. 
Top-down is the fragmentation of the protein backbone. Fragmentation 
produces two complementary ion pairs of the c-terminal and n-terminal ends of 
the amino acid sequence. The fragmentation can be induced in predictable ways, 
for example, collision induced dissociation (CID) produces primarily b/y ions, 
which is the breaking of the carbon-nitrogen bond between the carbonyl and 
the amide groups on the backbone, where as electron transfer dissociation 
(ETD) is likely to produce c/z ions which is the breaking of the carbon-nitrogen 
bond between the amide and the carbon attached to the side chain.  
Identification of proteins using the top-down method relies either on a database 
of proteins such as, Prosight PTM 2.0, where fragmentation data can be 
imported, or for smaller and simpler proteins where there is a detected ion from 
each amino acid cleavage, build the amino acid sequence from sequential amino 
acids linkages. The former method often needs confirming by using a fragment 
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calculator such as Protein Prospector to improve sequence coverage. The later 
relies on efficient fragmentation between every amino acid in the sequence. 
Using top-down methods post translation modifications (PTM’s), and variant 
amino acid sequences can be discovered and identified. Up until recently it has 
been necessary to purify the protein prior to analysis. 
Detections of proteins via LESA mass spectrometry was first demonstrated by 
Edwards et al [83]. Analysis of haemoglobin and haemoglobin variants from 
dried blood spots demonstrated that LESA mass spectrometry was suitable for 
the top-down analysis of proteins. Later this was used to diagnosis unknown 
haemoglobin variants [84] (~15 kDa) in neonatal samples. A number of other 
neonatal blood disorders have also been analysed and diagnosed giving this the 
potential to be used in the clinic to screen for neonatal blood disorders. [197] 
A continuous flow version of the LESA technology has been applied to the 
analysis of haemoglobin in dried blood spots from sheep. [198] LESA has also 
been applied to E.coli bacterial colonies, where 6 proteins (7kDa-15kDa) were 
identified. Here the LESA sampling was conducted by lowering the pipette tip 
into the colony rather than suspending the droplet on the surface. [86] Manual 
LESA was applied to sampling of intact proteins from thin tissue sections of 
bovine lens, and murine brain and kidney [199]. Proteins were extracted by 
LESA and then subjected to LC electron transfer dissociation MS/MS. Analysis 
of the lens samples resulted in the identification of a number of crystalline 
proteins (~21 kDa). Ten proteins (5-22 kDa) were identified from the brain 
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samples, and five (5-17 kDa) were identified in the kidney samples. It should be 
noted that the number of information-rich ETD MS/MS spectra was much 
greater than the number of identified proteins. This discrepancy reflect the 
difficulty in identify proteins on a large scale with top-down proteomics. The 
software often lacks the specificity and accuracy required to identify proteins. 
Despite these draw backs top-down is a growing field because analysis of intact 
proteins maintain post-translational modification,  
Bottom-up proteomics is a technique that requires a proteolytic digestion step. 
This breaks the protein into smaller peptides. Most digestion enzymes cut the 
amino acid chain at specific amino acids. In this report trypsin is used as the 
digestion enzyme. Trypsin cleaves at the C- terminal side of lysine or arginine 
except when proline is the subsequent amino acid. [200] The peptides that are 
produced are often separated via liquid chromatography and the peptides 
detected using mass spectrometry. This requirement is due to the fact that a 
larger number of peptides can be produced from a relatively small number of 
proteins and adding a separation step prior to mass spectrometry analysis 
enables more peptides to be identified adding more confidence to the 
identifications. Peptides are identified using fragmentation methods and then a 
data base search is conducted on these fragments to identify possible proteins 
that they originated from. 
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In order for LESA to be coupled with bottom-up proteomics, a proteolytic 
digestion step needs to be introduced into the workflow. There are two 
approaches; 
• Intact proteins are extracted by LESA prior to digestion. [85] 
• An in-situ digestion is performed prior to liquid micro-junction 
extraction [201, 202].  
The first approach has been applied to the analysis of dried blood spots, 
identifying over 100 proteins. The Advion Triversa Nanomate was used to 
extract the intact proteins via LESA and the solution was then deposited into a 
well of a 96-microtitre plate where the Triversa Nanomate proceeded to 
conduct an automated digestion procedure.  
There are currently no automated processes for the digestion and extraction of 
peptides in the second approach. This is because a key issue is to prevent the 
evaporation of the trypsin solution. In-situ digestion was demonstrated for 
protein arrays (cytochrome C, myoglobin and bovine serum albumin) printed 
on a biomaterial substrate commonly used for cell culture [203]. Trypsin was 
deposited onto the protein spots and the array was transferred to a humidity 
chamber and incubated for 18 hours. The array was then analysed by LESA and 
data-dependent MS/MS. Quanico et al. [201] applied the in-situ digestion 
approach to the analysis of thin tissue sections from frozen rat brain. Trypsin 
solution was repeatedly deposited on the tissue surface throughout the 
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incubation period (1 hour). The resulting peptides were extracted via liquid 
microjunction sampling. Five extracts were pooled and analysed by LC MS/MS. 
This approach enabled the identification of ~1500 proteins per sample. The 
approach was subsequently applied to formalin fixed and paraffin embedded 
tissue sections from fallopian tube cancer biopsies [202]. 
1.8 Work Presented 
In this thesis the LESA has been coupled to a LTQ Orbitrap Velos ETD 
(Thermo), a TSQ Vantage (Thermo) and a Synapt G2-S (Waters). In chapter 3, 
LESA sampling protocol to target lipids and proteins from human liver tissue 
has been investigated and the limitations of LESA spatial profiling have been 
explored. In chapter 4, analysis of proteins is taken further and in-situ proteins 
are extracted and identified using top-down and bottom up methods. Four 
intact proteins between 10,000 Da and 16,000 Da were fragmented from non-
diseased and diseased tissue sections using either CID or ETD. Bottom-up 
methods identified over 300 proteins, several of which were known biomarkers 
for liver disease. A greater number of species are detected due to the separation 
techniques, however, LC analysis is quite time consuming. In chapter 5 FAIMS 
analysis was employed to enhance protein signal without increasing the 
analysis time. By applying FAIMS, lipids and proteins could be separated post 
sampling enhancing the spectral quality for both these species. MS/MS analysis 
showed that the FAIMS can be used as an exploratory technique to identify 
protein that had previously had a signal to noise ratio too low to detect. In 
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chapter 6, the LESA was coupled to the TWIMS. Similar to the FAIMS the 
TWIMS was able to separate lipids and proteins. In addition the TWIMS 
showed separation between isobaric species. This is particularly useful for 
imaging and spatial profiling as the LESA analysis has a poor spatial resolution 
and therefore MALDI was employed. MS/MS imaging and TWIMS imaging 
were used to separate isobaric species. Images produced showed separate 
spatial locations for several isobaric species. 
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Chapter 2:  Materials and Methods 
2.1 Materials 
Methanol, ethanol and acetonitrile used in preparation of electrospray solvents 
were purchased from either Fisher Scientific (Leicestershire, U.K.) or 
acetonitrile J. T. Baker (The Netherlands). Water was purified by an ELGA 
Option 3 system (Marlow, UK). Formic acid (FA), lithium chloride and 
ammonium bicarbonate were purchased from Sigma-Aldrich Company Ltd. 
(Dorset, U.K.).  
2.2 Sample Preparation 
The work was approved by the NHS Walsall Local Research Ethics Committee 
(98/CA5192). All patient liver tissue was collected at The Queen Elizabeth 
Hospital in Birmingham with written informed patient consent. Non-diseased 
liver tissue was collected from donor material surplus to transplantation 
requirements or from resection margin specimens. Diseased liver specimens 
were collected upon transplantation surgery. All samples were rapidly 
processed and snap frozen in liquid nitrogen prior to storage at -80 °C.  
Sections of normal human liver tissue of area approximately 1.5 cm2 were 
obtained at a thickness of 10 µm using a CM1810 Cryostat (Leica microsystems, 
Wetzlar, Germany) and thaw mounted onto glass slides. Haematoxylin and 
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eosin (H&E, Leica UK) staining was performed according to standard protocols. 
[204, 205] 
Liver and brain from wild-type mice (extraneous tissue from culled animals) 
were the gift of Prof Steve Watson (University of Birmingham). Organs were 
frozen on dry ice prior to storage at -80 °C. Sections of murine liver tissue and 
brain tissue of area ~ 1.5 cm2 were obtained at a thickness of 10 µm using a 
CM1810 Cryostat (Leica Microsystmes, Wetzlar, Germany) and thaw mounted 
onto glass slides.  
Glass slides were loaded onto a universal LESA adapter plate and placed in the 
TriVersa Nanomate chip-based electrospray device (Advion, Ithaca, NY) 
coupled to the Thermo Fisher Scientific Orbitrap Velos  
2.3 Surface Sampling 
Automated sample analysis was performed using the LESA Points software 
(Advion Ithaca, NY), which controls the TriVersa Nanomate. An image of the 
tissue section was acquired using an Epson Perfection V300 photo scanner.  The 
LESA Points software (Advion) was used to select the location or locations on 
the tissue surface (x and y co-ordinates) and the z position, relative to the plate 
height, for sampling routines using the Nanomate probe. The LESA sampling 
routine involved the collection of a conductive tip from the Advion tip rack 
before moving to solvent well containing the electrospray solvent solution. The 
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Nanomate probe aspirated a pre-set volume into the conductive tip. The probe 
relocated to the predetermined location on the surface then descended to just 
above the surface. A schematic of the LESA stage is shown in Figure 23.  
 
Figure 23: Schematic of the universal plate adaptor indicating that the sample slide is held in 
place between the base plate and the fixed height arms insuring that the height of 
the sample slide is the same for each analysis. The zero line is the fixed distance 
between the sample slide and the LESA tip. Not including the height of the sample 
on top of the sample slide. 
 
The tip dispensed a proportion of the volume of the solution onto the sample 
forming a liquid micro-junction (LMJ) between the tip and the surface. The LMJ 
was maintained to allow sufficient time for analytes to be dissolved into the 
solution; the length of time varies depending on that analysis and is defined in 
more detail in specific methods later in this chapter. The solvent was then 
reaspirated into the tip. Finally the tip was rotated and engaged with the back 
of the ESI chip, and nanospray ionisation was initiated. The Triversa Nanomate 
was coupled with a Thermo Fisher Scientific LTQ Orbitrap Velos ETD mass 
spectrometer and a Waters Synapt G2-S. Values for the volumes, heights and 
length (time) of LMJ are recorded with specific experimental methods.  
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2.4 Mass Spectrometry.  
2.4.1. LTQ Orbitrap Velos ETD analysis 
LESA samples were introduced at a flow rate of ~80-150 nL/min with a gas 
pressure of 0.3 psi, a tip voltage of 1.75 kV and a capillary temperature of 250 °C. 
MS data were collected in full scan mode over a resolution of 100 000 at m/z 400 
and in selected ion monitoring (SIM) mode, over selected m/z ranges. In 
experiments where the AGC target was used the target was 1x106 with a 
maximum fill time of 2 s in full scan mode. Deviations from this, such as when 
the AGC is turned off, are described in the text for individual experiments.  
2.4.2. TSQ Vantage analysis 
LESA samples were introduced at a flow rate of ~80-150 nL/min with a gas 
pressure of 0.3 psi, a tip voltage of 1.75 kV. With a capillary temperature of 275 
°C.  
2.4.3. Synapt G2-S analysis 
LESA samples were introduced at a flow rate of ~80-150 nL/min with a gas 
pressure of 0.3 psi, a tip voltage of 1.75 kV. The Synapt G2-S capillary voltage 
was set to 2.98 and temperature was set to 100 °C with a desolation temperature 
of 250°C.  
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Data was collected in resolution mode (W mode). TWIMS was conducted in the 
traveling wave ion mobility cell was operated using nitrogen at a pressure of 
3.08 Torr.  
2.4.4. UltraFAIMS analysis 
FAIMS separation was carried out in positive ion mode using an NC chip 
(Owlstone) with trench length 78.1 mm, gap width 101.3 µm and total thickness 
700 µm. The FAIMS device was operated either in 2D mode, in which both the 
dispersion field and compensation fields are varied, or in static mode, in which 
DF and CF are fixed. 
2.5 Data processing 
Data were analysed using either Xcalibur version 2.1.0.1139 software where the 
Xtract program was used to calculate monoisotopic masses, MATLAB version 
R2011a-student, MassLynx 4.1 or HDimaging 1.2.  
2.5.1. Image construction 
For LESA – Orbitrap image construction, data in the Thermo RAW format were 
converted to mzML using msconvert as part of ProteoWizard. [206, 207] 
Sequential spectra that corresponded to the same pixel (as determined by time 
from the total ion chromatogram) were summed together and outputted to 
mzML using a MATLAB script. The summed spectra were then converted to 
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imzML using imzMLConverter. [208] All further data processing was 
performed in MATLAB using in-house software. 
For LESA- ESI - TWIMS image construction, the average mobilogram was 
calculated using the driftscope function in MassLynz. The total ion 
chromatogram was extracted for a specific m/z and drift time. Sequential 
spectra that corresponded to the same pixel as determined by time from the 
total ion chromatogram were summed together to determine the intensity of a 
peak at a given pixel.  
MALDI images were constructed using Waters HDimaging software version 
1.2.  
2.5.2. UltraFAIMS data processing 
In-house software was developed for the analysis of ultraFAIMS data. The 
software is described in detail in section 2.8.5. 
2.6 Experimental methods for Chapter 3 
2.6.1. Solvent Optimisation 
Automated LESA experiments were conducted using electrospray solvents 
comprised of 40, 50, 60, 70 and 80% methanol, ethanol or acetonitrile prepared 
in water plus 0.1% (v/v) FA using the surface sampling procedure and the 
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experimental parameters outlined in Table 2-1. Additional solvent systems 
containing 30% methanol in water with 0.1% (v/v) FA or 70% methanol in 
water with 0.1 (v/v) FA were also used for LESA 
2.6.2. LMJ delay 
An automated LESA method was conducted using 70% methanol in water and 
0.1% (v/v) FA and the surface sampling procedure and the experimental 
parameters outlined in Table 2-1. The sample was electrosprayed and mass 
spectra collected. AGC was turned off and the injection time set to 20 ms. 
2.6.3. Height and volume 
An automated LESA method was conducted using 70% methanol in water and 
0.1% (v/v) FA and the surface sampling procedure and the experimental 
parameters outlined in Table 2-1. Each analysis was conducted on a fresh region 
of tissue. Both the dispensing volume and the dispensing height were varied.  
2.6.4. Dilutions 
An automated LESA method was conducted using 70% methanol in water and 
0.1% (v/v) FA and the surface sampling procedure and the experimental 
parameters outlined in Table 2-1. The sample was electrosprayed and mass 
spectra collected. Each analysis was conducted on a fresh region of tissue using 
the parameters described in Table 2-1. AGC was turned off and an injection 
time of 50 ms was used.  
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2.6.5. Acid Concentration 
An automated LESA method (outlined in section 2.3 and Table 2-1) was 
conducted using 70% methanol in water and 0.1% (v/v) FA, 1% FA (v/v), 2% 
FA (v/v) and 3% FA (v/v). Analysis was conducted using TSQ Vantage as 
described in section 2.4.2. Each analysis was conducted on a fresh region of 
tissue. 
2.6.6. Tissue washing 
An automated LESA method was conducted using 50% acetonitrile in water 
and 0.1% (v/v) FA was carried out with the method outlined in section 2.3 and 
Table 2-1. Bulk tissue washing was conducted by submerging the glass slide in 
80% ethanol for 10 seconds and repeated up to twice more. The sample was 
electrosprayed and mass spectra collected on a TSQ Vantage (Thermo), using 
conditions outlined in section 2.4.2. 
Localized washing was also conducted using the LESA protocol outlined in 
section 2.3, using 80% ethanol and 0.1% (v/v) FA at the same spatial location 
prior to analysis with 50% acetonitrile in water and 0.1% (v/v) FA. The sample 
was electrosprayed and mass spectra collected using the mass spectrometry 
conditions described in section 2.4.2.   
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2.6.7. Repeat Analysis Of A Single Location On Tissue 
An automated LESA method was repeated at the same tissue location ten times. 
In this experiment single position surface analysis was conducted with a 
solvent system of 70% methanol in water and 0.1% (v/v) FA and parameters 
described in section 2.3 and Table 2-1. The electrosprayed sample was surveyed 
using the mass spectrometry conditions described for Orbitrap experiments 
section 2.4.1. AGC was turned off and the injection time set to 20 ms.  
2.6.8. AGC tests 
An automated LESA method was conducted using 70% methanol in water and 
0.1% (v/v) FA. The sample was electrosprayed and mass spectra collected 
using the mass spectrometry conditions described in the surface sampling 
section 2.3 and Table 2-1. AGC was turned off and injection times of 1, 2, 3, 4, 5 
ms were used.  
2.6.9. Tissue Imaging 
For imaging experiments LESA sampling was repeated using a solvent volume 
of 0.7 µL, dispensing 0.5 µL, re-aspirating 0.6 µL at sequential locations across 
the surface of the liver tissue, with x and y spacing of 1 and 2 mm (1 mm spaced 
image consisted of 60 pixels in 5 rows of 12, 2 mm spaced image consisted of 42 
pixels in 6 rows of 7). MS data were collected for 3 minutes per extraction. The 
AGC was turned off and the injection time set to 20 ms.  
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2.6.10. Volume and height 
An automated LESA method was conducted using 70% methanol in water and 
0.1% (v/v) FA, using the surface sampling protocol in section 2.3 and the 
conditions described in Table 2-1. The sample was electrosprayed and mass 
spectra collected using the mass spectrometry conditions described in section 
2.4.2. 
Table 2-1: Experimental parameters for LESA analysis conducted in Chapter 3 
Experiment Total 
solvent 
Height Dispensing 
volume 
LMJ 
Delay 
Re-aspirated 
volume 
Solvent 
Optimisation 
2.5 µL 0.4 mm 1.3 µL 10 sec 1.7 µL 
LMJ delay 3 µL 1.6 mm 1 µL 0, 5, 10, 15, 
20, 30, 40 
sec 
1.3 µL 
Height and 
Volume 
0.5 µL more 
than 
dispensed 
0.4, 0.8, 
1.2, 1.6 
mm 
0.3 µL/0.5µL 15 sec 0.2 µL more 
than 
dispensed 
Dilution 1, 2, 3, 4 µL 0.4 mm 0.5 µL 10 sec 0.7 µL 
Acid 
Concentration 
2 µL 0.4 mm 1 µL 10 sec 1.3 µL 
Washing 2.5 µL 0.4 mm 1.4 µL 10 sec 1.7 µL 
Repeat 
Extraction 
5 µL 0.4 mm 4 µL 10 sec 4.5 µL 
AGC tests 5 µL 0.4 mm 4 µL 10 sec 4.5 µL 
1mm and 2 mm 
image 
0.7 µL 0.4 mm 0.5 µL 10 sec 0.6 µL 
Volume and 
area 
5 µL 0.4 mm 0.5, 1, 2, 3 µL  10 sec 0.3 µL more 
than 
dispensed 
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2.7 Experimental methods for Chapter 4 
2.7.1. Top-down LESA mass spectrometry of human liver tissue sections: 
Sections of human liver thaw-mounted onto glass slides were washed in a 
solution of 80% ethanol prior to analysis. Using the LESA protocol in section 2.3 
2 µL of 40% acetonitrile + 1% formic acid was aspirated from the solvent well. 
The robotic arm relocated to a position above the tissue section and descended 
to a height of approximately 1 mm above the surface. One µL of the solution 
was dispensed onto the tissue section to form a liquid microjunction. The liquid 
microjunction was maintained between the probe tip and the surface for 10 s. 
1.3 µL was re-aspirated into the pipette tip. The dispense/reaspirate cycle was 
repeated 3 times. Full scan mass spectra (m/z 500-2000) were collected for 3 min. 
CID was performed in the ion trap at a normalized collision energy of 30% and 
the fragments detected in the Orbitrap (m/z 300-2000). The isolation width was 3 
Th. AGC target was 1x106 charges with a maximum injection time of 2 s. Each 
CID MS/MS scan comprised of 20 co-added microscans. Data were recorded 
for 10 min (~10 scans). ETD was performed in the ion trap and the fragments 
detected in the Orbitrap. The isolation width was 3 Th. AGC target was 1x106 
charges with a maximum injection time of 1 s. ETD activation time was 20 ms. 
Each ETD scan comprised of 20 co-added microscans. Data were recorded for 6 
min (~9 scans).  Number of scans for each experiment was determined by 
counting the scans after the analysis. 
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2.7.2. Bottom-up LESA mass spectrometry of human liver tissue sections: 
Intact proteins were extracted from non-diseased human tissue via automated 
LESA: Samples were mounted onto a 96-well microtitre plate (Thermo Scientific, 
Loughbrough, UK) and placed in the Triversa Nanomate nanoelectrospray 
device (Advion Biosciences, Ithaca, NY). Three of the sample wells contained 
extraction solvents: one contained 50mM ammonium bicarbonate, one 
contained 50% methanol and one contained 70% methanol. A fourth well 
contained 0.1 mg/ mL trypsin (Trpysin Gold, Promega, Southampton, UK) in 
50mM acetic acid. Surface sampling of the thin tissue section and trypsin 
digestion was performed by use of the advanced user interface. This involves 
the collection of a conductive tip from the Advion tip rack before moving to the 
well containing the extraction solvent to aspirate 2 µL from the solvent well. 
The arm relocated to a position above the tissue section and descended to a 
height of approximately 0.6 mm above the surface. One µL of the solution was 
dispensed onto the tissue section to form a liquid microjunction. The liquid 
micro-junction was maintained between the probe tip and the surface for 1 s. 
1.3 µL were reaspirated into the pipette tip. The dispense-reaspiration cycle was 
repeated three times before finally dispensing into a clean well in the microtitre 
plate. The experiment was conducted using three extraction solutions: (a) 50% 
methanol, (b) 70% methanol, and (c) 50mM NH4HCO3. After extraction, the 
50% and 70% methanol solutions were left for 30 min until dry to remove the 
organic content and the sample re-suspended in 10 µL 50mM NH4HCO3, using 
one mix cycle (repeat dispense/reaspiration) to promote re-suspension. For 
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each of the samples, 4.5 µL of trypsin solution was aspirated from the tryspin-
containing well and dispensed into the sample well. The solutions were mixed 
by a single mix cycle (repeat dispense/reaspiration).  The samples were 
incubated at 37 °C for 1 hour by use of the temperature control unit of the 
Triversa Nanomate. At 30 min and 1 h into the incubation, 7 µL of 50 mM 
NH4HCO3 was aspirated from the solvent well and added to the sample well in 
order to account for evaporation. The final volume was approximately 10 µL.  
2.7.3. On tissue digestion for bottom-up mass spectrometry of human liver tissue 
Using the advance user interface, 10 µL of 0.1 mg/ mL trypsin in 50mM acetic 
acid was aspirated from a well in a microtitre plate. The robotic arm relocated 
to a position above the tissue section and descended to a height of 
approximately 0.2 mm above the surface. All of the solution was dispensed 
onto the tissue section at a rate on 0.3 µL/min to form a liquid micro-junction. 
The liquid micro-junction was maintained between the probe tip and the 
surface for 30 min at which time any remaining solution is expelled from the 
pipette onto the tissue. This was repeated once more. The peptides were 
extracted using 10 µL 50 mM NH4HCO3 aspirated from a separate well in the 
96-well microtitre plate. The robotic arm relocated to the same position above 
the tissue section and descended to the same height. 5 µL of the solution was 
dispensed onto the tissue section at a rate of 10 µL/min and re-aspirated at 10 
µL/min. 5 µL were re-aspirated into the pipette tip and then the solution was 
dispensed into a clean well. This was repeated twice more, each time 
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dispensing the solution into a clean well in the microtitre plate. The sample was 
incubated at 35 °C for the length of the digestion and extraction process.  
2.7.4. LC MS/MS 
The microtitre plate was transferred to the HPLC autosampler (Ultimate 3000, 
Dionex Thermo Fisher Scientific Loughborough UK), which is coupled to an 
Orbitrap Velos ETD mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany) via the Triversa Nanomate. The proteolytic digests were each 
analysed in duplicate by LC-MS/MS. Five µL aliquots were injected onto a 
Pepmap 100, C18 100 mm trap (Thermo Fisher Scientific Loughborough UK). 
The trap was treated with a 5 min wash cycle with 0.1 % formic acid prior to 
injection onto the analytical column (Pepmap 100 reversed phase C18 75 mm, 3 
mm, 100 Å; Thermo Fisher Scientific Loughborough UK). Peptides were 
separated using a 30 min 3.2 % - 44 % acetonitrile (J.T Baker, Netherlands) 
gradient at a flow rate of 0.35 mL/min.  
Samples eluted into the mass spectrometer via the Triversa Nanomate chip-
based nano-electrospray device. Ionisation voltage was 1.4 kV, gas pressure 
was 0.3 psi and capillary temperature was 250 °C. Mass spectrometry analysis 
was performed via a ‘top 7’ method in which a survey scan was followed by 
MS/MS of the seven most abundant precursor ions. Survey scans were 
acquired in the Orbitrap with a m/z range 380–1800, an automatic gain control 
(AGC) target of 1×106 charges, a maximum fill time of 1 s and a resolution of 
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60,000 at m/z 400. CID was performed in the linear ion trap (AGC target: 30,000 
charges) with helium gas and a normalized collision energy of 35 %. The width 
of the precursor isolation window was 2 Th and only multiply charged 
precursor ions were subjected to CID. The mass exclusion window was m/z 
±0.05 and the exclusion list was set to 500. Dynamic exclusion was applied for 
60s. 
MS/MS data were searched against the SwissProt human database 
(downloaded Nov 2012), composed of 20203 sequences, using the Mascot and 
Sequest algorithms in Proteome Discoverer 1.4. The following parameters were 
applied: precursor ion mass accuracy 10 ppm, fragment mass tolerance 0.8 Da, 
methionine oxidation was allowed as a dynamic modification, up to 2 missed 
cleavages in the digestion. Data were filtered to a false discovery rate of 1% by 
including only high confidence peptides. The protein grouping algorithm was 
applied which grouped all non-unique peptides to the highest scoring protein.  
2.8 Experimental methods for Chapter 5 
2.8.1. Surface sampling 
For LESA analysis 6 µL of 70% methanol + 0.1% formic acid (mouse liver) or 
50% acetonitrile +1% formic acid (mouse brain) was aspirated from the solvent 
well. The robotic arm relocated to a position above the tissue section and 
descended to a height of approximately 0.2 mm above the surface. Three µL of 
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the solution was dispensed onto the tissue section to form a liquid micro-
junction. The liquid micro-junction was maintained between the probe tip and 
the surface for 10 s, 3.5 µL was re-aspirated into the pipette tip. Mouse brain 
were prewashed by LESA sampling with 80% ethanol, using the same method 
described above (Section 2.3).  
2.8.2. Mass spectrometry 
Full scan (m/z 400-2000) data was collected at a resolution of 100, 000 at m/z 400. 
AGC target was set at 1x106, with a maximum fill time of 1000ms. Each scan 
was composed of 1 microscan. Samples were introduced into the mass 
spectrometer via the TriVersa NanoMate, with gas pressure 0.3 psi, a tip 
voltage of 1.75 kV, and a capillary temperature of 250°C. 
2.8.3. UltraFAIMS 
ESI-FAIMS-MS was conducted in positive ion mode using the UltraFAIMS 
device (Owlstone, Cambridge, U.K.) mounted onto the Thermo Orbitrap Velos. 
The NC chip was employed with a trench length of 78.1 mm and a gap of 101.3 
µm and a thickness of 700 µm. 
For 2-D FAIMS analyses, FAIMS separation was carried out at eight discrete 
dispersion fields (DFs) between 130 Td and 270 Td with step size 20 Td. At each 
DF, the compensation field was varied between -1 to +4 Td over a time period 
of 180 s. 
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For static FAIMS analyses, optimal DF and CF conditions for the transmission 
of ions of interest were selected from the 2D FAIMS analyses. For the detection 
of lipids from mouse liver the conditions used were DF = 130 Td, CF=0.30 Td. 
For the detection of proteins from mouse liver the conditions used were DF = 
270 Td, CF=2.62 Td. For the detection of proteins from mouse brain the 
conditions used were DF=270 Td, CF=2.60 Td.  
2.8.4. Fragmentation 
Two peaks were isolated for MS/MS analysis, m/z 1021.54 and m/z 952.63, with 
an isolation width of 3 Th. CID, ETD and HCD were conducted on the 
precursor ions. Each MS/MS spectrum was comprised of 5 microscans. Data 
were recorded for 2-3 mins in each case. 
CID was carried out in the linear ion trap at normalised collision energy of 30%, 
and product ions were detected in the Orbitrap at a resolution of 100,000 at m/z 
400. AGC target was 1 x 106 charges (mouse tissue samples) with maximum 
inject time of 1s.  
HCD experiments (NCE 30%) were recorded at a resolution of 100,000 at m/z 
400. AGC target was 1 x 106 charges (mouse tissue samples) with maximum 
inject time of 1 second.  
ETD was performed with fluoranthene ions. AGC target for precursor ions was 
1 x 106 charges with maximum inject time 1s. AGC target for fluoranthene ions 
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was 1 x 106 charges (maximum inject time 1s). Precursor ions were activated for 
30 ms. 
2.8.5. Data processing 
The monoisotopic masses were calculated by using the Xtract function in 
Xcalibur software (Thermo Scientific). The .raw files of the extracted masses and 
the original data were converted to .mzml using msconvert as part of 
ProteoWizard conversion software. The .mzml files were then converted 
to .imzml files using imzMLConverter to produce two image data sets one of 
the raw data the other of the monoisotopic data. [208]. Heat maps of DF vs. CF 
and m/z vs. CF were produced using in house software. This software is 
described in detail in section 5.4.1. 
2.9 Experimental methods for Chapter 6 
2.9.1. Lithium Analysis 
Automated LESA experiments were conducted using electrospray solutions 
comprised of 0, 0.1, 0.5, 1, 5 10, 15, 20, 25, and 30 mg/mL lithium chloride in 
80% ethanol prepared in water plus 0.1% (v/v) FA. Using the surface sampling 
procedure in section 2.3, 5 µL was aspirated into the LESA pipette tip of which 
2 µL was dispensed on to the surface then 2.5 µL was re-aspirated after a 10 
second delay. 
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2.9.2. CID/HCD Comparison 
An automated LESA method was conducted using either 25 mg/mL LiCl in 
80% ethanol prepared in water plus 0.1% (v/v) FA for all MS/MS of Lithium 
adducts, or 70% methanol prepared in water plus 0.1% (v/v) FA for [M+H]+, 
[M+Na]+, and [M+K]+ ions. The LESA protocol in section 2.3 was used with a 
total solvent volume of 5 µL aspirated into the LESA pipette tip of which 2 µL 
was dispensed on to the surface then 2.5 µL was re-aspirated after a 10 second 
delay. 
HCD optimisation was conducted at normalised collision energies  
of 20%, 22%, 25%, 30%, 35%, 40%, 45% and 50%.  
A ‘top 7’ method was conducted the same as previous with the addition of a 
HCD (at normalised collision energy of 40%) scan immediately following the 
CID scan so that the top 7 peaks were analysed by CID and HCD in adjacent 
scans. All other parameters were kept the same.  
2.9.3. Data dependent analysis 
An automated LESA method was conducted using either 25 mg/mL LiCl in 
80% Ethanol prepared in water plus 0.1% (v/v) FA, using a total solvent 
volume of 5 µL aspirated into the LESA pipette tip of which 2 µL was dispensed 
on to the surface then 2.5 µL was re-aspirated after a 10 second delay. 
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Analysis was conducted using a ‘top 7’ method. Where by a survey scan is 
acquired and MS/MS is conducted on the top 7 most intense ions. Survey scans 
were acquired at a resolution of 60,000 at m/z 400 from m/z 400-1500 in the 
Orbitrap. CID was performed in the linear ion trap with helium gas at a 
normalised collision energy of 35%. Ions were detected in the Orbitrap at a 
resolution of 60,000 at m/z 400. Automatic gain control was set to 1 × 106, with a 
maximum fill time of 1000 ms. The precursor isolation window was set at 1 Th. 
Dynamic exclusion was applied for the duration of the analysis (15min), with a 
mass exclusion of ± 0.05, independent of charge states.  
2.9.4. Liquid extraction surface analysis MS/MS imaging 
For MS/MS imaging experiments a solvent volume of 1.5µL, dispensing 0.5µL, 
re-aspirating 1µL after a 10 second delay at sequential locations across the 
surface of the liver tissue, with x and y spacing of 2mm the image consisted of 
48 pixels in 6 rows of 8. Data were collected for 4.18 minutes per extraction. 
Each injection was subdivided into 16 events the 1st and 16th event was a full 
scan event (m/z 400-1000), MS data was acquired for 0.28 min (5 scans). The 2nd 
to 15th event were a MS/MS event, 14 ions (m/z 764.58, 601.54, 722.55, 729.61, 
502.35, 445.34, 774.54, 812.59, 814.59, 770.53, 90.59, 762.57) were isolated with a 
width of 1 Th and subjected to HCD analysis at a normalised collision energy of 
40%. MS/MS spectra were acquired from m/z 50 to 10 Da above the precursor 
ion. All spectra were comprised of 4 co-added micro scans (~0.22min) The AGC 
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was turned off and the injection time set to 20 ms for full scan data and 40 ms 
for MS/MS data.  
2.9.5. LESA Synapt Surface sampling 
For LESA analysis, 3 µL of 70% methanol + 0.1% formic acid was aspirated 
from the solvent well. The robotic arm relocated to a position above the tissue 
section and descended to a height of approximately 0.8 mm above the surface. 
Two µL of the solution was dispensed onto the tissue section to form a liquid 
micro-junction. The liquid micro-junction was maintained between the probe 
tip and the surface for 10 s. 2.5 µL was re-aspirated into the pipette tip.  
2.9.6. ESI-TWIMS 
The TriVersa Nanomate (Advion) was mounted onto a Synapt G2-S. The source 
temperature was set to 30°C and the cone voltage was set at 45 V. All data were 
acquired in resolution mode with traveling wave ion mobility.  
The traveling wave ion mobility cell was operated using nitrogen at a pressure 
of 3.08 Torr. A wave height of 40 V was used for all experiments. IMS 
separation was carried out at four wave velocities between 300 m/s and 450 
m/s with step size 50 m/s. 
For LESA experiments, the scan time was 0.5 sec and m/z range was 50–2000. 
Data were acquired for 12 sec in full scan mode  
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2.9.7. Fragmentation of ions using LESA coupled to TWIMS 
Three peaks were selected for MS/MS analysis, one observed at m/z 764.5 (drift 
bins 82-89) and two observed at m/z 792.6 (drift bins 79-86 and drift bins 123-
125) using a wave velocity of 350 m/s. Ions at m/z 764.2 were isolated in the 
quadrupole, prior to the Triwave, using a low mass resolution of 12.4 and a 
high mass resolution of 18.0. Ions were subjected to CID using an optimized, 
normalized collision energy of 35 %, in both the trap and transfer cell in 
separate experiments. Ions detected at m/z 792.6 were isolated using a low mass 
resolution of 10 and a high mass resolution of 20. Ions were subjected to CID 
using an optimized, normalized collision energy of 35 %, in the transfer cell. 
Data were acquired for 10 s and recorded between m/z 50-1200.  
Data were analysed using Mass Lynx software (ver. 4.1, Waters). 
2.9.8. ESI – TWIMS imaging  
LESA imaging experiments were conducted using volume of 1.5 µL, dispensing 
0.5 µL, re-aspirating 0.7 µL, after a delay of 5 seconds at sequential locations 
across the surface of the liver tissue, with x and y spacing 2 mm consisting of 56 
pixels in 7 rows of 8. MS data were collected for 5 minutes per extraction. IMS 
separation was carried out at a wave velocity of 500 m/s.  
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2.9.9. MALDI Sample preparation 
Sections of non-diseased and NASH human liver tissue, of area approximately 
1.5 cm2, were obtained at a thickness of 10 mm using a CM1810 Cryostat (Leica 
microsystems, Wetzlar, Germany) and thaw mounted onto glass slides. A 
matrix solution of 20 mg/mL CHCA in 85% MeOH +0.1% TFA was sprayed 
onto the tissue section (~15 mL) using an artist airbrush (Draper, Hampshire, 
UK) propelled by dry N2. Glass slides were placed onto MALDI imaging plate 
holder, and loaded into the MALDI source. For MS/MS analysis sections were 
fixed using 0.154 M LiCl in 4% formaldehyde solution for 30 min prior to 
matrix application. [45] 
2.9.10. MALDI MS/MS imaging 
MALDI MS/MS analysis was performed on a Synapt G2-S, using a Nd:YAG 
laser (355 nm) firing at a 1000Hz with a normalized laser energy of 300. The 
image was acquired using a sampling spacing of 100 µm. Spectra were 
produced from 500 laser shots per location. Fragmentation of m/z 792.5 was 
conducted in the transfer cell using a normalized collision energy of 30. 
Isolation of ions occurred in the quadrupole, and optimised so that only ions 
relating to peak m/z 792.5 were transmitted. Image was produced using in 
house software.  
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2.9.11. MALDI TWIMS 
MALDI TWIMS data were acquired from mouse liver extract using spot mode 
analysis. Lipids were extracted using the Folch extraction method and stored at 
-80ºC until required. [88] Samples were left at room temperature to defrost, and 
mixed with 25 mg/mL CHCA at a ratio of 1:1. 1 µL was spotted onto a 96 well 
MALDI spot target plate. Spot samples were interrogated in a spiral pattern 
using a normalized laser energy of 300 at a rate of 50 Hz. TWIMS was 
implemented in both static and variable mode. For static TWIMS analysis IMS 
separation was carried out at 6 wave velocities between 300 m/s and 800 m/s 
with step size 100 m/s. For variable TWIMS the wave velocities were changed 
at a linear rate during each duty cycle of the TWIMS nine gradients were 
implemented, 600-100 m/s, 700-100 m/s, 800-100 m/s, 900-100 m/s, 900-200 
m/s, 900-300 m/s, 900-400 m/s, 900-500 m/s, and 900-600 m/s. A wave height 
of 40 V was used for all experiments. Spectra were acquired every 1 sec (50 
scans per spectrum). Data were acquired for 10 second per sample spot at a 
mass range of m/z 50-2000.  
2.9.12. MALDI TWIMS imaging 
MALDI TWIMS MS/MS analysis was performed on a Synapt G2-S, using a 
ND:YAG laser (355 nm) firing at a 1000 Hz. The image was acquired at a 
resolution of 100 µm using a normalised laser energy of 300. Spectra were 
summed from 500 laser shots per location. A variable wave velocity of 900-300 
m/s and a constant peak height of 40 V was used for imaging. The mobility cell 
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was operated at a pressure of 3.08 Torr and contained nitrogen. Images were 
reconstructed using Waters HDImaging software. 
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Chapter 3:  Optimization of liquid extraction surface 
analysis for analysis and imaging of lipids and proteins 
in thin tissue sections 
3.1 Introduction 
Liquid extraction surface analysis (LESA) is a relatively new technique. It is 
based on the liquid-solid extraction of analytes, however it is the automation 
and the ability to link this technique to a mass spectrometer, which makes this 
technique so powerful.  
LESA is the process of dispensing a droplet of ESI solution onto a surface. 
Molecules will dissolve into the ESI solution. Re-aspiration collects the enriched 
solution and robotics position the tip to connecting it to the nano-ESI source. 
The nano-ESI source is a chip with capillaries running through it. Backpressure 
is applied to the solution encouraging it to flow through the capillary, voltages 
applied to the capillary causes ionisation.  
This chapter will describe optimisation of this process, with the aim of using the 
LESA technique as an imaging system.  
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3.2 Results and Discussion 
Representative full scan mass spectra acquired following LESA of human liver 
sections are presented in Figure 24. Use of a solvent solution containing ~70% 
methanol resulted in detection of both singly and multiply charged ions (panel 
A). Inspection of an enlarged spectral region from m/z 900-1600 revealed peaks 
corresponding to several species in various charge states (panel B). The most 
abundant species were found to be phospholipids, detected as singly charged 
ions between m/z 700-820 (shown in panel C with accompanying inset of m/z 
620-750), some lipids are shown in Table 3-1.  
Table 3-1: Selection of abundant phospholipids from human liver tissue. 
Measured m/z Theoretical m/z Error (ppm) Identification 
732.5547 732.5538 -1.23 [PC(32:1)+H]+ 
758.5704 758.5538 -1.32 [PC(34:1)+H]+ 
796.5464 796.5454 -1.51 [PC(34:2)+K]+ 
798.5418 798.5410 -1.00 [PC(34:1)+K]+ 
820.5266 820.5253 -1.58 [PC(36:4)+K]+ 
 
The effect of altering the organic composition of the electrospray solvent used 
for the liquid extraction surface analysis and ESI routine can be seen by 
comparing spectra presented in Figure 24 panels A, D and E. Reducing the 
percentage of methanol in the solution to ~50% resulted in a dramatic increase 
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in the relative abundance of multiply charged species, as shown in panel D. 
Singly charged ions were still detected between m/z 600-800 but spectra 
obtained were dominated by peaks corresponding to multiply charged ions. 
Further reduction of the methanol content to ~30% resulted in poor quality 
spectra as presented in panel E, indicating either poor extraction of molecules 
from the tissue surface or poor ionisation of extracted species during 
electrospray, or both. While extraction and ionisation of species from tissue are 
decoupled in LESA-ESI-MS, the most efficient routines in terms of throughput 
require the process to be achieved without the extracted sample being dried 
and re-dissolved in an alternative solvent prior to ESI-MS. 
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Figure 24: A) Spectrum acquired using 70% Methanol +0.1 % FA as the solvent in a LESA 
protocol of non-diseased human liver tissue. Enlarged region of this spectrum, are 
presented in B (protein region) and C ( lipid region), D) Spectrum observed using 
50% Methanol + 0.1 % FA as the solvent,  E) Spectrum observed using 30% 
Methanol + 0.1 % FA as the solvent.  
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Using varying percentages of methanol, ethanol and acetonitrile prepared in 
water and FA confirmed that solvent selection should be carefully considered 
with respect to the scope of analytes detected by mass spectrometry. Whilst all 
solvent solutions assessed were compatible with maintenance of a liquid micro-
junction, the solvent used altered the nature of analytes detected. Thus 
optimum solvent compositions for detection of multiply charged ions of 
peptides and proteins were found to contain ~40-50% acetonitrile. For analysis 
of lipids a solvent composition of ~80% ethanol yielded the richest spectra, and 
the most appropriate solvent solution for surveying both lipids and proteins 
comprised ~70% methanol. Representative spectra and a table summarising the 
most abundant species detected in LESA experiments using these solvent 
preparations are presented in Figure 25 and Table 3-2. In general solvent 
solutions containing a higher proportion of water resulted in superior detection 
of peptides and proteins and those with a higher organic content were found to 
be more useful for lipid analysis.  
Table 3-2: Summary of  pecies detected with differing solvent extractions 
Organic Content Methanol Ethanol Acetonitrile 
80% Lipids and Proteins Lipids Lipids and Proteins 
70% Lipids and Proteins Proteins Proteins 
60% Proteins Proteins Proteins 
50% Proteins Proteins Proteins 
40% Proteins Proteins Proteins 
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Figure 25: A) Enlarged region of a spectrum acquired using 80% Ethanol +0.1 % FA as the 
solvent in a LESA protocol of non-diseased human liver tissue. B) Enlarged 
region of a spectrum observed using 70% Methanol + 0.1 % FA as the solvent, C) 
Enlarged region of a spectrum observed using 50% Acetonitrile + 0.1 % FA as the 
solvent.  
 
3.2.1. LMJ delay 
The delay determines the length of time the LMJ is maintained. It was observed 
that lipids and proteins have different optimum extraction times. Lipids are 
observed at their most intense using a 10 sec LMJ, where as the optimum for 
proteins is a 30 sec LMJ. (Figure 26A and B) 
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Figure 26: Graphs display the intensity of specific ions at increasing LMJ delays (A and B) and 
using increasing number of 5 sec mixes (C and D). A and C) Singularly charged ion 
was detected at m/z 758.54 and identified as [PC34:2+H]+ , B and D) Ion in +15 
charge state, most abundant ion detected at m/z 942.23 identified as the +15 charge 
state of liver fatty acid binding protein. Error bars are 1 standard deviation from 3 
repeats. 
 
A solvent system comprising 70% methanol was used in this experiment.  
Lipids are very soluble in organic solvents where as proteins are less so. Under 
these conditions both lipids and proteins are soluble however lipids dissolve 
faster than proteins and spectra collected with short LESA extraction times 
were typically dominated by peaks associated with lipid species. Even still for 
optimum lipid analysis, a LMJ of 10 seconds was necessary to allow for the 
lipids to dissolve into the LMJ, but short enough before the protein 
concentration became too high.  
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In these experiments, the only movement of solvent occurs during the process 
is the dispensing and aspirating stages. Common practice when trying to 
dissolve compounds is to include a degree of agitation during the process. To 
increase the agitation during LESA, multiple dispensing and aspiration cycles 
were conducted each with a 5 second delay. 0, 1, 2, 3 and 5 repeats were 
investigated. Zero repeats mean that a single 5 second long LMJ was conducted. 
One repeat refers to two five second LMJ equating to a total LMJ time of 10 
seconds, and 5 repeats equates to a 30 second LMJ, in 6 parts. The results show 
that there is a drop in intensity for the lipids when using the repeat cycles 
(Figure 26C). In the previous experiment 10 seconds was found to be the 
optimum delay time. This is equivalent to using 1 repeat, (2 x 5 sec), where 
there is a dramatic reduction in the intensity.  Increasing the number of 
repeated cycles resulted in lower ion intensities for detected lipid species. The 
protein signal is not affected by the degree of agitation (Figure 26D), and it can 
be concluded that increasing the agitation by repeated mixing does not help 
improve the signal intensity of lipids or proteins.  
Without using any agitation the length of the LMJ delay can significantly affect 
the ions observed in the spectra. The spectra produced using a signal LMJ with 
increasing junction delays are shown in the mass spectra presented in Figure 27. 
Increasing the delay between 5 and 30 seconds resulted in detection of more 
multiply charged species. A delay time of 40 seconds did not result in any 
further improvement. In future experiments a time of 20 seconds was used 
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because increasing the length of the delay allows significant evaporation of the 
solvents reducing the volume that is recovered and increasing the likely hood 
of the LMJ breaking prior to recovery resulting in poor analysis of the sample.  
 
Figure 27: Enlarged region of a spectrum observed using 70% methanol +0.1 % FA as the 
solvent in a LESA protocol of non-diseased human liver tissue with a A) 0 sec LMJ 
delay, B) 5 sec LMJ delay, C) 10 sec LMJ delay, D) 20 sec LMJ delay, E) 30 sec LMJ 
delay, F) 40 sec LMJ delay. Blue triangles represent ions detected with multiple 
charges.  
 
3.2.2. LMJ volume and height. 
The height and dispensing volume are important parameters as they affect how 
far the droplet will spread. This will determine the spatial resolution of the 
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technique. There have been a wide range of droplet volumes reported from 0.5 
µL [81] up to 7 µL [83]. Two volume sizes have been used in this experiment 0.3 
µL and 0.5 µL, to assess these properties with respect to achievable spatial 
resolution (Figure 28). It was observed that at the higher dispensing height the 
LMJ was very difficult to maintain and during the re-aspiration the LMJ 
collapsed, leaving part of the solvent on the tissue. In these instances proteins 
were not detected, and the spectrum only revealed lipid ions. This is because 
proteins are less soluble in 70%MeOH(aq) so it takes longer for them to 
dissociate and as a result are predominantly at the interface between the sample 
and the LMJ and are not efficiently extracted if the LMJ breaks or if a large 
proportion of solution is left behind. This could be corrected if there is a longer 
delay on the tissue. Using a lower dispensing height was generally found to be 
more effective at complete re-aspiration of the LMJ. The highest signal intensity 
of 4 selected ions (Figure 28) (m/z 796.5257 identified as [PC34:2+K]+, m/z 
758.5699 identified as [PC34:2+H]+, m/z 942.2346 identified as the +15 charge 
state of the liver fatty acid binding protein, m/z 124.5011 is unidentified) was 
observed to be when a height of 0.8 mm was used. Data shown in Figure 28. 
As for the dispensing volume, higher signal intensity was observed using 0.5 
µL for singly charged molecules, where as a higher intensity was observed 
using 0.3 µL for multiply charged molecules. High intensities of lipids are 
contrasted with low intensity of proteins. This may be a symptom of the 
extraction process rather than the height and volume.  
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The optimum height for single positional analysis is 0.8 mm above the surface 
however; the LMJ is liable to break more often than a LMJ of 0.4 mm above the 
surface. For imaging it is important for the sampling method to be reliable and 
consistent therefore a lower height should be used even thought there is a 
reduced sensitivity. This is because it is more important to get data from each 
pixel than it is to achieve the maximum sensitivity of the method. If single 
positional analysis is being conducted then it would be feasible to do the 
analysis at a higher height.  
 
Figure 28: The intensity of four of peaks, m/z 796.5357 in +1 charge state, m/z 758.5699 in +1 
charge state, m/z 942.2349 +16 charge state, and m/z 1124.5011 in +3 charge state, 
observed using a 0.1% formic acid in 70% methanol as the extraction solvent in a 
LESA protocol. Four dispension hights (0.4 mm, 0.8 mm, 1.2 mm, 1.6 mm) and two 
dispension volumes (0.3 µL and 0.5 µL) were used.  
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3.2.3. Dilutions 
Only a proportion of the total volume in the LESA pipette tip is dispensed. 
Changing the residual volume in the pipette that does not alter the volume 
associated with the LMJ but will affect the dilution of the sample. Larger 
volumes resulted in a longer spray time, a total volume of 1 µL resulted in an 
average spray time of 4 min 7 sec, (over 3 repeats), increasing to 8 min 52 sec for 
2 µL, 15 min 34 sec for 3 µL, and, 21 min 11 sec for 4 µL. The relationship 
between liquid volume and ESI spray time was not found to be linear. 
A long analysis time would be ideal, especially for inhomogeneous samples 
where it is necessary to obtain the maximum amount of information from a 
single location. However, with larger volumes, a dilution effect was observed 
between the initial spray and the later spray. Different molecular species were 
observed at different time points. The length of time the droplet was spraying 
was determined by the background noise, which is more intense when spraying. 
In larger droplet volumes, 2, 3 and 4 µL the intensity of the peaks of interest 
reduces to the point that they are no-longer observed (Figure 29). These results 
indicate an inhomogeneous mixture of analytes within the solvent plug when 
using large residual volumes. Including a pause between extraction and 
analysis to allow a homogenous solution to be formed unfortunately resulted in 
the entire solution being too dilute to be detectable. The optimum sampling 
conditions for imaging were found to be a small LMJ volume and a small 
residual volume. This is to produce the smallest area on the surface while 
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maintain the ideal conditions in which to detect analytes from the surface via a 
LMJ.  
 
Figure 29: Signal intensity of a singly charged ion m/z 758.53 (red) and an ion in +16 charge state 
m/z 942.23 (blue) over the time course of the injection. Observed using 0.1 % formic 
acid in 70% Methanol in a LESA protocol where the total volume is 1, 2, 3, or 4 µL.  
 
3.2.4. Acid Concentration 
Modifiers are added to help the Ionisation process. Proton donors and 
acceptors are used to protonate and deprotonate molecules. [84] To assess how 
the acid affects Ionisation of lipid and protein species a 70% Methanol solution 
was used to observe both these species. Four acid concentrations were 
investigated, 0.1% formic acid, 1% formic acid, 2% formic acid and 3% formic 
acid. 
0 0.5 1 1.5 2 2.5 3 3.5 40
200
400
600
800
1000
Time from begining of injection (min)
In
te
n
si
ty
Total volume = 1uL
m/z 758
m/z 942
0 5 10 15 200
500
1000
1500
2000
Time from begining of injection (min)
In
te
n
si
ty
Total volume = 4uL
m/z 758
m/z 942
0 2 4 6 8 10 12 14 160
500
1000
1500
2000
2500
3000
3500
Time from begining of injection (min)
In
te
n
si
ty
Total volume = 3uL
m/z 758
m/z 942
0 2 4 6 8 100
200
400
600
800
1000
1200
Time from begining of injection (min)
In
te
n
si
ty
Total volume = 2uL
m/z 758
m/z 942
107 
Lipids form adducts with sodium and potassium that are extracted from the 
tissue. By increasing the acid concentration in the LESA solvent, formation of a 
protonated molecule is favoured. The protonated molecule is the least useful 
for characterization as it produces very few fragments therefore it is most useful 
to keep the protonated peak to a minimum. [209, 210] (The use of additives for 
lipid identification will be explored further in chapter 4).  
The most intense protein peaks are detected using a solution containing 1% 
formic acid. It was observed during the experiment that the electrospray of 
solutions containing 2% and 3% formic acid were very unstable reducing the 
intensity of the peak (Figure 30). The detections of hemoglobin variants via 
LESA has been reported, in this case a solution containing 3% formic acid was 
used, however this was to target hemoglobin in blood spots on card. [83, 84, 
197] 
 
Figure 30: The intensity of three of peaks, m/z 1081.45 in a +13 charge state, m/z 1084.75  in +13 
charge state, m/z 1087.07 in a +14 charge state, observed using 70% methanol as the 
extraction solvent with 4 concetrations of formic acid, in a LESA protocol. Two 
repeats (red and blue). 
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Different solvents including Chloroform/Methanol/Isopropanol 1:2:4 with 
ammonium acetate as a solution have been recommended for extraction and 
analysis of lipids. [79, 87, 193] However, each of these components have a very 
low surface tension (Chloroform = 26.7 dynes/cm2 Methanol = 22.1 dynes/cm2, 
Isopropanol = 23.3 dynes/cm2 at 25 ºC [211]) and when dispensed onto glass 
the LMJ breaks and the solution forms a thin film on the surface. Additionally 
methanol, chloroform and Isopropanol are volatile solvents and when 
dispensed will quickly evaporate.  
LESA analysis using Chloroform/Methanol/Isopropanol solutions would be 
very difficult. To combat this the height from which is recovered is reduced to 
zero, so that the LESA tip is in contact with the surface. In addition the area that 
would be affected could be quite large, as the solvent would spread along the 
samples surface a relatively long way affecting the spatial distribution of lipid 
ions. For a reliable liquid micro junction to be formed it is necessary to have a 
proportion of water (surface tension of 72.7 dynes/cm2 at 25 ºC [211]) in the 
solvent mixture to insure that the LMJ droplet is stable and the sampling area is 
as restricted as possible, while still providing an organic component for 
optimum ESI analysis.  
1.1.1 Washing 
Tissue washing was found to improve analysis of proteins in tissue, reducing 
suppression effects caused by abundant salts and lipids, which are typically 
removed in the washing step. This strategy has been relatively widely deployed 
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by the MALDI imaging community in studies of peptide and protein 
distributions across a tissue surface. [44, 212-214] 
 
Figure 31: Top) Spectrum observed using 0.1% formic acid in 50% Acetonitrile as the solvent in 
a LESA protocol of non-diseased human liver tissue. Bottom) Spectrum observed 
using 0.1% formic acid in 50% Acetonitrile as the solvent in a LESA protocol, from 
the same spatial location that had previously been sampled via LESA using 0.1% 
formic acid in 80% Ethanol. 
 
Liquid micro junction analysis can be viewed as a localised washing where the 
eluent is then analysed. A washing step using the LESA protocol was 
conducted using a favourable lipid extraction (80% Ethanol + 0.1% FA) 
followed by a favourable protein extraction (50% Acetonitrile + 1% FA). This 
resulted in almost double the number of proteins being observed in the second 
extraction, 13 proteins above 3 kDa were observed from a 50% Acetonitrile + 
1% FA extraction, whereas 18 proteins (Appendix 1) were observed from a 50% 
Acetonitrile + 1% FA extraction using tissue washing. In both cases the largest 
protein observed was the beta chain of haemoglobin at 16 kDa. (Figure 31) 
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When targeting proteins, using the LESA as a localised washing mechanism is 
time consuming. In these instances it is better to wash the entire sample prior to 
analysis. Four sequential tissue sections were dipped into 80% ethanol for 10 
seconds and then left to dry. Three were then dipped for a further 10 seconds, 2 
for additional 10 seconds and then 1 section for a fourth time. Each tissue 
section was analysed three times using the method stated in materials and 
methods chapter. With one dip the signal intensity approximately doubles, and 
subsequent washes there is no improvement (Figure 32). A one way Anova 
statistical analysis on this data shows that for m/z 1081 and m/z 1084 there is a 
statistical difference between the groups, (95% confidence), where as for m/z 
1087 there is no statistical difference. (Analysis in Appendix 2) 
 
Figure 32: The intensity of three of peaks, m/z 1081.45 in a +13 charge state, m/z 1084.75 in +13 
charge state, m/z 1087.07 in a +14 charge state, observed using 70% methanol as the 
extraction solvent. Tissue pretreadted with a series of washes in 80% Ethanol. Error 
bars are one standard deviation from three repeats. 
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3.2.5. Multiple sampling 
In washing experiments the eluent is discarded however this solution is rich in 
analytes. The effect of multiple, serial extractions at the same x, y co-ordinate 
was evaluated using ~70% methanol. The relative abundances of selected ions 
detected in ten sequential extractions are presented in Figure 33. In graph B and 
C the change in intensity of ions in sequential extractions may be explained by 
the effect of repeated washing steps, depleting surface salts. Where as in graph 
A there is no trend in the ion intensity. This could be attributed to the ion being 
a protonated species and the addition of formic acid in the LESA solvent, 
repeatedly contributing to the salt content of the solution. The relative 
intensities of numerous other detected ions in ten repeated extractions are 
presented in Appendix 3. Similar repeat extraction experiments were conducted 
by Eikel et al in an investigation of drug detection from tissue via LESA. [80] 
The authors did not mention other lipids or proteins and were using a solvent 
system specifically optimised for the extraction of the target drug. [80] It is 
important to not when doing LMJ surface sampling of tissue that the sampling 
is not 100% efficient, and that the sample changes due to the analysis that can 
affect the analysis.  
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Figure 33: The intensity of three peaks (A) m/z 758.57 in +1 charge state, (B) m/z 796.53 in +1 
charge state and (C) m/z 942.24 in +15 charge state, observed from ten sequential 
LESA from the same tissue location, using 0.1% formic acid in 70% methanol as the 
extraction solvent. 
 
3.2.6. AGC 
The automatic gain control (AGC) is a parameter that estimates the number of 
ions present, and adjusts the injection time into the Orbitrap for the optimum 
analysis and is typically set at 1,000,000 charges. The AGC relies on a pre-scan 
in the iontrap, which is used to hold the ions before injecting them into the 
Orbitrap. [215, 216] The total current in the iontrap is used to determine an 
approximate number of charges present, this then calculates the fill time 
required to inject the target value for the number of charges. This greatly 
improves spectral quality, as there is compensation for both concentrated and 
weak samples in order to achieve optimum results. However, the AGC is not 
suited to imaging or quantitative analysis. Imaging using the Orbitrap is 
typically conducted using a MALDI source where the AGC is turned off. The 
AGC on a MALDI Orbitrap controls the number of laser shots the reach the 
number of target charges. During imaging experiments the number of laser 
shots per position is maintained. Alternative Orbitrap imaging data sets have 
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been performed using a DESI source. There is conflicting advice for controlling 
the AGC in one instance the AGC is reported to be turned off while performing 
the imaging [217] however in a publication aimed at introducing DESI imaging 
it is suggest that the AGC should remain on, incase of instances where an ESI 
spray is formed instead of a DESI, so that the AGC can prevent a overload of 
ions, [218] many reports fail to mention how or if the AGC is controlled. [219-
222]  
Very few people have used LESA as an imaging platform, Eikel et al, used the 
LESA coupled to an Orbitrap mass analyser for imaging tissue, in this report 
data was not shown instead a photograph displaying sampled regions was 
reported instead. It was noted in the method that a short fill time was used 
(50ms) but the AGC target was on [82]. The only other LESA image was 
produced on a triple quadrupole and therefore did not use an AGC [80].  
The AGC is not suitable for the use with imaging. When the AGC is off, the 
maximum fill time is reached for each scan. Optimisation of the maximum fill 
time included assessment of the signal to noise ratio and the mass accuracy had 
been conducted (see Appendix 4). In conclusion the signal intensity is lower 
that when the AGC is turned on but the s/n ratio is not affected as the noise 
value decreases as well. The mass accuracy is also affected by the maximum fill 
time (Appendix 5). The greater the disparity between the maximum fill time 
and the fill time assessed by the AGC the poorer the mass accuracy is. Therefore 
to maintain a high mass accuracy during imaging, a single position on a serial 
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section to the imaged section was analyzed with the AGC and the fill time was 
noted. This value was then used to fix the maximum fill time when the AGC 
was turned off.  
3.2.7. Imaging 
The optimum solvent system for direct analysis of lipids and proteins in tissue 
sections was found to comprise ~70% methanol. This solvent system was used 
for an automated LESA method to sample 60 locations (5 rows of 12 locations) 
spaced 1 mm apart in a sequential manner across a section of human liver. 
Limitations in the software only allow integers from 1 to 5 mm to be defined as 
the distance between two sampling locations.  
Ion images were constructed from the mass spectrometry data using in-house 
software. Figure 34A shows an example mass spectrum acquired from a single 
pixel location, the average mass spectrum from all 60 locations is presented in 
Appendix 6. An inset of the H&E stained tissue and sampling locations 
showing the area surveyed is also shown. Selected ion images are presented in 
panel B from six singly charged lipid adducts.  
• PC(32:1) +H+ detected at m/z 732.5533, +Na+ detected at m/z 754.5351, 
+K+ detected at m/z 770.5093.  
• PC(34:1) +H+ detected at m/z 760.5844, +Na+ detected at m/z 782.5678, 
+K+ detected at m/z 798.5403.  
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• Lyso-PC(18:2) +H+ detected at m/z 524.3549, +Na+ detected at m/z 
546.3366, +K+ detected at m/z 562.3109.  
• PC(36:4) +H+ detected at m/z 782.5678, +Na+ detected at m/z 804.5507, 
+K+ detected at m/z 820.5250.  
• SM(32:0) +H+ detected at m/z 703.5745, +Na+ detected at m/z 725.5557, 
+K+ detected at m/z 741.5308.  
• PE(40:6) +H+ detected at m/z 764.5217, +Na+ detected at m/z 786.5032, 
+K+ detected at m/z 802.4778.  
Images presented are summed spectral intensity of a window ± 0.005 Da from 
the specified mass. In panel C, distributions of proteins that were detected as 
multiply charged ions are presented. Further ion images were produced by 
summing intensities of 5 peaks (±0.01 m/z) relating to FABP1 +15 charge state 
(m/z 942.1006, 942.1676 942.2339, 942.3010 and 942.3681) and +16 charge state of 
the alpha chain of heamoglobin (m/z 946.2509, 946.3141, 946.3766, 946.4389, 
946.5641). Four unidentified peaks are also presented m/z 845.8645 +10 charge 
state, m/z 1012.1735 +7 charge state, m/z 1058.8244 +15 charge state, and m/z 
1134.3104 +14 charge state. 
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Figure 34: Panel A) Spectum produced during the imaging run, from the location indicaticated. 
Inset, enlargment of the protien region of the mass spectrum. Inset, Photograph of 
the imaged tissue section stained using H and E, overlay indecates pixle locations. 
Mass spectrum from blue pixel is displayed. Panel B) Distributions of six lipids as 
their protonated, sodiated and poassiated adducts and the sum of the three 
adducts. Panel C) Distribution of the sum of 5 isotopic peaks from the +15 charge 
state of L-FABP. Distribution of the sum of 5 isotopic peaks from the +16 charge 
state of α-hgb. Distribution of four unidentified peaks. 
 
It was observed during the experiment that the droplets for each pixel 
overlapped the same area as the previous analysis. To determine the spot size 
of the LMJ the tissue was stained using hematoxylin and eosin (H and E) after 
the extraction process. The H and E staining process interacts with the tissue 
differently between where the LMJ has been and the rest of the tissue, perhaps 
attributed to the acidity of the LMJ solution (Figure 35). The size of the LMJ was 
measured for 4 volumes, 0.5 µL, 1 µL 2 µL and 3 µL. Using these measurements 
it is possible to predict the overlap and spacing of the LMJ when conducting an 
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image (Figure 36). A 0.5 µL droplet forms a LMJ with a diameter of 1.54 mm. 
Using a 1 mm spacing will result in a degree of oversampling. It has been 
shown previously that resampling the same region can change the spectra. This 
can improve some species and hinder others and is highly inappropriate in an 
imaging scenario. 
 
Figure 35: Graph showing the area that is affected by the LMJ during LESA analysis. Inset) 
Photograph of a heamotoxalin and eosin stained non-dieased human liver tissue 
section that has been sampled three times using LESA.  
 
 
Figure 36: The theorectial coverage of imaging with a 0.5 µL LMJ with 2 mm spacing (Left) 
between sampling locations and 1mm sampling (right) locations. Unsampled areas 
are dark blue, areas sampled once are light blue, green indicates the area has been 
sampled twice, orange indicats the area has been sampled three times, and red 
indicates the area has been sampled four times.  
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A second imaging experiment was conducted using 2 mm spacing between 
each sampling location to insure that the sampling locations did not overlap. 
Figure 37A shows an example mass spectrum acquired from a single pixel 
location. Selected ion images are presented in panel B from seven singly 
charged lipid adducts. Lipid identities and sn1 and sn2 FA were confirmed 
using MS/MS techniques outlined in section 6.2.1.3. 
• Lyso-PC(18:2) +H+ detected at m/z 524.3549, +Na+ detected at m/z 
546.3366, +K+ detected at m/z 562.3109.  
• Lyso-PC(20:4) +H+ detected at m/z 544.3428, +Na+ detected at m/z 
566.3276, +K+ detected at m/z 582.3019.  
• SM(32:0)+H+ detected at m/z 703.5745, +Na+ detected at m/z 725.5557, 
+K+ detected at m/z 741.5308.  
• PC(32:1) +H+ detected at m/z 732.5533, +Na+ detected at m/z 754.5351, 
+K+ detected at m/z 770.5093.  
• PC(34:2) +H+ detected at m/z 758.5788, +Na+ detected at m/z 780.5614, 
+K+ detected at m/z 796.5356.  
• PC(36:4) +H+ detected at m/z 782.5678, +Na+ detected at m/z 804.5507, 
+K+ detected at m/z 820.5250.  
• PC(38:4) +H+ detected at m/z 810.6112, +Na+ detected at m/z 786.5032, 
+K+ detected at m/z 848.5686. 
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In panel C, distributions of proteins that were detected as multiply charged ions 
are presented. Further ion images were produced by summing intensities of   
three peaks (±0.01 m/z) relating to FABP1 in the +15 charge state (m/z, 942.1676 
942.2339, 942.3010) and FABPTA in the +15 charge state (m/z, 940.2460, 940.1788, 
940.3127). As well as α-hgb in the + 16 charge state (m/z 946.2509, 946.3141, 
946.3766) and β-hgb in the + 16 charge state (m/z 1134.3269, 1134.2529, 
1134.3979). The other map in the panel present distribution of a currently 
unidentified specie found at m/z 1148.1944 in a +3 charge state. An inset of 
panel C is the H&E stained tissue and sampling locations showing the area 
surveyed. 
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Figure 37: Panel A) Spectum produced during the imaging run, from the location indicaticated. 
Inset, enlargment of the protien region of the mass spectrum. Panel B) 
Distributions of seven lipids as their protonated, sodiated and poassiated adducts 
and the sum of the three adducts Panel C) The distributions of 5 protiens β-hgb 
(+16 charge state), α-hgb (+16 charge state), FABP1 (+15 charge state), FABPTA (+15 
charge state) and an unidentified species in a + 3 charge at m/z 1148.1944. 
Photograph of the imaged tissue section stained using H and E, overlay indecates 
pixle locations. Spectrum from blue pixel is shown in panel A.  
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These results highlight the opportunities for profiling a diverse selection of 
endogenous analytes in tissue using LESA methods. The two-dimensional 
profiles of proteins and lipids show an inversely proportional relationship, 
pixels that show high lipid intensity correspond to pixels of low protein 
intensity. This is not ideal, as ion images produced will depend heavily on 
other species that are present in the solution. Therefore separation of these 
species for imaging is essential. Subsequent chapters in this thesis will explore 
the use of LESA with liquid chromatography for the analysis of proteins and 
the LESA coupled to ion mobility spectrometry for the analysis of lipids and 
proteins directly from human liver tissue.  
3.3 Conclusion 
Here has been demonstrated a single LESA protocol for the direct analysis of 
lipids and proteins. The simultaneous analysis of these molecules are 
challenging for most reported techniques, for example, analysis of proteins and 
peptides via MALDI use carefully selected, matrices and laser powers, which 
may not be suitable for analysis of lipids in the same section. In addition 
optimal analysis conditions lipids and proteins have been determined. For 
optimum lipid analysis, a solution of 0.1% formic acid in 80% ethanol is used, 
with a 10 second LMJ delay, where as for protein analysis the optimal 
conditions is a solution of 1% formic acid in 50% acetonitrile, with a 30 second 
LMJ delay. The analysis of specific lipids and proteins in human liver sections 
will be explored further in subsequent chapters in this thesis. 
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In addition, LESA methods can be used to obtain spatially resolved profiles 
directly from tissue. Current pixel sizes are 1.86 mm2 this relates to an ideal 
pixel spacing of 1.54 mm, this sits between the 1 mm and 2 mm spacing that is 
allowed by the instrumentation. At 1 mm spacing there is a degree of over 
sampling, whereas at 2 mm spacing leaves un-sampled tissue. It would be 
possible to adjust the droplet size to make a more effective sampling area. A 
droplet of 1.6 µL would give a diameter of approximately 2 mm, preventing 
oversampling and reducing the amount of un-sampled tissue. To do the same 
for a 1 mm spaced image it would be necessary to reduce the droplet volume to 
approximately 0.2 µL. A recent report shows the potential for the reduction of 
the contact area of the liquid micro-junction by applying electro-focusing 
without reducing the droplet volume. [223] Alternative surface sampling probe 
introduced by the Van Berkel group, [94] and nano-DESI introduced by Laskin 
et al, [95] provide a route to improved resolutions and analysis times in LMJ 
sampling. At present, possibly the most significant advantage of using LESA 
spatial profiling is the relatively long spray times per pixel, over 4 min when 
compared to other imaging techniques such as MALDI and DESI which are less 
than 1 sec. There is the possibility to enhance the data acquisition and improve 
the quality of the analysis. 
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Chapter 4:  Top-down and bottom-up identification of 
proteins by liquid extraction surface analysis mass 
spectrometry of healthy and diseased human liver tissue. 
Work presented in this chapter has been published as an article in the Journal of 
the American Society for Mass Spectrometry [vol. 25. p.1953-1961 2014], on 
which I am first author. The article was written in collaboration with my 
supervisors, and is included in Appendix 7. 
4.1 Introduction 
The work presented in Chapter 3 demonstrated that LESA is suitable for the 
detection of proteins. In this chapter, LESA has been applied to the analysis of 
proteins in thin tissue sections from human liver. Specifically, the aim was to 
explore LESA as a means for interrogating protein biomarkers of non-alcoholic 
liver disease.  
Identification and characterisation of liver fatty acid binding protein (FABP1) 
was of particular interest. The fatty acid binding protein has been shown to 
have a natural variant that is associated with an increased risk in the detection 
of fatty liver disease [181]. The variant has a single amino acid substitution at 
the 94th amino acid residue: Thr→Ala. Top-down and bottom-up approaches 
for the analysis of proteins extracted by LESA have been investigated. Top-
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down methods were applied to 4 proteins to determine their identity. These 
four proteins were assessed in both non-diseased and NASH liver tissue from 
four tissue sections (two non-diseased samples, one from tumour resection 
margin, and one from a donor liver not suitable for transplantation). A bottom-
up approach conducted on the tumour resection margin tissue section, in which 
intact endogenous proteins were extracted by LESA prior to automated trypsin 
digestion was used to investigate the scope of proteins that can be analysed and 
detected via LESA via an automated trypsin digestion [85, 224]. 
4.2 Results and discussion 
4.2.1. Top-down analysis of intact proteins in human liver 
Four protein ions detected using a solvent system of 50% acetonitrile (Figure 38) 
were subjected to CID and ETD. These ions were,  
• m/z 775 in a +14 charge state (MWmeas 10836.8056 Da) 
• m/z 940 in a +16 charge state, and m/z 1081 in a +15 charge state (both 
with a MWmeas of 14081.3600 Da) 
• m/z 942 in a +16 charge state, and m/z 1084 in a +15 charge state (both 
with a MWmeas of 14111.4161 Da) 
• m/z 946 in a +16 charge state (MWmeas of 15117.9167 Da) 
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Figure 38: Spectra aquired using 50% acetonitrile + 0.1% FA as the solvent in a LESA protocol of 
non-dieased liver tissue section. Four protein signatures indicated are 10kDa heat 
shock protein (mitonchondrial), α-hemoglobin, FABP1 and FABPTA. 
 
Ions of m/z 775.42 (+14 charge state, MWmeas 10836.8056 Da) observed in the 
LESA mass spectrum from non-diseased human liver tissue were selected and 
subjected to CID and ETD MS/MS. The CID and ETD product ions were 
processed using Xtract software to produce [M+H]+ and were searched against 
the simple human database using Prosight PTM 2.0. [196]. The protein was 
identified as the mitochondrial 10 kDa heat shock protein (m-HSP) (MWcalc 
10836.8485 Da, Δ 3.96 ppm). All identified peaks are listed in Appendix 8 and 9. 
The spectra (Figure 39) were processed manually and 15 b ions and 21 y ions 
were identified from the CID spectrum resulting in 23% coverage. A coverage 
of 24% was achieved using ETD (2 a ions, 1 b ion, 17 c ions, 5 y ions and 10 z 
ions). Together a combined coverage of 40% was obtained (Figure 40). A peak 
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at this m/z was also observed in the LESA mass spectrum obtained from NASH 
tissue however its abundance was insufficient for MS/MS. 
 
Figure 39: MS/MS spectra observed form the 10 kDa mitrocondrial heat shock protein using A) 
CID and B) ETD. 
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Figure 40: Protein sequence coverage of the 10 kDa mitochondrial heat shock protein 
determined from spectra aquired following CID (Top) and ETD (Bottom) 
fragmentation. b/y fragments are indicated using black markers, c/z fragments 
with red markers, and a fragments with blue markers.  
 
Ions at m/z 946.40 (+16 charge state, 15117.9167 Da) observed in the LESA mass 
spectrum from non-diseased human liver tissue were selected for CID (Figure 
41A). The CID product ions were processed using Xtract software to produce 
[M+H]+ and were searched against the simple human database using Prosight 
PTM 2.0.  
The protein was identified as alpha chain of haemoglobin (MWcalc 15117.8924, Δ 
1.60ppm). The sequence coverage obtained using CID was 31% from 17 b ions 
and 52 y ions (Complete list of CID fragments is presented in Appendix 10). A 
peak was observed in NASH tissue at the same m/z and selected for ETD 
(Figure 41B). Again, the protein was identified as α-heamoglobin, with a 
coverage of 13% from 17 c ions and 6 z ions (Complete list of ETD fragments is 
presented in Appendix 11). Together a combined coverage of 42% was obtained. 
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Diagrams for the sequence coverage of the CID and ETD analysis are shown in 
Figure 42. 
 
Figure 41: Enlarged regions of spectra aquired using A) CID and B) ETD of ions detected at m/z 
946.40 identified as the alpha chain of heamoglobin 
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Figure 42: Amino Acid coverage of α-haemoglobin observed from CID and ETD fragmentation. 
b/y fragments are indicated using black markers, c/z fragments are red. 
 
A protein of mass 14111.4161 Da was detected in a series of charge states from 
+10 to +16. This protein was observed in both non-diseased and NASH tissue 
sections. The +15 charge state (m/z 942.23) ions were selected from non-diseased 
tissue for ETD fragmentation. The +13 charge state (m/z 1087.04) ions from 
NASH tissue were selected for CID analysis. Different m/z values were targeted 
in the MS/MS experiments because for CID the most intense peak provided 
good separation from neighbouring peaks for optimum isolation. For ETD, a 
higher charge state was selected for optimum fragmentation. The CID and ETD 
product ions were processed using Xtract software to produce [M+H]+ and 
were searched against the simple human database using Prosight PTM 2.0 
(Complete list of fragments identified is presented in Appendix 12 and 13). The 
protein was identified as the liver-fatty acid binding protein (FABP1) (MWcalc 
14111.3892, Δ 1.9 ppm). (Figure 43A and Figure 44A) The protein was observed 
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with the initiator methionine removed and an acetylation of the N-terminal 
amino acid. Manual analysis of the CID data identified 7 a ions, 48 b ions and 60 
y ions resulting in a coverage of 47%. For ETD, 6 a ions, 44 c ions, 11 y ions and 
26 z ions were identified resulting in a coverage of 38%. The combined coverage 
was 63%. 
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Figure 43: A) Enlarged region of the spectra observed from CID of ions found at m/z 942.24, and 
sequence coverage of the protien identified as FABP1. B) Enlarged region of the 
spectra observed from CID of ions found at m/z 940.29, and sequence coverage of 
the protien identified as FABPTA. C) Illustration of the mass shift of fragments 
between the two proteins. 
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Figure 44: Enlarged region of the spectra observed from ETD of ions found at m/z 1087.04, and 
sequence coverage of the protien identified as FABP1. B) Enlarged region of the 
spectra observed from ETD of ions found at m/z 1084.04, and sequence coverage of 
the protien identified as FABPTA. 
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The final protein that was identified by top-down mass spectrometry was the 
variant FABP1. This protein had a measured molecular weight of 14081.3600 Da 
and was detected in a series of charge states from +10 to +16. Peaks 
corresponding to this protein were observed in both non-diseased and NASH 
tissue sections. The +15 charge state (m/z 940.29) ions were selected from non-
diseased tissue for ETD fragmentation. The +13 charge state (m/z 1084.04) ions 
from NASH tissue were selected for CID analysis. The different charge states 
were selected for the same reasons discussed above. The CID and ETD product 
ions were processed using Xtract software to produce [M+H]+ and were 
searched against the simple human database using Prosight PTM 2.0. The 
protein was identified as the liver-fatty acid binding protein with the same N-
terminal post translational modification, with a single acid substitution of the 
94th amino acid of Thr→Ala (MWcalc 14081.3687, Δ 0.6 ppm) (Figure 43B and 
Figure 44B) Manual analysis of the CID spectrum identified 2 a ions, 32 b ions 
and 46 y ions resulting in a coverage of 37%. For ETD 30 c ions, 3 y ions and 20 
z ions were identified resulting in a coverage of 29%. (Complete list of 
fragments identified is presented in Appendix 14 and 15). The combined 
coverage was 52%. FABP1 and FABPTA were observed in both the non-diseased 
and NASH tissue sections. The study was expanded to include a further non-
diseased and NASH tissue section from alternative donors. Figure 45 shows 
expanded m/z regions containing the +15 charge states of the FABP1 and 
FAPBTA and the +16 charge state of a-haemoglobin. It is clear to see that ions 
from the three molecules are not always detected. The FABP1 is observed in 
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both the non-diseased sections but only one of the NASH sections, whereas the 
FABPTA is observed in both the NASH sections but only one of the non-
diseased sections. It has been demonstrated recently that FABPTA is linked to an 
increased risk of developing NASH. [181] It should be noted that the detection 
of the FABPTA in the non-diseased is not a direct indicator of NASH as there are 
other risk factors associated with the disease, such as diet, diabetes, ethnicity 
and gender. [225]  
The non-diseased sections are also characterised by reduced signals for a-globin. 
This is due to the treatment of the tissue prior to freezing and sampling. One of 
the sections (Figure 45A) was from a liver rejected for transplantation due to a 
lesion on the exterior of the liver, the procedure to help preserve the liver and 
prevent organ rejection involved the liver being perfused with phosphate buffer 
to remove the donors blood. The other section is tumour resection margin; this 
means that a tumour was surgically removed with some of the surrounding 
tissue, and non-diseased regions were removed. During the surgical procedure 
it is likely that local haemolysis reduced the blood supply to the excised tissue.  
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Figure 45: Enlarged regions of spectra aquired using a LESA protocol from four liver sections 
from different patients showing the relative abundance of three know proteins. 
 
4.2.2. Automated extraction, digestion and LC-MS/MS analysis 
Top down analysis has been used to identify four proteins extracted from 
human liver tissue. It is hypothesised that more proteins are extracted during 
LESA than are detected using direct infusion electrospray. To investigate this, 
bottom-up analysis was conducted. Bottom-up analysis has been shown to 
detect numerous proteins. For example, bottom-up analysis of dried blood 
spots using LESA identified over 100 proteins, [85] Here non-diseased  human 
liver tissue was sampled using LESA with three different extraction solutions 
(50 mM NH4HCO3(aq), 50% MeOH(aq), 70% MeOH(aq)). The extracted intact 
proteins were subjected to an automatic digestion protocol described by Martin 
et al. [85] The digest was then analysed in duplicate via LC-MS/MS. In total 549 
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non-redundant proteins were identified, 464 from the 50mM NH4HCO3 (aq) 
extraction, 214 from the 50% MeOH extraction and 116 from the 70% MeOH 
extraction (Figure 46) 
 
Figure 46: A) Venn diagram of the number of proteins identified using 3 extraction conditions. 
B) Amino ace sequence of FABP1 with highlighted regions of peptides identified 
from the two technical repeats of the aqueous extraction. 
 
As expected, a substantially greater number of proteins were observed than 
detected by top-down methods (Typically 10-20 proteins (Appendix 16) 
proteins for direct infusion depending on extraction conditions and can increase 
to 34 protiens (Appendix 20) when using FAIMS (See chapter 5). There are two 
main reasons behind this. First the digestion process breaks down large 
proteins that were not detected into smaller peptides that are easier to detect. 
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The second is the chromatography that was used to separate the peptides, 
reducing the number of peptides entering the mass spectrometer at any time 
point during the analysis. This reduces ion suppression and increases the 
number of species detected. The MS/MS acquisition and data processing is 
mostly automated and provides an easy method to identify large numbers of 
proteins.  
The ammonium bicarbonate extraction identified the greatest number of 
proteins. This is expected, because proteins are most soluble in water-based 
solutions. Work presented in earlier chapters of this thesis have shown that 
reducing the organic content of the extraction solvent increases the number of 
proteins detected, until a point where there is ineffective ionisation. It is 
interesting although not completely unexpected that there are proteins that are 
only detected in organic containing solutions. Proteins consist of polar and non-
polar regions based on their function therefore it is likely that some proteins 
have larger non-polar region enhancing their extraction efficiency in organic-
containing solvents. It may be that these proteins have a function in low 
aqueous regions of the cell, e.g., the lipid membrane. Not all proteins known to 
be present in liver were identified. With further optimization it may be possible 
to identify more proteins using the ammonium bicarbonate solution. 
Three known biomarkers of liver disease were identified using all extraction 
conditions. These proteins were identified by at least one unique peptide in the 
current database. Gamma-glutamyltransferase (MW 77,329 Da) [202] was 
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identified with a maximum coverage of 32.90% from the ammonium 
bicarbonate extraction. Aspartate amino transferase was identified in two forms, 
the mitochondrial (MW 47,518 Da), and the cytoplasmic (MW 46,248 Da), both 
of which are associated with liver disease [176]. The homology between these 
two proteins is 68% (as calculated by BLAST 
http://blast.ncbi.nlm.nih.gov/Blast.cgi). The mitochondrial aspartate amino 
transferase was identified with maximum sequence coverage of 48.37% from 
ammonium bicarbonate extraction. The cytoplasmic aspartate amino 
transferase sequence coverage was 52.52% identified from the 50% methanol 
extraction. The fatty acid binding protein was also identified (FABP1) (MW 
14208 Da) [181] and was observed in all extractions and in both repeats with a 
coverage of 53-57%. (Figure 47B and Appendix 17). The variant (FABPTA) was 
not initially identified as it was not in the database. After manually entering the 
amino acid sequence for FABPTA, the variant was identified in only one of the 
ammonium bicarbonate repeats.  
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Figure 47: Spectra aquried during bottom-up analysis of non dieased human liver tissue. CID 
spectra of FABP peptide that distinguishes between FABPTA (A) and FABP1 (B).  
 
It is possible that FABPTA is present in more than one extraction however these 
proteins only differ by one amino acid. The majority of peptides that are 
identified could be from either protein (FABP1 or FABPTA). If the peptide 
containing the site of substitution is identified then the protein is considered to 
be detected. Due to the automatic acquisition it is possible that the peptide 
could be detected but not selected for fragmentation. Cross validation using 
accurate mass and retention time (collected from the one occurrence when it 
was identified) confirmed that the peptide relating to FABPTA was not detected 
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in the other replicates. The fragmentation of this significant peptide required to 
differentiate between the two peptides is poor, indicating that the bottom-up 
method of identification may be unreliable. It may be possible to improve the 
detection of this peptide by adding the peptide to an inclusion list to insure that 
if it is detected it is fragmented. Improving the fragmenting may be possible if 
the timing is optimised. Every peptide is eluted from the LC over a range of 
retention times. Typically fragmentation occurs when the peptide is first 
detected and meets minimum intensity limits, however conducting the 
fragmentation when the peptide is at its maximum would produce a better 
spectrum and more fragments may be detected.  
4.2.3. Automated on-tissue digestion with LC-MS/MS 
To try and improve the detection and identification of the differentiating 
peptide for FABP1 and FABPTA, as well as to increase the number of proteins 
detected, an on-tissue digestion protocol was developed. For optimum 
digestion, the trypsin needs to be held at 37 ºC for 1 hour. [226] This 
requirement leads to the obvious problem of reagent evaporation: however it is 
possible to reduce the rate of dispensing so that it approximately matches the 
rate of evaporation and thereby maintaining a stable liquid micro-junction for 
extended periods of time. Using the conditions outlined in (section 2.7.3) liquid 
micro-junctions were maintained for 30 min while the tissue was heated to 35 
ºC. Tissue section was positioned on a glass slide mounted on a 96-well 
microtiter plate. The plate holder was then set to the maximum temperature 
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setting of 55 ºC, this subsequently heated the glass to a temperature of 35 ºC. 
This was measured by a thermometer placed on the glass slide. 35 ºC is not the 
optimum temperature for trypsin digestion, which is 37 ºC, but was sufficiently 
close for successful digestion. When this procedure is conducted twice, near 
ideal digestion conditions are met. Three extractions were conducted: 282 
proteins were identified from the first extraction, 298 from the second and 127 
from the third.  
Literature also reports the use of multiple extractions to collect the digested 
peptides from a tissue surface using LESA in this case the trypsin was 
deposited by an inject printer and the digestion was conducted in an humid 
incubation chamber to prevent the droplet of trypsin from evaporating. LESA 
was then used to extract the peptides from the surface. [201] One, 5 and 10 
extractions were pooled and although the methods are different the results 
show that for optimum protein extraction multiple extractions are required 
however there is a point at which no more proteins can be extracted. Here it 
was determined to be the 3rd extraction, which is within the same range as 
literature reports. 
A total of 374 proteins were identified using this method. The FABP was one of 
the proteins identified with coverage of 35%, 53% and 25% for 1st 2nd and 3rd 
extractions respectively. The sequence coverage obtained are similar or less 
than those obtained following the digestion protocol described in Section 4.2.2. 
Combining all the extractions did not improve the coverage. Unfortunately the 
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important peptide to determining the variant was not identified, and upon 
manual inspection it was determined that these peptides were not detected. 
 
Figure 48: Venn diagram of proteins identified using on-tissue digestion 
 
It was anticipated that a greater number of proteins would have been identified: 
The  LESA process would only extracted the soluble proteins whereas, the on-
tissue trypsin would have been exposed to all the proteins on the surface 
increasing the number of proteins that could be digested. This in tern should 
produce soluble peptides. On tissue digestions have previously used humidity 
chambers to control the digestion process. There are a number of possibilities 
that could prevent the effective digestion of proteins on tissue.  
• The trypsin solution is stored in a microtitre plate. For the tissue to be 
heated to 35 ºC ,the LESA plate holder is heated to 50 ºC. The trypsin at 
the bottom of the well is exposed to higher than optimum temperatures 
for an extended period of time. That will increase the rate of 
denaturisation of the enzyme. 
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• The liver is protein rich. It is possible that the concentration of trypsin 
may be too low to fully digest the proteins from the region of tissue. 
4.3 Conclusion 
Top-down and bottom-methods have been successfully implemented to 
identify proteins using LESA from thin tissue sections. Top-down is capable of 
differentiating between the FABP1 and the FABPTA that differs by only one 
amino acid. Amino acid substitutions and post-translational modifications 
appear as mass shifts in a number of fragments allowing the substitution/PTM 
to be located. The restriction of top down analysis is that only a limited number 
of proteins are detected and the accompanying database search algorithms 
requires improvement. Bottom-up analysis has identified 549 proteins 
including several biomarkers for liver disease. FABP1 is also detected however 
due to the nature of bottom-up the peptide that distinguishes FABPTA from 
FABP1 is not always detected in a sample that is known to contain both. 
Furthermore poor fragmentation of this peptide means that accurately 
pinpointing the modification is more difficult. 
Top-down and bottom up are very different approaches to identifying proteins. 
Top-down coverage is defined as the percentage of cleavages between each 
amino acid, whereas bottom-up coverage is the percentage of peptides that 
have been identified even if the peptide has only a few fragments. This makes 
direct comparison of the efficiency of these two techniques difficult however 
the quality of information can still be compared. In the case of FABP1 and 
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FABPTA, top-down is a more effective method for identifying these proteins due 
to the ease at which they can be recognised and the substitution confirmed. 
Nevertheless, not every protein can be identified using top-down mass 
spectrometry and it may be necessary to implement bottom-up identification in 
order to observe the protein. 
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Chapter 5:  Liquid extraction surface analysis mass 
spectrometry coupled with ultra-high field asymmetric 
ion mobility spectrometry for the analysis of intact 
proteins from mouse tissue 
Work presented in this chapter has been published as an article in Analytical 
Chemistry [vol. 87, p.6794-6800 2015], on which I am first author. The article 
was written in collaboration with my supervisors. (Appendix 18) 
5.1 Introduction 
Methodology for the analysis of biological systems by mass spectrometry uses 
separation techniques, such as liquid chromatography and ion mobility. Often 
these techniques increase the time taken for analysis. Exceptions are the TWIMS, 
which will be discussed in chapter 6 of this thesis, and the recently developed 
ultra-high field asymmetric ion mobility spectrometry. [161, 162] 
Recent developments in surface sampling have included the development of 
liquid extraction surface analysis (LESA). This method is an automated solid-
liquid extraction of analytes from a surface with electrospray solvent.  [227] 
Chapter 3 demonstrated the ability of LESA mass spectrometry to detect lipids 
and proteins directly from human liver tissue at specific locations and the use of 
optimised solvent systems to target specific analyte groups. Protein analysis by 
LESA mass spectrometry was explored in Chapter 4: a comparison of top-down 
and bottom-up methods for protein identification was conducted. The results 
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showed that there were a vast number of proteins that are not detected but are 
successfully extracted using LESA.  
The work in this Chapter seeks to extend the range of species that can be 
detected and identified in a single injection. To achieve this objective, FAIMS 
(high field asymmetric waveform ion mobility spectrometry) has been coupled 
to LESA extraction to conduct a real time separation of lipids and proteins. 
The ultraFAIMS device replaces the inlet cone of the Orbitrap mass 
spectrometer, (Figure 49) and enables separation of ions in real time. A chip is 
supported in the middle of the inlet cone, an alternating field is applied to the 
chip inducing a separation of the ions due to the differing mobilities of ions in 
high and low electric fields. The ultraFAIMS device can be operated in three 
modes: static analysis in which the compensation field and dispersion field are 
kept constant; 1-D FAIMS analysis in which the dispersion field is kept constant 
and the compensation field is varied; and 2-D FAIMS analysis in which both the 
dispersion field and the compensation field are varied. In this work, the 
ultraFAIMS device was operated in static mode and in 2D mode. 
The work presented in this chapter is the first reported instance of the coupling 
of the ultraFAIMS with the LESA. This is also the first report of lipid and intact 
proteins being detected through the ultraFAIMS from a biological sample.  
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Figure 49: A) Photograph of the ultraFAIMS chip in the holder. B) Photograph of half of the 
ultraFAIMS cone, with the chip and electrodes visible C) Photograph of both 
halves of the ultraFAIMS cone not connected D) Photograph of the whole 
ultraFAIMS cone ready to be connected to the ESI inlet. 
 
5.2 Results and discussion 
The ultraFAIMS chip was mounted in an ESI inlet cone designed to couple with 
the Orbitrap mass spectrometer. The chip is held in the path of the ions and the 
ions traverse the chip through the shortest dimension. Due to the length of the 
cone and the need to attach electronics to the chip, the LESA is mounted 4.2 cm 
further away from the instrument (Figure 50) than in the standard set-up. LESA 
was conducted on thin tissue sections of mouse brain and liver, which were 
thaw mounted onto glass slides. The electrosprayed sample passes through the 
ultraFAIMS chip. 
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Figure 50: A) Photograph of the ultraFAIMS and electronics attached to an Orbitrap Velos ESI 
inlet B) The same as panel A with the addition of the Triversa mount C) A 
photograph of the set up of the Triversa with the ultraFAIMS 
 
5.3 Spectral Quality 
5.3.1. Two dimensional FAIMS analyses 
5.3.1.1 Mouse Liver 
Thin tissue sections of mouse liver were thaw mounted onto glass slides and 
placed into the Triversa Nanomate platform. The tissue was sampled by LESA 
and a 2-D FAIMS analysis was performed. The 2D FAIMS analyses were 
conducted 3-5 minutes after sampling and initiation of electrospray in order to 
enable the electrospray current to stabilise. 2D FAIMS analyses consist of eight 
discrete dispersion fields (DF): 130 Td to 270 Td in 20 Td steps. At each DF, the 
compensation field (CF) was swept between -1 Td and 4 Td shown.  Each mass 
spectrum comprises a single scan, ensuring the data was collected at the fastest 
possible rate.  
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Using the ultraFAIMS there is a reduction in signal intensity, by about an order 
of magnitude. However, the spectra are comparable between these two 
conditions this is to be expected, as there is a longer path length for the ions to 
travel prior to entering the vacuum of the mass spectrometer. The LESA bracket 
is extended by 4 cm to allow for the longer inlet cone, no other features are 
changed, a picture is shown in Appendix 19. 
The total ion chromatogram obtained following LESA 2D FAIMS analysis of 
mouse liver is shown in Figure 51. The results show that there is a general 
decease in the maximum intensity of the total ion chromatogram (TIC) at higher 
DF values. There is also a greater range of CF values in which ions are 
transmitted, indicating greater FAIMS separation of ions at higher DF values. 
At a DF of 130 Td, ions are detected between CF values of -1 Td and 2.2 Td, 
whereas at 270 Td ions are detected at all CF values.  
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Figure 51:  The total ion chromatorgtam of a 2D sweep, aquired using an extraction solvent of 
70% methanol + 0.1% formic acid in a LESA protocol of mouse liver tissue.  
 
At each DF step there are two features observed in the TIC. Figure 52D shows 
TIC obtained for DF step 270 Td) and the corresponding mass spectra at various 
CFs. The ions transmitted at CF of -0.48 Td are observed in the first feature of 
the TIC (Figure 52A). These ions contribute to the background noise of a typical 
LESA mass spectrum of tissue in the absence of FAIMS. The possible identities 
of these ions are large unresolved proteins however they cannot be 
characterised. Shvartsburg et al. showed that larger proteins (> 30 kDa) are 
transmitted through the ultraFAIMS at lower CF values as a result of dipole 
alignment [228]. The second peak in the TIC (Figure 52B) corresponds to well-
resolved smaller proteins of <16,000Da (Appendix 20). The ions that elute at the 
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end of the CF sweep are singly charged ions made up of predominately lipid 
species. (Figure 52C) 
 
Figure 52: Representative spectra from 3 different CF values during a sweep at DF of 270 Td. A) 
Spectra observed from location A in the TIC shown in panel D. B) Spectra observed 
from location B in the TIC shown in panel D. C) Sepctra observed from location C 
in the TIC in panel D. D) TIC observed from a DF of 270  with CF values from -1 to 
4 Td, with markers of the location of the spectra presented in panels A-C. 
 
The order in which ions are observed, that is, signals that have not been 
characterised, lower MW proteins, small molecules, in a single CF sweep is the 
same. At a DF of 130 Td the transmission of these species overlap with each 
other whereas at a DF of 270 Td the separation is greater however the intensity 
of the ions is reduced.  
FAIMS conditions for the transmission of lipids and proteins differ. For lipids, 
the optimum conditions were DF of 130 Td and a CF of 0.87 Td (Figure 53A).  
The optimum conditions for transmission of proteins were DF of 270 Td and a 
CF of 2.62 Td (Figure 53B). The mass spectrum obtained using the ultraFAIMS 
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is more informative than the spectrum obtained in the absence of FAIMS field. 
A comparable single scan spectrum (Figure 53C) shows very few peaks and 
none that are associated with proteins. Combining scans to create an average 
spectrum is common practice. Co-adding 37 microscans (~1min of data 
acquisition) (Figure 53 D) improves the spectral quality when the ultraFAIMS is 
not applied however it is still insufficient to match the quality with the 
ultraFAIMS field applied.  
 
Figure 53: A) Optimum single scan spectrum using the ultraFAIMS showing Lipids and single 
charged molecules.  B) Optimum single scan spectrum using the ultraFAIMS 
showing proteins C) Equivalent single scan spectrum without the ultraFAIMS D) 
spectrum without the ultraFAIMS produced from co-adding 37 microscan spectra 
(1min on analysis) 
 
The signal to noise ratio of a particular peak can be calculated using the noise 
value that is allocated to each peak by the Xcalibur software algorithm and the 
absolute signal intensity for each peak. Table 5-1 compares the signal intensity, 
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the noise value and the calculated signal to noise value for six peaks. Three of 
the peaks correspond to the most abundant protein ions (m/z 1099.9689, m/z 
1021.4731, m/z 883.1610) and the remaining three are lipid peaks (m/z 796.5205, 
m/z 720.4169, m/z 496.3398). To minimise any variations arising from sampling 
differences, the values given in Table 5-1 are taken from the same extraction. 
 
Table 5-1: Signal to noise ratio of peaks with and without the ultraFAIMS field 
m/z 
Not applying the ultraFAIMS 
field 
Applying ultraFAIMS field 
Signal Noise 
Ratio 
(s/n) 
Signal Noise 
Ratio 
(s/n) 
1099.9689 3096.8 315.4 9.8 1164.5# 34.99# 33.3 
1021.4731 3740.1 296.5 12.6 1420.3# 33.5# 42.4 
883.1610 2505.9 218.8 11.5 1116.8# 28.7# 38.9 
796.5205 2399.3 191.9 2.5 1195.4* 22.0* 54.3 
720.4169 337.2 138.0 2.4 476.2* 21.1* 22.5 
496.3398 3818.9 60.3 63.3 2844.5* 18.98* 149.7 
#Using a DF of 270 Td and a CF of 2.62 Td (Optimum protein analysis), *Using a DF of 130 and a 
CF of 0.87 (Optimum lipid analysis).  
As previously mentioned, generally absolute signal intensity is reduced in the 
presence of the FAIMS device. This observation is the result of both the physical 
presence of the FAIMS grid (ions collide with the chip and are neutralised) and 
ion diffusion between the electrodes. There is one exception in the present case: 
the peak at m/z 720.4169 has higher absolute signal intensity when the 
ultraFAIMS field applied. This observation may be the results of the 
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competitive nature of the detection and the use of automatic gain control in the 
Xcalibur software. By removing competing ions, a larger proportion of the total 
ions detected are those with m/z 720.4169. There is an overall reduction of 
absolute signal by about half, however, significantly, there is a more than 3 fold 
reduction in the noise in all examples, and in most cases there is over 7 fold 
reduction in noise. This leads to an increase in the signal to noise ratio of up to 
22 fold. The signal to noise of the protein signal typically shows over a 3-fold 
improvement. The UltraFAIMS can be used to separate haemoglobin related 
ions from small peptides. At a DF of 270 Td and a CF of 2.6 small peptides were 
transmitted and were observed at a higher intensity than haemoglobin ions, 
which are typically the dominant species in mouse liver.  
5.3.1.2 Mouse Brain 
Mouse liver and brain were both analysed via ultraFAIMS. The data acquisition 
for mouse brain was more difficult. This could be because brain tissue has a 
particularly high concentration of salts that are used to transmit signals along 
neurones. For signalling along a neuron an ion gradient is formed using 
potassium, sodium and chlorine. The creation of electrical potential imbalance 
and the neutralisation of this create a pulse that travels the length of the neuron. 
These salts are typically contained within the cell or the myelin sheath 
surrounding the cell, during section the salts are exposed on the surface. [229] 
Furthermore the myelin sheath is an extension of the phospholipid membrane 
increasing the amount of lipids in brain tissue. [187, 230] High concentrations of 
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lipids and salts prevent proteins from being observed in the spectrum, and 
causes what visually appeared to be effective extraction using the LESA, the 
electrospray current temporally drops resulting in gaps in the 2D FAIMS 
spectrum (Figure 54).  
 For brain tissue it was necessary to wash the tissue using an 80% ethanol LESA 
extraction prior to analysis with 40% acetonitrile and allow sufficient time 
between washing and sampling for the tissue to dry. The trends observed in the 
mouse brain were similar to that observed in the mouse liver. In a separate 
experiment conducted using the same conditions, a repeat of the CF sweep at 
DF 270 Td was conducted in order to acquire a more complete sweep when the 
spray was more reliable. The single scan data from this sweep is shown in 
Figure 55. As with the mouse liver analysis there are two features in the FAIMS 
spectrum, the first feature at a CF of -0.6 Td comprising of non-characterised 
signals. The second feature at CF of 1.5 Td comprising smaller proteins 
however these are not clearly observed above the noise. Clear proteins 
signatures are observed at a CF of 2.6 Td. Lipids are not observed in this 
experiment due to the washing system and the solvent system used for 
extraction (50% Acetonitrile)  
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Figure 54: The total ion chromatorgtam of a 2D sweep aquired using an extraction solvent of 
50% acetonitrile + 1% formic acid in a LESA protocol of mouse brian tissue.  
 
Figure 55: A) Single CF from -1 to 4 Td sweep at a DF 270 Td from mouse brian. B) Single scan 
with a CF of -0.6 from location marked 1 from panel A, C) Single scan with a CF of 
1.5 from location marked 2 from panel A. D) Single scan with a CF of 2.6 from 
location marked 3 from panel A.  
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5.3.2. Static analysis 
Static analysis using the ultraFAIMS involves maintaining a single DF and CF 
for the duration of the experiment. Thin tissue sections of mouse brain were 
sampled by LESA and subjected to a 2D FAIMS analysis as described above. 
The 2D FAIMS analysis enabled the optimum conditions for transmission of 
protein ions to be determined. A subsequent static FAIMS analysis was 
performed at a DF of 270 Td and a CF of 2.6 Td, allowing scans acquired under 
the same conditions to be co-added. (Figure 56) 
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The mass spectra shown in Figure 56 are the result of one min of data 
acquisition. The comparison mass spectrum (Figure 56 top) was recorded in 
absence of the ultraFAIMS field. In the absence of the ultraFAIMS field peaks 
corresponding to the charge state envelopes of three proteins were observed, 
whereas in the presence of FAIMS field, peaks corresponding to the charge state 
envelopes of 39 proteins were observed (Appendix 21). The monoisotopic 
masses of the proteins were between 4895 Da and 15839 Da. Monoisotopic 
masses were calculated using the Xtract function in Xcalibur software (Thermo, 
M mass mode and a minimum s/n 3). The majority of the additional proteins 
detected were small proteins below 10,000 Da. The brain is particularly rich in 
peptides and small proteins because they are used in signalling and regulation. 
[231] Many peptides are also able to cross the blood brain barrier and being able 
to detect these molecules is particularly usefully for progressing understanding 
of brain function [232, 233]. Larger proteins were also observed: two of these 
were identified as the alpha and beta subunits of haemoglobin. These also make 
up two of the three proteins observed in the absence of the ultraFAIMS field. 
Work presented earlier in this thesis showed that high concentrations of 
haemoglobin could inhibit the detection of less abundant proteins (Chapter 3).  
Static FAIMS analysis can also be used for fragmentation, where longer analysis 
times aid in optimum detection, see below. 
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5.4 Fragmentation of ions detected using the ultraFAIMS 
Proteins ions transmitted via the ultraFAIMS were subjected to top-down mass 
spectrometry. Two unknown peaks were isolated and fragmented from mouse 
tissue, one observed in mouse liver, m/z 1021.47 (14+ charge state, MWmeas 
14279.4328) and one observed from mouse brain m/z 952.63 (9+ charge state, 
MWmeas 8560.6457). Both were subjected to ETD, CID and HCD MS/MS. 
 
Figure 57: Spectra aquired using 70% methanol + 0.1% FA as the solvent in a LESA protocol of 
mouse liver with a DF of 130 Td and a CF of 0.3 Td. CID (A), HCD (B) and ETD (C) 
fragmentation of m/z 1021.47 identified as liver fatty acid binding protein. Spectra 
aquired using 50% acetonitrile +1% FA as the solvent in a LESA protocol of mouse 
brain with a DF of 270 Td and CF of 2.6 Td. CID (D), HCD (E) and ETD (F) 
fragmentation of m/z 952 identified as ubiquitin.  
 
Work presented earlier in this thesis on human liver showed that the abundant 
proteins detected using LESA mass spectrometry were fatty acid binding 
protein and haemoglobin proteins. Mouse liver fatty acid binding protein is 127 
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amino acids long with a monisotopic mass of 14237.4705 Da, a mass shift of  -42 
Da from the measured monoisotopic mass for m/z 1021.47 (MWmeas 
14279.4328). A known PTM of this protein according to UniProt is acetylation of 
the initiator methionine. With this PTM, the theoretical monoisotopic mass for 
mouse L-FABP is 14279.5011, which has an error of Δ -4.78 ppm. Manual 
analysis of the CID MS/MS data lead to the identification of 46 product ions 
(Appendix 22), which correspond to 30 amino acid cleavages and gave a 
sequence coverage of 24%, HCD fragmentation gave a coverage of 13% from 17 
fragments and ETD gave a sequence coverage of 18% from 23 fragments. 
Combining the information these three techniques there were 52 fragments 
resulting in sequence coverage of 41%.  
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Figure 58: Coverage of the mouse liver fatty acid binding protein using CID, HCD and ETD 
with the ultraFAIMS at a DF of 130 Td and CF of 0.3 Td and without the 
ultraFAIMS. b/y ions are indicated in blue and c/z ions are indicated in red. 
 
For comparison, the same MS/MS analyses were conducted without the 
ultraFAIMS. The precursor peak in the full scan had a higher signal intensity 
however the signal to noise ratio was lower (s/n without the ultraFAIMS was 
6.78 as opposed to s/n of 14.34 using the ultraFAIMS). There was an increase in 
intensity when the isolation window was applied without any fragmentation. 
The ions were subjected to the same fragmentation conditions. The results 
showed that there was a decrease in the number of product ions detected from 
all three fragmentation methods (Appendix 23). CID fragmentation gave the 
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largest coverage of 15 % from 19 fragments, and HCD resulted in 10 product 
ions yielding 8 % coverage. The ETD mass spectrum was the poorest, with only 
9 fragments being identified resulting in 7 % coverage. Combining the fragment 
identifications resulted in 31 fragments, which produces sequence coverage of 
24 %.  
Many more proteins were observed following LESA FAIMS mass spectrometry. 
The peak at m/z 952 is the most abundant protein signature under the 
conditions of the static analysis and has a s/n of 95.3. Without the ultraFAIMS 
the s/n of this peak is reduced to 8.9 and is only just detected The direct tissue 
analysis of mouse brain using liquid microjunctions has been conducted and 
published by Schey et al. [199]. In that work they used liquid chromatography 
coupled to mass spectrometry analysis to analyse the eluent from the liquid 
micro-junction. Several proteins were identified, one of which was ubiquitin. 
Ubiquitin has a calculated mass of 8560.6240 Da, which agrees with the 
measured mass (MWmeas 8560.6457) with an error of 2.53 ppm. Three 
fragmentation techniques were conducted on the ions: CID, HCD and ETD 
(Appendix 24). CID fragmentation yielded 12 b ions and 22 y ions giving a 
coverage of 37%. HCD fragmentation produced 15 fragments (2 b ions and 13 y 
ions) and sequence coverage 20%. ETD produced the smallest number of 
fragments, 10 fragments (7 c ions, 1 y ion and 2 z ions), giving a sequence 
coverage of 13%. The combined coverage from all fragmentation methods was 
42%.  
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Figure 59: Coverage of mouse brain Ubiquitin using CID, HCD and ETD with the ultraFAIMS 
device at a DF of 270 Td and a CF of 2.6 Td. b/y ions are indicated in blue and c/z 
ions are indicated in red 
 
5.4.1. Visualisation of ultraFAIMS data 
There is no commercial software to process ultraFAIMS data. Two methods of 
visualising the data were developed in MATLAB. The first method visualises 
the distribution of a single peak (m/z or mass) over all DF and CF values 
recorded and is referred to here as a single ion transmission map. The second 
visualises the distribution of all peaks (all m/z) detected at a single DF across the 
CF sweep and is referred to here as a total ion transmission map. 
5.4.1.1 Single ion transmission maps.  
To produce single ion transmission maps several steps of processing were 
required. Lipids and proteins were treated separately. Lipids are observed as 
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salt adducts and are identified using their m/z whereas proteins are observed in 
multiple charge states and so were de-convoluted and their molecular weight 
was considered. Deconvolution of the protein peaks was performed by use of 
the Xtract function in the Xcalibur software (Thermo). The Xtract function was 
applied to every mass spectrum in the FAIMS analysis. The end product is a 
series of files relating to each scan (mass spectrum) in the 2D sweep. These files 
are converted to .mzml files using Proteowizard’s msconvert program [206]. 
The .mzml files are then converted to .imzml files using .imzml converter [208] . 
The .imzml files were opened using mzAnalysis, an in-house program 
developed using MATLAB that enables mass spectrometry data to be displayed 
as images. For lipids, where the Xtract process is not required, the RAW file 
was directly converted to a single .mzml file and this file converted to 
an .imzml file. Using mzAnalysis a single m/z or MW value is isolated and the 
array is exported out of mzAnalysis into the MATLAB workspace. The array is 
a linear representation of the 2D sweep. To visualise the data, pixels 
representing a single DF sweep were isolated and stacked on top of each other 
(Figure 60 top). The challenge associated with this is that there are a different 
number of scans in each DF sweep, and the CF value that corresponds to a 
single scan is different in each DF sweep. 
5.4.1.1.1  Aligning scan number to CF value and CF values between sweeps 
The number of scans in each DF sweep is different. This is because automatic 
gain control (AGC) was used to obtain optimum quality mass spectra. AGC 
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adjusts the fill time based on the number of ions present and as a result each 
scan takes a different length of time. In addition to this, the CF sweep is 
continuous and is not connected to the scans of the Orbitrap Velos. (The 
ultraFAIMS software and the mass spectrometry acquisition software are not 
integrated). Together these factors mean that during a scan the CF is changing 
and the CF at the start of each mass spectrometry scan is not evenly spaced. To 
calculate the CF at the start of the scan (CFs) it is necessary to calculate the rate 
at which the CF is changing. This can be calculated using Equation 19, where tn 
is the length of time for a single sweep, and CF0 and CFn are the start and end 
CF values, tx is the time point at which the CF is being calculated.  
Equation 19 !"! = !"! − !"!!! × !! + !"! 
It is important to note that this would result in the calculated CF increasing 
indefinitely, when in actual fact it cycles between CF0 and CFn. Therefore if the 
value of CFs exceeds CFn then it is known that another sweep has started. Each 
time this occurs the value of the numerator in Equation 19 (CFn-CF0) is taken 
away from CFs one or multiple times to ensure that CFs is always between CF0 
and CFn, and hence calculating the CF value for the start of each scan. The 
MATLAB code for this calculation is supplied in Appendix 25. 
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Figure 60: Top) Visual representation of the CV at each scan, where dark blue is CV= -1 Td and 
dark red is CV = 4 Td Bottom) The same sweeps after the MATLAB transformation 
has been applied.  
 
To align the scans there are several considerations: 
• The first mass spectrometry scan in each CF sweep does not correspond 
to a consistent CF value.  
• The last mass spectrometry scan in each CF sweep will include data from 
the start of the subsequent CF sweep. 
• The first mass spectrometry scan of the experiment aligns exactly with 
the first scan of FAIMS analysis. 
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The first two points are due to the dis-connected nature of the delivery of the 
ultraFAIMS field and the data recording process of the Orbitrap. The third 
point must be assumed true for the calculations to work. However it is unlikely 
to be true. The CF sweep will have started at some point during the first scan of 
the data set  
To align the data a template of artificial scans were created with even spacing. 
These scans ranged from the highest starting CF to the lowest finishing CF that 
was calculated. This means that scans that included both the end of one sweep 
and the start of the next were excluded and ensured that only scans where there 
is an equivalent scan in each sweep were included. The spacing between each 
scan is defined as 1.2 second, which corresponds to the shortest scan acquisition. 
To populate the template with recorded data, the signal intensity at a specific 
CF value was approximated by interpolating between the two nearest recorded 
time points (one above and one below) and assuming a linear relationship. The 
scan number of the template directly corresponds to a CF value and each 
column of pixels spanning each DF refers to the same CF value. This 
transformation is applied to all single ion transmission maps. 
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Figure 61: 2D sweeps of selected ion from mouse liver displayed as single ion transmission (SIT) 
maps. A) m/z 758.57 +/- 0.01 identified as PC(34:2)+H+ B) m/z 760.58 +/- 0.01 
identified as PC(34:1)+H+. C) m/z 806.57 +/- 0. identified as PC(38:6)+H+. D) m/z 
796.52 +/- 0.01 identified as PC(34:2)+K+. E) m/z 798.54 +/- 0.01 from identified as 
PC(34:1)+K+. F) m/z 844.52 +/- 0.01 identified as PC(38:6)+K+ G) Protein of 
monoisotopic 15607 Da. H) Protein of monoisotopic 15971 Da. I) Protein of 
monoisotopic 14278 Da identified as the Liver fatty acid binding protein  
 
The single ion transition maps of 9 species are displayed in Figure 61. There are 
three types of species presented, protonated lipids (panels a-c), potassiated 
lipids (panel d-f) and proteins (panels g-i). All maps show a drift to higher CF 
values at higher DF. These results are consistent with published results, where a 
reserpine standard has been analysed, and shows that there is a reduction in 
intensity, a widening of the peak width and a shift to higher CFs at increasing 
increments of DF [162]. 
There is a similarity between the single ion transmission maps for the 
protonated and potassiated lipid species. There are subtle differences in the CF 
values in which the two adducts are transmitted. The potassium adducts 
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favours slightly lower CF values than the protonated species. Despite this, there 
is a large overlap of the CF values in which these species are transmitted and it 
would not be possible to isolate a specific adduct type. It would be possible to 
reduce the relative intensity of a specific salt adduct.   
The protein maps show significant difference to those of the lipids. The proteins 
in panel G and panel H have been identified as the alpha and beta subunits of 
haemoglobin. These proteins display similar FAIMS transmission 
characteristics. The protein in panel I was identified as the liver fatty acid 
binding protein and display a very different ion transmission pattern.  
5.4.1.2 Total ion transmission maps 
An alternative approach for viewing the data is to display the total ion 
transmission, i.e., the entire mass range across a single CF sweep. This approach 
will produce a single total ion transmission map for each DF condition. To 
achieve this, the m/z ratio needs to be maintained, therefore the data sets are 
converted to an .imzml file using in-house software SpectralAnalysis. This 
software allows the entire dataset to be exported to MATLAB workspace. Here 
the data needs to be binned because each individual mass spectrum is not the 
same number of data points in length. Data was binned by summing the 
contents of the bin, to produce a single value This is because the m/z values for 
each spectrum is calculated at the end of each scan causing small variations in 
the mass recorded as well as variations in the number of m/z data points that 
 171 
make up a single peak. This is especially true when the sample is continuously 
changing, as it is with 2D sweep data, where only specific windows of DF and 
CF values transmit specific ions. Assembly of a matrix that encompasses every 
possible calculated m/z is unsuitable due the memory requirements and 
therefore the data was binned. Figure 62 shows 6 total ion transmission maps 
obtained following LESA FAIMS analysis of mouse liver in which the bin sizes 
are m/z = 0.1, 0.3, 0.5, 0.75, 1 and 2. If the bin size is too small, shifts in peak m/z 
result in a patchy ion distribution over the CV range; however, if the bin size is 
too large, neighbouring peaks will merge into one. The optimum bin width is 
m/z 0.5.  
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Figure 62: The total ion transmission map of the ultraFAIMS sweep at DF 270 Td, from data 
aquired using 70% methanol +0.1% FA as the solvent for a LESA protocol of mouse 
liver procesed using different bin sizes. 
 
Figure 63A shows the complete series, it is clear to see the dominant species in 
the spectrum. The protein distribution is the predominant feature. Similar 
features are observed as previously seen: ions are transmitted at a higher CF at 
increasing DFs and there is a wider distribution of ions at higher DFs. By 
displaying the data like this the separation between signal and noise becomes 
clear. A disadvantage of viewing the data in this manner is the dynamic range 
of the ion abundance. When displayed as a linear colour scale, the lower 
intensity peaks may be of too low an abundance to visualise. Under these 
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sampling conditions, it is the lipid species that are lower in abundance. To 
enhance visualisation of these species it is possible to normalise the data. The 
normalisation approach used here was to normalise within each bin. This 
approach enhances each bin revealing lower abundance peaks. These 
normalised maps need to be read carefully, as the intensities of adjacent bins 
are no longer comparable, however the advantage of these normalised maps is 
that it is clear to see the FAIMS separation of the different species. 
 
Figure 63: Total ion transmission maps of the 2D sweep of mouse liver, A) un-normalised B) 
normalised.  
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5.5 Conclusion 
The work presented in this chapter is the first reported instance of the 
ultraFAIMS being coupled to LESA sampling. Direct tissue analysis has been 
successfully conducted using the ultraFAIMS as a real time separation 
technique. Lipids and proteins can be separated from each other and from the 
large amount of background that is produced when analysing complex samples. 
The advantage of LESA is that there is little sample preparation; however, this 
is accompanied by production of an incredibly complex mixture in which many 
type of ions are present. Current methods for complexity reduction in biological 
samples increase the sample preparation time, some by a little such as tissue 
washing [44], others considerably, such as liquid chromatography, [85, 199]. 
The ultraFAIMS acts as a gas-phase separation technique.  
It has been shown that the reduction in the noise and the corresponding 
increased signal to noise ratio has increased the number of proteins detected. 
Fragmentation of these proteins revels an increased number of fragments being 
identified in those proteins. MS/MS of proteins detected using the ultraFAIMS 
revealed greater sequence coverage than when fragmented without the 
ultraFAIMS  
A MATLAB program was created to visualise the ultraFAIMS data. Two types 
of maps were produced: single ion transmission maps in which a single ion or 
molecule at all the CF and DF values can be visualised; and total ion 
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transmission maps in which all ions across a single CF sweep are visualised. 
These maps show the differences in ion behaviour through the ultraFAIMS and 
reveal optimum conditions for analysis of lipids and proteins. 
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Chapter 6:  Identification of lipids from tissue using 
LESA-ESI and MALDI coupled to traveling wave ion 
mobility mass spectrometry. 
6.1 Introduction 
Lipids are small molecules that are insoluble in water. Lipids are an important 
component of biological systems, they form the basis of the cell membranes, 
and they are important signaling molecules. One such lipid class is 
phosphatidylcholine (PC) lipids. These lipids have a glycerol backbone with a 
phosphocholine head group on carbon one, with carbon two and three 
supporting hydrocarbon chains. Due to the nature of PC lipids it is common to 
have isobaric species, this is where two sets of two hydrocarbon chains have the 
same number of carbons and hydrogens, however the chain lengths, and 
number of double bonds in the chains are different. For example, PC(34:2) has 
two fatty acid chains with a total number of 34 carbons and 2 double bonds. 
This could comprise of a 16:0 (Hexadecanoic acid) and an 18:2 (Octadecadienoic 
acid) chain, an alternative would be a 16:1 (Hexadecenoic acid) and an 18:1 
(Octadecenoic acid) chain. It is important to differentiate between these two 
lipids as structure and function are closely related.  
In the previous chapter suitable solvents for analysis were determined to be 
80% Ethanol+0.1% FA, a highly organic solution. Fragmentation of lipids 
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produces characteristic fragments. The neutral loss of choline produces a 
fragment 59 Da below the precursor ion. This is helpful to identify the class of 
the lipid. Identification of the side chains also involves monitoring the neutral 
loss fatty acids. Monitoring the intensity of the neutral loss of the fatty acid and 
the head group enables the location of the fatty acid to be determined. The more 
abundant fragment will result from the neutral loss of the fatty acid in the sn1 
position.[209, 234, 235]  
Here analysis of lipids has been conducted using collision induced dissociation 
(CID) and high-energy collision induced dissociation (HCD). CID and HCD are 
very similar fragmentation techniques, both these techniques cause dissociation 
by bombarding the ions with neutral molecules. The difference is that HCD 
ions are trapped and held within an electrical field higher than that of CID. This 
causes ions to have an excited state, and increasing the probability of 
fragmentation. On an LTQ Orbitrap ETD, CID is performed in the ion trap 
where as HCD is performed in the HCD collision cell. As a result of this CID 
has a lower mass limit of 1/3 of the m/z of the ion being fragmented, where as 
HCD does not have this limitation (see section 1.5 of the introduction for 
further information). The implication of this is that any fatty acid backbone 
fragments that may be produced would not be observed using CID and only 
HCD when using the LTQ Orbitrap ETD. However in the Synapt G2-S 
fragmentation occurs in the trap or transfer cells and so the full mass range can 
be observed. 
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In chapter 3 analysis of lipids and proteins from human liver tissue was 
investigated and it was found that they could be targeted using solvent 
optimisation. In this chapter, methods for the identification of lipids via HCD 
and CID extracted from human liver tissue via LESA are presented.  
LESA is an excellent tool for in-situ lipid identification as there are long spray 
times enable multiple fragmentation events to occur increasing the number of 
lipids that can be identified from a single location. Coupled to the TWIMS, 
LESA provided opportunities to distinguish between lipid and protein in their 
drift time and arguably more significant the separation of isobaric lipids. 
Spatially directed approach that the LESA can provide does not produce a good 
enough resolution to view the intricate disease specific tissue scaring that is 
observed in NASH. To view this detail from the tissue a MALDI source was 
implemented. MS/MS imaging of a precursor ion produced images of the two 
precursor ions, further more when coupled with the TWIMS isobaric species 
that displayed separate spatial locations were revealed.  
  
 179 
6.2 Results and Discussion 
LESA of formal lithium fixed tissue has been reported as a powerful strategy 
for the in-situ lipid identification. [45]cd Formaldehyde causes cross-linking of 
proteins [236] and so analysis of proteins in the same experiment is not possible. 
Fixed tissue has the advantage of binding the proteins, which prevents their 
extraction and ionisation and means that they are not detected. [45] In this work 
the lithium is introduced to the system by dissolving lithium chlorides in the 
extraction solvent, and by using 80% ethanol + 0.1% formic acid (optimised in 
chapter 3). Even with this optimised solvent extraction there are very small 
contributions of proteins. It was observed that by including lithium in the 
solvent system it has removed any remaining trace of proteins from the 
spectrum. The advantage of this is that it is possible to utilise the advantages 
that lithium adducts can give without the need to fix the tissue.  
6.2.1. Adduct formation 
CID fragmentation of lipids is well documented and widely reported to differ 
depending on the adduct type of the precursor ion [45, 209]. Typical ions 
associated with the neutral losses in CID experiments are illustrated for the 
commonly detected PC(34:2), listed in the Table 6-1 and Table 6-2 and serve as a 
guide for the fragmentation described in this chapter.  
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Table 6-1: Product ions arising from neutral losses of the lipid PC(16:0/18:2) 
 Neutral Loss of fatty acid Neutral Loss of fatty acid and head group 
Fatty 
Acid 
[M+H]+ [M+Na]+ [M+K]+ [M+Li]+ [M+H]+ [M+Na]+ [M+K]+ [M+Li]+ 
16:0 502.3292 524.3111 540.2851 508.3374 443.2557 465.2376 481.2116 449.2639 
18:2 478.3292 500.3111 516.2851 484.3374 419.2557 441.2376 457.2116 425.2639 
All values are m/z 
Table 6-2: Head group product ions arising from neutral of losses the lipid PC(16:0/18:2) 
 [M+H]+ [M+Na]+ [M+K]+ [M+Li]+ 
 Neutral loss of 
choline 
698.4875	
(86.0964)* 721.4773 737.4513 705.5036 
Neutral loss of PC 
Head group 
575.5028	
(184.0733) 597.4853	 613.4593	 581.5116	
PC Head group 
without Choline 124.9998	 146.9812	 162.9552	 131.0075	
All values are m/z. values in brackets indicate the values the head group fragments 
would be detected at. * Is a rearrangement of ethyl choline in the head group, choline by 
its self is not detected. 
 
 
The different adducts of lipids was first investigated for shotgun lipidomic 
approaches, to improve the fragmentation and the subsequent identification of 
the lipid. The salt is incorporated into LC-MS systems between the column and 
the ESI source. A splitter and a second pump is used to combine a solution 
containing the salt adducts and the LC eluent. This then resulted in salt adducts 
being formed during ionisation. Sodium adducts have been used to quantify 
lipids from biological extracts.  [237] The first use of lithium was reported in 
1998 to enhance the fragmentation of lipid species and to improve the 
identification of the fatty acids at sn1 and sn2 positions on phospholipids. [238]. 
Here salt adducts have been applied for the direct infusion of lipids sampled by 
LMJ using LESA.  
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6.2.1.1 CID	of	protonated	lipid	molecules	
Protonated lipid molecules are reported to give few product ions. The 
protonated PC(18:2/16:0) molecule detected at m/z 758.5681 was subjected to 
CID and HCD fragmentation.  
 
Figure 64: A) CID and B) HCD spectrum of [PC34:2+H]+ detected at m/z 758.5681. Acquired 
using LESA sampling with 70% Methanol(aq) + 0.1% FA.  
 
The mass spectrum acquired from CID of m/z 758.5681 (Figure 64A) displays 
informative peaks however all of the peaks are extremely low abundance and 
surrounded by equally abundant non-informative peaks. From the fragments 
detected it is possible to identify peaks relating to the neutral loss of the fatty 
acids (MWmeas 502.3290 neutral loss of 16:0 Δppm -0.40, MWmeas 478.3290 
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neutral loss of 18:2 Δppm -0.42) as well as a peak relating to the neutral loss of 
the head group (MWmeas 575.5032 neutral loss of HG Δppm 0.70,). However 
none of these peaks are the most abundant and would be very difficult to 
identify the lipid without prior knowledge. The HCD scans provides similar 
information (Figure 64B), however there is an abundant resembling the 
protonated head group at MWmeas 184.0734 (Δppm 0.54). Very small peaks were 
observed in the spectrum approximately 1000 times less abundant than the 
main peak. Two of these peaks relate to the neutral loss of the fatty acids 
(MWmeas 502.3292 neutral loss of 16:0 Δppm 0.00, MWmeas 478.3289 neutral loss 
of 18:2 Δppm -0.63). The protonated adduct does contain suitable information to 
identify a lipid however it would be difficulty to interpret unknown lipid due 
the low intensity in the MS/MS spectra. It should also be noted that 
PC(18:2/16:0) is the most abundant lipid observed from non-diseased human 
liver and fragmentation ions are barely detected, product ions from less 
abundant lipids may not be detected at all. The product ions identified are more 
informative than those reported in literature. The most dominant fragment ion 
for a PC lipid is found at m/z 184.5 corresponding to the head group fragment, 
other fragments identified are all of very low abundance, all of which were 
head group related. [239] Here fragments relating to the some neutral loss of 
the fatty acids chains were also identified.  
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1.1.1.1 CID	of	sodium	lipid	adducts	
Sodium is present in tissue and may be introduced as a contaminant in the 
water of the solvent system. The sodium adduct is observed in low abundance 
and has been reported to be beneficial for fragmentation [235, 240]. The sodium 
adduct of PC(18:2/16:0), is detected at m/z 780.5500, and was subjected to CID 
and HCD fragmentation.  
 
Figure 65: A) CID and B) HCD spectrum of [PC34:2+Na]+ detected at m/z 780.5500. Acquired 
using LESA sampling of non-dieased human liver tissue with 70% Methanol(aq) + 
0.1% FA 
 
The CID spectra and HCD spectra (Figure 65) show product ions relating to the 
neutral loss of the head group, and the side chains (Table 6-3 and Table 6-4). The 
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detection of fragments relating to the neutral loss fatty acid and the head group, 
(found at m/z 465.2369 and m/z 441.2369) enable the assignments of the fatty 
acids to the sn1 and sn2 positions on the glycerol. The neutral loss of fatty acid 
16:0+choline is more intense than the neutral loss of the fatty acid 18:1+choline 
therefore the fatty acid 16:0 is in the sn1 position. Using the nomenclature 
sn3(sn2/sn1), PC(34:2) can be identified as PC(18:2/16:0). The product ions 
detected have enabled identification of the lipid, however, the intensity of these 
peaks are very low and there are many other peaks observed that could confuse 
identification. 
Table 6-3: Fragments identified from CID spectrum using sodium adduct of PC(34:2) 
Mass (m/z) Identity Δppm 
721.4766 Neutral loss of choline -0.97 
597.4845 Neutral loss of head group -1.34 
575.5029 Neutral loss of head group with sodium 0.17 
524.3104 Neutral loss of fatty acid 16:0 -1.33 
502.3289 Neutral loss of fatty acid 16:0 with sodium -0.60 
500.3103 Neutral loss of fatty acid 18:2 -1.60 
478.3285 Neutral loss of fatty acid 18:2 with sodium -1.46 
465.2369 Neutral loss of fatty acid 16:0 with head group -1.50 
441.2369 Neutral loss of fatty acid 18:2 with head group -1.59 
 
In the HCD spectra additional peaks are observed at the lower m/z values. It 
should be noted that the sodium adduct is the least abundant adduct that is 
observed, and is it still possible to detected all of these product ions.  
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Table 6-4: Fragments identified from HCD spectrum using sodium adduct of PC(34:2) 
Mass (m/z) Identity Δppm 
184.0734 Head group 0.54 
146.9818 Head group with sodium without choline 4.08 
86.0965 Choline 1.16 
 
6.2.1.2 CID	of	Potassium	adducts	
Potassium adducts are observed as the most intense peaks in a typical spectrum 
from non-diseased human liver. The potassium adduct of PC(18:2/16:0) is 
observed at m/z 796.5239. The neutral loss of the head group is the most intense 
peak, in the CID spectrum (Figure 66A), and there are very small peaks that 
relate to the side chains (Table 6-5). 
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Figure 66: A) CID and B) HCD spectrum of [PC34:2+K]+ detected at m/z 796.5239. Acquired 
using LESA sampling of non-dieased human liver tissue with 70% Methanol(aq) + 
0.1% FA 
 
Table 6-5: Fragments identified from CID spectrum using potassium adduct of PC(34:2) 
Mass (m/z) Identity Δppm 
737.4510 Neutral loss of choline -0.41 
613.4592 Neutral loss of head group -0.16 
575.5034 Neutral loss of head group with potassium  1.04 
540.2850 Neutral loss of fatty acid 16:0 -0.19 
478.3290 Neutral loss of fatty acid 16:0 with potassium -0.42 
481.2114 Neutral loss of fatty acid 16:0 with head group -0.42 
457.2116 Neutral loss of fatty acid 18:2 with head group  0.00 
 
In the HCD spectrum (Figure 66B) very few informative peaks were observed. 
Head group related peaks and one side chain related fragments were observed. 
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The only additional peaks observed in the HCD spectra were potassium adduct 
of the head group without choline and the choline fragment. (Table 6-6) 
Table 6-6: Fragments identified from HCD spectrum using potassium adduct of PC(34:2) 
Mass (m/z) Identity Δppm 
162.9558 Head group with potassium without choline 3.68 
86.0965 Choline 1.16 
 
6.2.1.3 Lithium	
Lithium has been shown to give increased lipid fragmentation and enables the 
two fatty acids to be assigned to sn1 and sn2 positions. [45, 210, 234, 240] 
Lithium is not native in tissue so needs to be added.  
Lithium was first introduced for the analysis of lipids and carbohydrates in LC-
MS systems to their improve the signal intensity and identification. For LC-MS 
the lithium salt is added post column, prior to ESI.  
Incorporating Lithium chloride into the solvent system introduces the lithium 
to the system. By increasing the concentration of the lithium salt solution might 
be possible to force the Ionisation of the lipids to the lithium adduct (Figure 67). 
The inclusion of 25 mM LiCl in to the LESA solution can force the formation of 
the lithium adduct so that for a specific lipid more then 75% is detected as the 
lithium adduct. Abundant lipid species are shown in Figure 68, with and 
without the addition of LiCl. The spectra show that the majority of peaks 
observed in the spectra are a lithium adduct. Protonated molecules are still 
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observed, however are much less abundant than previously detected. This 
method of doping LESA solvents with lithium has enhanced the detection of 
low abundant lipids, observed between m/z 800-850 
 
Figure 67: Percentage composition of PC(34:2) in the four adduct states observed in the 
spectrum. Error bars are 1 standard deviation of three repeats.  
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Figure 68: Enlarged region of a spectra aquired using 80% Ethanol + 0.1% formic acid (top) and 
25mg/mL LiCl in 80% Ethanol+0.1% formic acid (bottom). Different adducts have 
been labled.  
 
The resulting CID spectrum acquired from doping the LESA solution with 25 
mM LiCl shows the lithium adduct of PC(34:2) detected at m/z 764.5820. Every 
informative peak is detected in high abundance (Figure 69 and Table 6-7). Each 
fragment ion is detected and they appear as the most abundant peaks observed 
the spectrum. Further more neutral loss of 16:0 is more abundant than 18:2 
indicate that the lipid detected can also be identified as PC(18:2/16:0). 
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Figure 69: A) CID and B) HCD spectrum of [PC34:2+Li]+ detected at m/z 764.5820 identified as 
Acquired using LESA sampling with 70% Methanol(aq) 
 
Table 6-7: Fragments identified from CID spectrum using lithium adduct of PC(34:2) 
Mass (m/z) Identity Δppm 
705.5012 Neutral loss of choline -3.40 
581.5091 Neutral loss of head group -4.30 
575.5010 Neutral loss of head group with lithium -3.13 
508.3353 Neutral loss of fatty acid 16:0 -4.13 
502.3271 Neutral loss of fatty acid 16:0 with lithium -4.18 
484.3353 Neutral loss of fatty acid 18:2 -4.34 
478.3271 Neutral loss of fatty acid 18:2 with lithium -4.34 
449.2619 Neutral loss of fatty acid 16:0 with head group -4.45 
425.2619 Neutral loss of fatty acid 18:2 with head group -4.70 
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In the HCD spectrum the same fragments were also detected and identified in 
addition the lithium adducts of the neutral loss of the fatty acid fragments are 
easily identifiable. As with the previous analysis the choline ion is also present 
in the HCD spectrum (MWmeas 86.0962, Δppm 2.32).  
6.2.1.4 HCD	analysis	
In previous experiments the collision energy (CE) for HCD was lower than the 
CE for CID. This is because less energy is required to produce comparable 
results. Increasing the CE for HCD was shown to further increases the 
fragmentation. As the CE is increased there is an increased detection of 
fragments below m/z 200. These ions were identified as fragments of the fatty 
acid back bone. These fragments were identified as the R+ and RCO+, however 
published reports detecting the backbone of fatty acids have detected the 
neutral loss of part of the fatty acid both were conducted of free fatty acid 
standards using either lithium or N-(4-aminomethylphenyl)pyridinium to 
modify the acid group on the fatty acid enhancing fragmentation. [241, 242] 
Detection of the fatty acid fragments from phosphatidylcholine in complex 
samples has been shown, using mouse plasma. The use of liquid 
chromatography and ion mobility were used to reduce spectral complexity 
prior to fragmentation. [243] Reported here is the first instance where backbone 
fragments have been identified directly from tissue using LESA.  
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Figure 70: Fragmentation of lithium adduct of PC(18:2/16:0) produced from HCD with a 
collision energy of 35%. In the spectrum blue ions are lithiated red ions are 
protonated and black ions are RCO+ ions.  
 
6.2.2. Identification of multiple lipids from a single tissue location 
Many of the peaks detected from human liver tissue can be assigned to a lipid. 
In several cases there may be two or more lipids associated with a peak. A high 
throughput method was developed to identify peaks from the direct infusion of 
LESA. Using data dependent analysis to select peaks for fragmentation, 90 
lipids were identified in a single injection. Using lithium is beneficial for 
identifying multiple species, driving adduct formation to a specific adduct, in 
this case lithium, can double the intensity of some lipids. This reduces the 
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number of lipids that are fragmented twice in different adduct forms in 
addition the increase in intensity that is observed and reduce the time for 
analysis as the AGC target will be reached in a shorter amount of time. The 
addition of lithium also helps ionize diacylglycerides and triacylglycerides, 
which are subsequently identified. In total 90 lipids were identified from a 
single 15 min injection using 80% Ethanol with 25 mg/mL LiCl (Appendix 27). 
Literature reports of the detection of lipids using LESA have detected wax 
esters, cholesterol esters as well as sphingomyelins and phosphatidylcholines. 
The difference in the types of lipids detected can be attributed to a different 
solvent system used for the LESA extraction (4:2:1 chloroform/methanol/IPA) 
and the sample (contact lenses). [193] Another example of lipid analysis using 
LESA sampling, sampled from atherosclerotic plaques where 150 lipids were 
identified using both positive and negative mode. [79] In both these methods 
QqQ were used to screen for specific lipids. Here the most abundant ions have 
been fragmented in an untargeted manner. 
 
 
Figure 71: Pie charts of the classes of all lipids identified 
PE	13%	PC	28%	
DG	26%	
TAG	30%	
SM	1%	
Lyso	PC	1%	
Lyso	PE	1%	Other	3%	
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6.2.3. Liquid extraction surface analysis MS/MS imaging 
Using data dependant analysis, each analysis has the potential to be different if 
there are subtle differences in the intensity of the ions at any time point during 
the spray or any differences in the extraction process or the tissue samples. 
Therefore to use data dependant analysis for imaging would not be ideal. Using 
data independent analysis would be suitable. 14 specific lipids were targeted, 
and a full scan spectrum was also collected during a 5 min analysis time. In 
multiple MS/MS images can be produced using this method. Of the 14 lipids 
selected 13 produced MS/MS spectra with suitable for full characterisation. 
This is substantially more than what is achievable using other techniques such 
as MALDI, which may monitor one or two lipids during an image. [45, 244, 245] 
This is a major advantage of using LESA as an imaging technique, due to the 
large pixels and the long spray times that can be achieved, when compared to 
MALDI imaging. The disadvantage of using lithium adducts is that a residue of 
lithium is left on the surface which means that proteins cannot be detected in 
any subsequent analysis. Therefore this cannot be coupled to the repeat analysis 
discussed in chapter 3. 
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Figure 72: MS/MS images aquired using 25mg/mL LiCl in 80% ethanol +0.1% FA as the solvent 
is a LESA imaging protocol of non-dieased human liver tissue. Four ions from the 
full scan spectrum are presented in the top row. Product ions corresponding to 
lithium adduct of PC(18:2/16:0) are presented in the bottom row. 
 
6.3 Traveling wave ion mobility spectrometry 
Previously it has been noted that multiple lipid species have been detected and 
identified with the same mass to charge ratio and that it is possible to separate 
them based on their product ions. However this limits the number of species 
that can be imaged at any point in time. Chromatography techniques increase 
the analysis time substantially an alternative is ion mobility spectrometry. 
Traveling wave ion mobility spectrometry is incorporated into the mass 
spectrometer and separates ions in real time dependant on their average 
collisional cross section. [160] There are two reports coupling the LESA and the 
Waters Synpat G2-S, the first [82] investigated spatially targeted quantification 
of radioactive drug metabolites, this method used the TWIMS results in lower 
spectral complexity the spectrum to achieve a more sensitive quantification 
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approach. The second paper did not use the TWIMS, but instead used the ToF 
capabilities to detect native protein complexes. [246] 
Here the LESA was coupled with the TWIMS for spatially resolved lipid and 
protein analysis.  
6.3.1. Liquid extraction surface analysis coupled to traveling wave ion mobility 
 
Figure 73: The ion mobility drift scopes that were aquired using 70% methanol +0.1% FA as the 
solvent in a LESA protocol of non-disease human liver tissue, at four wave 
velocities.  
 
To tune the TWIMS for specific use the wave velocity is adjusted. In ideal 
situations ions are transmitted between bin 20 and 180 of the 200 bins available 
and there should be minimal carry over of ions. A range of wave velocities were 
analysed from 300 ms to 450 ms in steps of 50 ms. As the velocity is increased 
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there is a greater degree of separation however the range of bins that a peak is 
detected also increases. Having the ions spread over a number of bins decreases 
the overall intensity of the ions. For fragmentation intensity is just as important 
as separation. Figure 73 shows the drift scopes from the wave velocities, the 
quality of the drift scope produced using a wave velocity of 350 m/s is lower 
than the other drift scopes. This is probably due to the spray stability of the 
LESA extraction from human liver tissue, where the occasional debris can 
temporally reduce the spray quality for the duration of the data being recorded. 
The 300 m/s wave velocity there is insufficient separation and with 450 m/s 
wave velocity many of the peaks have merged back together. The optimum is 
between these two parameters. At a wave velocity of 400 m/s is the overall 
ideal compromise for the full scan spectrum there is multiple clear patterns 
within the drift scope.  
 
 
Figure 74: Drift scope using a wave velocity of 400 m/z. Spectra of the regions labelled A-F are 
presented in Figure 75 
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One of the advantages of using TWIMS is that after the ion mobility data has 
been recorded is it possible to select a region and extract a spectrum relating to 
that region. There are several regions of the spectrum that are the product of 
biological noise, these are species that do not have specific peaks and contribute 
to the baseline of the spectrum.  This can be observed in region A and B, (Figure 
74) corresponding spectra can be found in Figure 75. There are many regions 
that do contribute analyte signal. Ions from panel G are the ions that dominate 
the spectra in when no ion mobility is applied and have already been identified 
as lipid species. However, there are many ions that would not typically be 
noticeable above the baseline, specifically from regions, E, F, I, from Figure 74 
(spectra in Figure 75). Regions H and J are particularly interesting, There is a 
large separation of these ion on the drift scope however the spectra for these 
regions are almost identical and are dominated by peaks with the same m/z. 
Further investigation is required to determine and what these species are.  
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Region C on Figure 74 is the isolation of a single peak in drift scope that is part 
of an extended series of peaks, however it lies on a region of background noise. 
This drift scope peaks relates to a multiply charged species, in the +5 charge 
state. This isotopic distribution is completely obscured without the use of ion 
mobility (Figure 76). 
 
Figure 76: Extracted spectrum from location C from Figure 74 and full scan data 
from same m/z range 
 
The ion mobility cell has an increased pressure due to the gases necessary for 
the collisions, hindering the progress and causing the separation of ions. A side 
affect of this the collisions is the possibility of an ion being neutralised, or being 
redirected out of the ion beam, resulting in a reduction in the number of ions 
reach the ToF. For MS/MS the isolation of a single mass occurs prior to the ion 
mobility therefore the only necessary separation occurs for the mass that is 
being isolated. A wave velocity of 350 m/s was selected because of the more 
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intense ion isolation that can be produced. For m/z 764.5 at this wave velocity 
the isolation is effective (Figure 77) in the Synapt G2-S there are two locations 
for fragmentation, before (trapping cell) and after (transfer cell) the ion mobility 
cell. Fragmentation in the trapping cell prior to ion mobility cell results in the 
fragments being separated by drift. This would be used to separate intact 
isobaric species that the mobility cell cannot separate. The mobility of product 
ions may be used to distinguish between them. Fragmentations in the transfer 
cell, after ion mobility, results in all the fragments being detected from the same 
drift bin. This is used to identify ions that occur from the same intact mass. The 
potential for this method is that that all ions passing through the ion mobility 
are fragmented, and the fragments are related to the intact ion based on their 
drift.  
 
Figure 77: Isolation of m/z 764.5 in drift space and the fragmentation of this ion in the trapping 
cell, prior to ion mobility, and tranfer cell after the ion mobility 
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Analysis of m/z 792.6135 using the Orbitrap mass analyser has shown that a 
peak at this mass refers to 3 lipids, PC(18:1/18:1)+Li+, PC(18:0/18:2)+Li+ and 
PC(16:0/20:2)+Li+ (Appendix 26). Using TWIMS in the isolation of m/z 792.6135 
using a wave velocity of 350 m/s two peaks were present. Fragmentation in the 
transfer cell enabled the fragments to remain associated with the mobility of the 
intact ion. Extraction of the fragmentation spectra shows that the main peak 
with a maximum in bin 126, shows the product ions from the three lipids that 
were known about. The smaller peaks with a maximum in bin 83, shows the 
fragmentation of 4 lipids. Three are known and one is new to the investigation, 
PC(20:0/16:2)+Li+. Product ions for this lipid are minor peaks in the 
fragmentation spectrum. Furthermore the smaller drift peak, is a result of 
smaller ions that relate to a more compact structure whereas the ions from the 
later drift bins relate to a larger structure. As these two peaks are separate, both 
structures are stable. This difference may occur due to the placement of the 
lithium ion during the ionisation.  
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Figure 78: Separation of ions observed m/z 792.6135 using traveling wave ion mobility 
spectrometry and the MS/MS spectra from both the drift peaks detected.  
 
LESA provides a sustainable level of quality in each analysis. Here it has been 
shown that TWIMS separation reduces spectral complexity enabling more 
species to be detected. This technique coupled to imaging could be an 
extremely powerful technique. The simultaneous analysis of lipids and protein 
that could then be separated during data processing would enable studies into 
both these species on the same tissue section.  In addition coupled to the 
MS/MS capabilities identification of these species would also be possible. 
However LESA has a low spatial resolution. A higher spatial resolution can be 
achieved using techniques such as MALDI.  
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6.3.2. MALDI 
MALDI has been used extensively for imaging lipids [52, 210, 247-249]. Using 
the Synapt G2-S there are two potential methods for separating isobaric species. 
The use of MS/MS imaging can separate isobaric species by isolating unique 
product ions. The alternative is the use of ion mobility, this would rely on the 
two species having a different integration with an electrical field. In chapter 5 
the ultraFAIMS separation occurs due to the folding and unfolding of proteins 
in a variable electrical field. Here the traveling wave ion mobility separates ions 
based on collisional cross-section.  
6.3.2.1 MS/MS	Imaging	
There are a wide number of reports using MS/MS imaging [31, 45, 250-252].  A 
recent report developed a method for introducing lithium in the fixation 
procedure [45]. The publication reported an MS/MS image of mouse brain 
tissue, the peak fragmented was the most abundant lipid in the spectrum and 
was not found to have any isobaric species. Here the same techniques were 
used to produce an MS/MS of diseased human liver tissue. In this case the 
method was targeted at low abundant species, which was known to contain 
multiple isobaric species. The laser energy was optimised so that the spectra 
contained both the intact ion and the informative peaks (Figure 79).  
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Figure 79: Optimised single scan MS/MS spectra aquired using CHCA as a matrix in a MALDI 
protocol from NASH liver tissue,  
 
There is a difference between spot mode analysis and imaging analysis. In spot 
mode analysis, the laser rasters in a specific pattern at a specified rate and 
spectra are acquired over a period of time. In imaging mode the laser rests in 
one location and collects the spectra from a specified number of laser shots. As 
a result, a single scan spectrum during set up can be different to a single scan 
spectrum during imaging. A single scan spectrum from the imaging data shows 
a greater degree of fragmentation and with a greater number of the fatty acid 
acyl chains being detected rather than the neutral loss of these chains.  
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Figure 80: Single pixal spectrum aquired using CHCA as the matrix in a MALDI MS/MS 
imaging protocol of NASH liver tissue. 
 
PC(18:1/18:1) and PC(18:0/18:2) are the two most abundantly detected lipids at 
m/z 792. The image showing the neutral loss of the head group this is indicative 
of all the PC lipids. The neutral loss of fatty acid 18:0 is a fragment from the 
lipid PC(18:1/18:1). Whereas PC(18:0/18:2) has been detected from the neutral 
loss of the fatty acid chains 18:2 and 18:0.  
 
Figure 81: MALDI MS/MS image of 4 product ions of PC(36:2)+Li, from lithium fixed tissue. 
NL Head group is presecent from all isobaric lipids, NL(18:1)+cho, is only detected 
from PC(18:1.18:1) and NL (18:2)+Cho and NL(18:0)+cho are two complementary 
side chains from the lipid PC(18:2/18:0). 
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6.3.2.2 TWIMS	Optimization	
The second imaging option with the Synapt G2-S is imaging with the ion 
mobility. Initially the TWIMS was optimised using a constant wave velocity, 
(Figure 82) At higher velocity there is optimal separation between the low 
molecular weight species. However at these velocities larger ions travel through 
the mobility cell very slowly, this can be seen as ions are carried over into 
subsequent analysis and appear to have a short mobility time.  
 
Figure 82: Drift scope of non-diseased human liver samples using 6 wave velosity. Aquired 
using MALDI surface sampling. 
 
Using variable velocity profile, the wave velocity can be changed during the 
course of the analysis. The velocity changes along a linear gradient between the 
start and end velocity. This enables a greater separation of low mass ions, as 
well as insuring larger ions are completely through the ion mobility prior to 
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succeeding analysis. The shallowest gradient that can be achieved, that 
efficiently separates ions without leaving carry over is a gradient from 900 m/s 
to 300 m/s ( Figure 83). 
 
 Figure 83: Drift scope of non-diseased human liver samples using variable wave 
velosity. Aquired using MALDI surface sampling.  
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6.3.2.2.1 MALDI TWIMS imaging 
Combining mass spectrometry and ion mobility for imaging tissue is a newly 
expanding area, Within the last couple of years numerous publication have 
combined these two techniques. [253-258] A number of publications show that 
this technique has a lot of promise. Here six tissue sections were analysed using 
the optimised ion mobility settings, four non-diseased sections from different 
donors, and two NASH sections also from separate donors. The advantage of 
imaging using ion mobility is that it is possible to separate overlapping matrix 
peaks from tissue specific peaks. There are also cases where two tissue specific 
peaks are separated, this may be due to different species being detected or it 
may be due to different conformations of the same ion. There is a particularly 
interesting instance of two tissue specific peaks at m/z 699.42, where one of 
these peaks is only observed in NASH tissue, the differing spatial locations of 
these species indicate that the species have different biological functions. Under 
imaging conditions that would not have used the TWIMS the image would 
have been interpreted as an ion that is present in both non-diseased and 
diseased and in some areas of diseased tissue the ion is more intense, this 
would this would not make the ion particularly interesting. However if an ion 
is only expressed in diseased tissue this has significant implication into 
identification and understanding the disease state. Previously the only method 
to determine if a distribution is due to a single or multiple ions is to conduct 
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MS/MS imaging. MS/MS imaging is a targeted approach where as the TWIMS 
is able to analyse multiple ion and can be used as an exploratory technique.  
 
Figure 84: MALDI-TWIMS images aquired using CHCA of 4 non-dieased tissue sections and 2 
NASH sections.  
 
Biological samples are extremely complex. The advantages of using ion 
mobility are evident, real time separation of ions. However there are a number 
of disadvantages. The TWIMS cell reduces the intensity of the intact ion by 
approximately 100 fold. This means that conducting TWIMS-MS/MS imaging 
on my not be possible, as the precursor ion would be too low in abundance for 
the fragments to be detected. Furthermore due to size of the data sets that are 
collected and the limited methods for viewing the data, to date only Waters 
software is capable of visualising ion mobility data from the Synapt G2-S. 
Vendor specific data reduction tools mean that processing and accessing all of 
the data is difficult.  
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6.4 Conclusion  
Here it has been shown that HCD coupled to LESA analysis are a powerful 
combination for the in situ identification of lipids. Over 90 lipids were identified 
from a single location on human liver tissue, spanning several different classes 
of lipids. Further more the coupling of TWIMS to LESA has shown to be an 
excellent tool to separate isobaric species with different collisional cross-
sections. And can separate different classes of molecules simplifying the spectra 
revealing more than would have been previously observed, this can all be done 
post analysis. This means that all the data can be collected initially and the 
software and data processing can be used to reveal species that would have 
otherwise gone undetected.  
The spatial localisation of LESA sampling has lead to MS/MS imaging of over 
14 lipids from a single location. When compared to MALDI analysis form a 
single location only one lipid can be imaged. The advantage of MALDI MS/MS 
imaging is that the spatial localisation is a lot smaller enabling distinctive 
features of the tissue to be observed.  
TWIMS analysis on the LESA and the MALDI are distinctly different. LESA is 
able to detect lipids and proteins using the same extraction solvents where as 
only lipids were detected using the MALDI source. Further more using the 
MALDI matrix and matrix cluster contribute significantly to the spectrum, 
using the TWIMS it is possible to separate using drift matrix related peaks and 
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tissue related peaks. Imaging using the TWIMS was conducted using the 
MALDI source. Experimentally a LESA-TWIMS imaging was produced 
however, the data produced as so large that the software used to view the drift 
scope could not open the data set. In contrast MALDI-TWIMS images can be 
processed using specialist software the uses peak picking algorithms to reduce 
the data size, for imagines to be produced.  
The imaging using the MALDI –TWIMS produced imagines of isobaric species 
that were separated in drift and spatial distributions. This is particularly 
important form imaging as it is another step towards revealing the true 
distribution of a species. Three cases were identified, first the separation of a 
matrix related ion and an analyte ion, the separation of patient specific ion from 
an analyte common to all patients and possibly the most important the 
separation between analytes common to all patients and a disease specific 
analyte. This could only have been done using the MALDI- TWIMS coupling as 
using LESA the spatial resolution would have been too poor, and without the 
TWIMS these ion would have been detected using the same mass.  
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Chapter 7:  Conclusions and further work 
7.1 Conclusions 
This thesis has focus on the capability of the LESA system for the direct 
sampling of human liver tissue and simultaneous detection of in situ lipids and 
proteins. Investigations into spatial profiling have shown the potential for using 
this as an explorative technique. The LESA technique benefits from having long 
acquisition times from a single location. The quality and quantity of data 
produced out performs other imaging techniques such as MALDI for single 
pixel data, however LESA cannot compete with spatial resolution of these 
techniques. The LESA has a large spatial resolution and as a consequence uses 
large volumes, therefor there is more to analyse resulting in the quality and 
quantity of data. The spatial resolution and the volume of material to be 
analysed are inversely proportional. Another benefit of the LESA system is that 
there is very little sample preparation required. This makes analysis quick and 
efficient when sampling directly from a surface.  
The sample preparation has been used to target lipid and proteins be increased 
using washing techniques to target proteins, and by optimising the solvents to 
target and identify lipids or proteins.  
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Three proteins were identified using top-down methods, including 10 kDa heat 
shock protein, the beta chain of haemoglobin and the fatty acid binding protein. 
The FABP was identified from non-diseased and NASH tissue in two forms 
with a single amino acid variation. The presence of the FABPTA form has been 
linked to the NASH disease state, in this thesis this was also noted. Both NASH 
samples analysed contained FABPTA and both non-diseased sampled contained 
FABP1. Although it should be noted that these were not exclusive, in one of the 
non-diseased sample FABPTA was detected and in one of the NASH samples, 
FABP1 was detected. Suggesting that the FABP variant is not solely responsible 
for the disease. 
Enhancing the analysis by digesting the sample and with coupling liquid 
chromatography revealed three further markers for the NASH disease state. 
Bottom-up analysis was also able to differentiate between FABPTA and FABP1 
however prior to being identified using top-down methods FABPTA was not 
present in the database and therefore would not have been identified.  
An alternative method for enhancing protein analysis has also been utilised. 
The ultra-high field asymmetric ion mobility spectrometer (ultraFAIMS) has 
been coupled to LESA to increase the sensitively of direct infusion of LESA by 
tuning the compensation field, the background noise is removed and protein or 
lipid signal can be enhanced. This has lead to the observation of many more 
proteins. This real time ion mobility techniques means that the improved 
 215 
quality does not come with a time cost. Further more, there are distinctly 
different optimal dispersion and compensation fields for lipids and proteins, 
and therefore can be separated post-LESA sampling.  
Lipid targeted analysis has revealed more than 80 identified lipids in a 15 min 
injection many were isobaric species. Using lithium salts and increasing the 
collision energy for HCD analysis fatty acid backbone fragments were observed 
this enable to further increase the number of species by being able to assign the 
location of the double bond. This coupled to spatial profiling 14 lipids were 
mapped. This is a vast increase in the number lipids that were imaged using 
MALDI. The spatial resolution for the MALDI image (100µm) was 20 fold 
smaller than LESA (2mm) however, the sensitivity of the LESA enabled the 
fragmentation of low abundant lipid species where as the MALDI image of the 
m/z 792, which was a relatively abundant species, occasionally did not show all 
the informative peaks.  
Overall LESA is capable for obtaining spatially resolved data for lipids and 
proteins. It is an ideal surface sampling technique to be coupled with multiple 
separation techniques to enhancing the quality of the data. 
7.2 Future work.  
There are several areas in which the LESA can be developed in imaging, 
analysis, data processing and biomarker discovery.  
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The smallest resolution that is possible with the current formatting is the 1mm; 
this is approximately the diameter of the LESA tip. Reducing the diameter of 
the tip would reduce the volume of liquid that would be necessary for a LMJ, 
and recuse the area affected by the LMJ, reducing the resolution. This could be 
achieved using capillary tubing or using a fused silica tip that had a tapered 
end to less than 100µm. The disadvantage of using the capillary is that it would 
not be disposable and therefore would possibly suffer from cross-
contamination between injections. Using a fused silica tip would be disposable 
however there would be cost implications, as these tips would be expensive and 
for an image of 1mm squared, at 100µm 100 tips would be necessary. Further 
more there is a time consideration each injection required over 30 s to conduct 
the LESA with the analysis time current capabilities analyse for 5 min per pixel, 
the time for acquiring the data for 1mm2 would be over 9 hours. Even reducing 
the time for analysis down, to 1 min per pixel, imaging using the LESA would 
be incredibly slow. During this time period under ambient conditions, the 
sample may change during the time course of the experiment. Reducing the 
area affected in a single liquid micro-junction would also benefit direct 
sampling of a single location. Enabling more accurate localised representation, 
of a tissue type or a collection of cells. This coupled with the long analysis time 
would enable in-depth interrogation from a specific location.  
Some methods for improving the quality and quantity of LESA sampling have 
been demonstrated in this thesis. Investigations into these areas can be 
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developed further. Coupling the LESA to liquid chromatography would 
enhance the numbers of intact proteins observed. As proteins will elute over the 
course of a few scans, it would be possible to fragment the protein in the 
remaining, time. Identifying variations in amino acid sequences and post-
translational modifications are an important part of investigations into disease 
biomarkers. Function of proteins is determined by their structure, the structure 
is directly related to the amino acid sequence and any post-translational 
modifications. Bottom-up, identifications is still very helpful, there are vast 
databases that include many known biomarkers. Bottom up analysis identified 
about 500 proteins. This is a fraction of what is contained within tissue, for full 
in-depth analysis strong cation exchange chromatography can be used to 
fractionate the sample reducing the complexity of the sample prior to LC 
analysis, enhancing the numbers of proteins detected. [259] 
An alternative method for reducing spectral complexity is using ion mobility. 
Traveling wave ion mobility and ultra-high field asymmetric ion mobility 
spectrometry have been used to enhance spectra acquired in this thesis. There is 
scope for further investigations, several features of the Synapt G2-S were not 
utilised in this thesis, and wide-band enhancements is one of these features. 
This synchronises the pusher of the ToF to a specific m/z being transmitted at 
each bin of the TWIMS, this would increase the sensitivity of specific masses. 
This would aid a specific band of analytes of interest and would reduce the 
contribution of other analyse. This has the potential to counteract the reduction 
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of sensitivity that is observed using the TWIMS. This would be particularly 
useful for MS/MS analysis of low abundant ions. There are also capabilities to 
calculating the collisional cross section of molecules. There is also a function on 
the TWIMS called MSE, this is where all ions passing through the TWIMS are 
fragmented in the transfer cell. Product ions that are related to each other will 
occur in the same bin. This would be particularly useful for explorative 
techniques, to identify as many analytes as possible in the same injection or 
location. The transmission of ions through the TWIMS is portioned to the size 
average collisional cross section. By calibrating the TWIMS it would be to state 
that one conformation is larger than another by a specific amount.   
Imaging using the TWIMS has a lot of potential. MALDI MS/MS imaging was 
conducted without using as the intensity of these ions from a single location is 
relatively low, however with the wide band enhancement mentioned 
previously it may be possible to conduct MALDI MS/MS imaging using 
TWIMS separation. In addition MSE analysis would insure the identity of a 
precursor ion throughout the imaging process, without having to conduct 
subsequent imaging runes for each individual ion. Conducting LESA spatial 
profiling on the Synapt is possibly however there are some technical obstacles 
to over come first. The synapt and the LESA technology are currently 
incompatible, for example the data acquisition is not triggered by the contact 
closure of the LESA resulting in the data being collected in one long file, 
alternatively the user creates and names a data file for each location during the 
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sampling process. In house data processing methods are able to process this 
type of data, however currently the processing of TWIMS data is only available 
using vendor specific software such as HDimaging and MassLynx. Only 
HDimaging can process imaging data, however the software assumes a MALDI 
source where there is one spectrum per location. In LESA analysis multiple 
spectra are acquired for a single location and the spectra for the pixel is the 
average. There is no software suitable for this kind of analysis at this current 
moment in time, which makes processing images a long task. Suitable software 
would enhance the user experience enabling the LESA TWIMS spatial profiling 
to reach it’s full potential, analysing lipids and proteins, with capabilities of 
fragmenting and potentially identifying every peak in the image.  
Ion mobility spatial profiling with the LESA would be possible using the 
ultraFAIMS. Conducting a series of static analysis or a single sweep at each 
location would be possible with the LESA where the analysis time for each 
location can be up to 5 min. This will enhance the spectra quality for multiple 
analytes, for example using extraction conditions suitable for lipids and 
proteins, and differentiating between them using the ultraFAIMS, enhancing 
the sensitivity of LESA.  
Data processing is currently and will become more difficult. By using multiple 
separation techniques liquid chromatography and ion mobility, there is an 
increase in the dimensionality of the data acquired. The increased data sizes 
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that this produces can make processing the data more difficult. Strategies to 
manage this data have been developed [260-262] and will need to be 
continually developed as data sizes continue to expand.  
There is potential for numerous instrumental developments using the LESA 
and coupled instrumentation, some have been mentioned. The other aspect of 
this thesis has been furthering the understanding of the human liver and the 
NASH disease state. The work included in this thesis has looked at four patient 
samples, to draw biologically significant conclusions it would be necessary to 
expand the number of patient samples. It is also unclear how FABPTA 
contributes to the disease, weather individuals with FABPTA in non-diseased 
livers at the time of biopsy go on to develop NASH later in life, and if every 
individual with NASH disease has the FABPTA variant. Further more, early 
research into the identification of these proteins determined the amino acid 
sequence from the DNA sequence [263, 264]. It is possible that this is an 
inherited aspect of the disease, however, errors in copying DNA in cell 
replication may introduce this fault later in life.  
LESA has shown its self to be an extremely powerful technique, with potential 
to answer important biologically significant questions.  
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Appendix 1 — Relative molecule masses of proteins 
detected from tissue using 40% acetonitrile with and 
without a prior wash. 
40% Acetonitrile 
No Wash Ethanol Wash 
MW MW 
15858.2571 15858.3208 
15278.9684 15856.2641 
15117.8356 15117.9084 
15087.8610 14111.4080 
14111.3973 14081.3555 
14081.3079 10836.8616 
10836.7687 10835.8622 
9949.9868 9950.0196 
8559.5974 8560.6326 
6106.1696 7018.1799 
6081.2177 6107.2729 
3440.5199 6080.2142 
3369.4853 5354.7798 
 
4961.5025 
 
3484.5137 
 
3462.4956 
 
3440.5231 
 
3369.4865 
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Appendix 2 — One-way Anova Statistical analysis for 
dipped tissue analysis.   
m/z 1081 
 
Total Sum of Squares = 3.55 x 1014 with 8 degrees of freedom  
Sum of Squares within groups = 1.29 x 1014 with 3 degrees of freedom  
 
Sum of Squares between groups = 2.25 x 1014 
 
F=4.65 
 
Fcritical 95% = 4.07  
 
 
m/z 1084 
 
Total Sum of Squares = 2.54 x 1014 with 8 degrees of freedom  
Sum of Squares within groups = 1.00 x 1014 with 3 degrees of freedom  
 
Sum of Squares between groups = 1.53 x 1014 
 
F=4.08 
 
Fcritical 95% = 4.07 
 
 
m/z 1087 
 
Total Sum of Squares = 2.49 x 1014 with 8 degrees of freedom  
Sum of Squares within groups = 1.41 x 1014 with 3 degrees of freedom  
 
Sum of Squares between groups = 1.08 x 1014 
 
F=2.03 
 
Fcritical 95% = 4.07 
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Appendix 3 —Intensity of ions from repeated extractions 
from the same location. 
Surveying a sample with a liquid micro-junction may be considered a local 
washing step. The effect of multiple, serial extractions at the same x, y co-
ordinate was evaluated using ~70% methanol. The absolute abundances of 
selected ions detected in ten sequential extractions are presented. The change in 
intensity of ions in sequential extractions may be explained by the effect of 
repeated washing steps, depleting surface salts.  
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Appendix 4 — Graphs showing the effects of the 
automatic gain control on noise, signal and resolution. 
A) The intensity of peaks detected from non-diseased human liver tissue with 
the AGC on and the AGC off at 5 fill times.  
B) The noise associated with peaks detected in A, calculated by Xcalibur 
software. 
C) The signal to noise ratio of peaks detected from non-diseased human liver 
tissue. Data Collected on an Orbitrap. 
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Appendix 5 — Graph showing the effects of the automatic 
gain control on the signal to noise ratio 
The resolution of peaks detected from non-diseased human liver tissue using 
LESA with the AGC on and the AGC off at five different fill times, calculated 
using Xcalibur software. Data Collected on an Orbitrap 
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The deviation of mass accuracy of common peaks detected from non-diseased 
human liver tissue via LESA from the AGC on condition to the AGC off 
conditions. Horizontal lines are the average ppm shift.  
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Appendix 6 — Average spectrum from 1mm spaced LESA 
image 
Average spectrum of all pixels (60) from spatial profiling data set. including all 
tissue and non-tissue pixels. 
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Appendix 7 — Publication: Top-Down and Bottom-Up 
Identification of Proteins y Liquid Extraction Surface 
Analysis Mass Spectrometry of Non-diseased and 
Diseased Human Liver tissue 
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Appendix 8 — MW of proteins detected using 70% 
Methanol, 50% Methanol and 50% Acetonitrile 
 
70%	Methanol	 50%	Methanol	 50%	Acetonitrile	
3195.67	 3195.67	 3369.49	
3369.5	 3326.72	 3440.52	
3440.53	 3369.5	 3484.51	
3484.52	 3440.53	 3585.87	
3901.06	 3484.52	 3938.8	
8446.62	 4745.45	 4006.07	
9950.04	 8446.61	 4961.5	
14081.43	 8560.65	 5005.52	
14111.4	 9950.04	 6080.21	
15960.75	 14065.39	 6107.29	
	
14081.41	 7569.94	
	
14100.49	 8560.67	
	
14111.44	 10836.86	
	
14120.39	 14067.44	
	
14122.4	 14081.38	
	
14133.39	 14111.45	
	
14149.41	 15118.07	
	
14186.27	 15835.87	
	 	
15858.37	
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Appendix 9 — Fragments observed following CID of +14 
ions with m/z 775.42 from non-diseased liver tissue 
(identified as 10kDa heat shock protein (mitochondrial)). 
Measured (m/z) Theoretical (m/z) Δppm Assignment 
581.2924 581.2930 1.03 y51+ 
659.1627 659.1622 -0.76 b60-NH39+ 
661.8642 661.8644 0.30 b234+ 
668.3382 668.3384 0.30 y295+ 
679.0526 679.0540 2.06 b609+ 
685.8093 685.8081 -1.75 b44-NH37+ 
699.8188 699.8201 1.86 b45-H2O7+ 
702.3912 702.3931 2.71 b457+ 
709.7940 709.7950 1.41 b325+ 
727.0272 727.0284 1.65 y183+ 
739.7415 739.7377 -5.14 y639+ 
755.8973 755.8986 1.72 y132+ 
762.9104 762.9107 0.39 y416+ 
799.7760 799.7775 1.88 b44-H2O6+ 
809.1444 809.1454 1.24 y537+ 
816.2874 816.2889 1.84 b45-H2O6+ 
819.2888 819.2907 2.32 b456+ 
823.2969 823.2980 1.34 y547+ 
832.0836 832.0790 -5.53 y63-NH38+ 
833.4447 833.4462 1.80 y557+ 
835.1697 835.1711 1.68 y296+ 
844.6394 844.6398 0.47 b47-H2O6+ 
847.5953 847.5988 4.13 y567+ 
863.4402 863.4421 2.20 y304+ 
876.0657 876.0671 1.60 y395+ 
880.4868 880.4882 1.59 b405+ 
886.9909 886.9920 1.24 b324+ 
910.9621 910.9645 2.63 y142+ 
915.2896 915.2913 1.86 y415+ 
948.8537 948.8555 1.90 b253+ 
968.4762 968.4780 1.86 y162+ 
1037.8581 1037.8606 2.41 y273+ 
1061.5872 1061.5891 1.79 b91+ 
1094.8294 1094.8321 2.47 y394+ 
1113.2240 1113.2258 1.62 y293+ 
1188.6136 1188.6151 1.26 y313+ 
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Appendix 10 — Fragments observed following ETD of 
+14 ions with m/z 775.42 from non-diseased liver tissue 
(identified as 10kDa heat shock protein (mitochondrial)). 
Measured (m/z) Theoretical (m/z) Δppm Assignment 
666.1198 666.1210 1.80 c234+ 
668.0371 668.0386 2.25 c366+ 
690.3671 690.3682 1.59 c61+ 
690.5825 690.5835 1.45 c315+ 
698.8852 698.8852 0.00 c386+ 
716.1491 716.1501 1.40 c254+ 
716.4074 716.4090 2.23 c183+ 
718.4129 718.4141 1.67 c122+ 
736.7445 736.7458 1.76 c406+ 
741.4122 741.4120 -0.27 c264+ 
758.4180 758.4194 1.85 y345+ 
771.629 771.6288 -0.26 a355+ 
775.9272 775.9275 0.39 c132+ 
801.4445 801.4448 0.37 c365+ 
821.1307 821.1324 2.07 c213+ 
830.2134 830.2175 4.94 c304+ 
838.4611 838.4608 -0.36 c385+ 
887.8237 887.8256 2.14 c233+ 
915.2896 915.2913 1.86 y415+ 
964.2852 964.2842 -1.04 a35-NH34+ 
973.2548 973.2561 1.34 z344+ 
978.1647 978.1666 1.94 z263+ 
1012.2776 1012.2785 0.89 z364+ 
1016.2817 1016.2832 1.48 y364+ 
1044.0497 1044.0503 0.57 y37-NH34+ 
1047.8200 1047.8242 4.01 c384+ 
1061.5872 1061.5891 1.79 b91+ 
1100.3869 1100.3862 -0.64 z515+ 
1113.2240 1113.2258 1.62 y293+ 
1171.8651 1171.8723 6.14 z424+ 
1297.3378 1297.3390 0.92 z343+ 
1307.1917 1307.1938 1.61 z484+ 
1349.3694 1349.3690 -0.30 z363+ 
1392.0636 1392.0630 -0.43 z373+ 
1562.1624 1562.1607 -1.09 z423+ 
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Appendix 11 — Fragments observed following CID of +16 
ions with m/z 946.40 from non-diseased liver tissue 
(identified as α=haemoglobin). 
Measured (m/z) 	 Theoretical (m/z) Δppm Assignment 
527.7966 527.7982 3.03 y92+ 
553.3101 553.3093 -1.45 y41+ 
620.8496 620.8484 -1.93 y112+ 
623.3494 623.3483 -1.76 y234+ 
654.3581 654.3570 -1.68 y51+ 
656.3680 656.3670 -1.52 y122+ 
672.3766 672.3772 0.89 y183+ 
677.7105 677.7093 -1.77 b203+ 
693.3874 693.3930 8.08 b7-H2O1+ 
696.0576 696.0563 -1.87 y193+ 
701.3896 701.3884 -1.71 b213+ 
712.9102 712.9090 -1.68 y132+ 
741.7438 741.7426 -1.62 y203+ 
755.1591 755.1578 -1.72 y28-H2O4+ 
759.6616 759.6605 -1.45 y284+ 
767.4425 767.4410 -1.95 y61+ 
774.7673 774.7654 -2.45 y213+ 
786.4440 786.4432 -1.02 y142+ 
787.9330 787.9315 -1.90 y294+ 
824.7938 824.7918 -2.42 y23-H2O3+ 
830.7966 830.7953 -1.56 y233+ 
836.7724 836.7713 -1.31 b253+ 
850.4922 850.4907 -1.76 y152+ 
864.1694 864.1696 0.23 b11314+ 
864.4794 864.4779 -1.74 y243+ 
866.5108 866.5094 -1.62 y71+ 
903.4657 903.4645 -1.33 b273+ 
905.7042 905.7067 2.76 b10013+ 
910.2216 910.2201 -1.65 b34-H2O4+ 
911.2490 911.2477 -1.43 y344+ 
911.9266 911.9312 5.04 y587+ 
913.5023 913.5007 -1.75 y253+ 
927.2371 927.2386 1.62 y13816+ 
929.6957 929.6940 -1.83 b799+ 
931.6800 931.6774 -2.79 y139-H2O16+ 
931.6800 931.6764 -3.86 y139-NH316+ 
 245 
932.6817 932.6781 -3.86 y13916+ 
936.0169 936.0148 -2.24 y354+ 
938.2323 938.2342 2.03 y607+ 
956.5168 956.5149 -1.99 y263+ 
980.1953 980.1939 -1.43 y273+ 
993.8845 993.8832 -1.31 b758+ 
1010.3902 1010.3882 -1.98 b768+ 
1012.5463 1012.5449 -1.38 y283+ 
1018.5608 1018.5591 -1.67 y384+ 
1021.9672 1021.9661 -1.08 y475+ 
1036.7795 1036.7752 -4.15 b788+ 
1043.5821 1043.5808 -1.25 y192+ 
1045.7826 1045.7798 -2.68 b798+ 
1049.4150 1049.4132 -1.72 y576+ 
1050.2403 1050.2396 -0.67 y293+ 
1054.5902 1054.5891 -1.04 y91+ 
1058.8553 1058.8546 -0.66 y687+ 
1063.7533 1063.7516 -1.60 y586+ 
1082.7680 1082.7659 -1.94 y596+ 
1094.6065 1094.6053 -1.10 y606+ 
1095.9266 1095.9259 -0.64 y304+ 
1108.9402 1108.9441 3.52 y616+ 
1112.1114 1112.1104 -0.90 y202+ 
1135.8672 1135.8654 -1.58 b757+ 
1154.4374 1154.4426 4.50 b767+ 
1213.2925 1213.2982 4.70 b1029+ 
1245.6904 1245.6894 -0.80 y232+ 
1268.3189 1268.3173 -1.26 b363+ 
1277.7085 1277.7058 -2.11 y474+ 
1296.2147 1296.2132 -1.16 y242+ 
1311.7273 1311.7267 -0.46 y121+ 
1369.7483 1369.7474 -0.66 y252+ 
1518.3146 1518.3137 -0.59 y282+ 
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Appendix 12 — Fragments observed following ETD of 
+16 ions with m/z 946.40 from NASH liver tissue 
(identified as α=haemoglobin).  
Measured (m/z) Calculated (m/z) Δppm Assignment  
521.7976 521.7982 -1.15 c102+ 
585.8450 585.8457 -1.19 c112+ 
600.3344 600.3352 -1.33 c61+ 
621.3635 621.3642 -1.13 c122+ 
656.8821 656.8828 -1.07 c132+ 
728.4296 728.4301 -0.69 c71+ 
749.9214 749.9225 -1.47 c142+ 
778.4325 778.4332 -0.90 c152+ 
823.4394 823.4397 -0.36 c243+ 
829.4771 829.4778 -0.84 c81+ 
842.4797 842.4807 -1.19 c162+ 
908.4953 908.4971 -1.98 z253+. 
918.9791 918.9793 -0.22 c354+. 
1000.0522 1000.0529 -0.70 z182+ 
1042.5890 1042.5891 -0.10 c101+ 
1044.8998 1044.9000 -0.19 z293+ 
1127.1196 1127.1212 -1.42 z424+. 
1128.8341 1128.8350 -0.80 c424+ 
1153.1239 1153.1242 -0.26 c232+ 
1159.1432 1159.1449 -1.47 z434+. 
1224.6322 1224.6341 -1.55 c353+. 
1234.6555 1234.6559 -0.32 c242+ 
1545.1897 1545.1908 -0.71 z433+. 
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Appendix 13 — Fragments observed following CID of +15 
ions with m/z 1087.04 from non-diseased liver tissue 
(identified as FABP1). 
Measured (m/z) Theoretical (m/z) Δppm Assignment 
620.6970 620.7011 -6.61 y16-H2O3+ 
630.4153 630.4192 -6.19 y102+ 
664.7148 664.7189 -6.17 y173+ 
687.9283 687.9326 -6.25 y112+ 
692.3941 692.3980 -5.63 y18-H2O3+ 
698.3972 698.4015 -6.16 y183+ 
712.3259 712.3301 -5.90 b61+ 
716.4390 716.4434 -6.14 y122+ 
730.0882 730.0927 -6.16 y19-H2O3+ 
736.0916 736.0962 -6.25 y193+ 
772.9807 772.9854 -6.08 y132+ 
823.5043 823.5096 -6.44 y142+ 
831.1353 831.1403 -6.02 y223+ 
840.3837 840.3886 -5.83 b71+ 
843.8865 843.8916 -6.04 b142+ 
869.1495 869.1547 -5.98 y233+ 
880.0189 880.0242 -6.02 y15-H2O2+ 
885.0999 885.1049 -5.65 y395+ 
889.0242 889.0295 -5.96 y152+ 
906.8436 906.8493 -6.29 y243+ 
919.7096 919.7146 -5.44 y415+ 
930.5424 930.5480 -6.02 y16-H2O2+ 
935.4568 935.4621 -5.67 b8-H2O1+ 
939.5477 939.5533 -5.96 y162+ 
983.5407 983.5461 -5.49 y263+ 
985.2162 985.2200 -3.82 y536+ 
987.5637 987.5695 -5.87 y17-H2O2+ 
992.8021 992.8067 -4.63 y354+ 
996.5689 996.5748 -5.92 y172+ 
1007.2662 1007.2725 -6.25 b354+ 
1010.8091 1010.8126 -3.46 b63-NH37+ 
1017.3183 1017.3238 -5.41 y364+ 
1023.7342 1023.7347 -0.49 y556+ 
1033.9520 1033.9573 -5.13 y9310+ 
1038.0872 1038.0933 -5.88 y18-H2O2+ 
1042.5673 1042.5733 -5.79 y56-H2O6+ 
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1045.4028 1045.4085 -5.42 y566+ 
1045.5881 1045.5948 -6.41 y374+ 
1047.0925 1047.0986 -5.83 y182+ 
1060.0547 1060.0603 -5.25 b576+ 
1063.5144 1063.5207 -5.92 b9-H2O1+ 
1064.2476 1064.2558 -7.67 y576+ 
1090.7665 1090.7709 -4.03 b486+ 
1094.6290 1094.6354 -5.85 y19-H2O2+ 
1100.2465 1100.2511 -4.15 b596+ 
1100.5572 1100.5636 -5.82 b394+ 
1103.6342 1103.6406 -5.80 y192+ 
1116.5825 1116.5871 -4.15 b60-NH36+ 
1119.2524 1119.2582 -5.15 b606+ 
1121.0315 1121.0355 -3.59 b111-NH311+ 
1122.5780 1122.5834 -4.83 b11111+ 
1124.4329 1124.4382 -4.68 y606+ 
1128.5775 1128.5846 -6.29 b404+ 
1131.5600 1131.5663 -5.60 b1069+ 
1137.9231 1137.9276 -3.93 b61-NH36+ 
1140.5886 1140.5941 -4.82 b505+ 
1140.7582 1140.7653 -6.19 b616+ 
1145.6049 1145.6096 -4.10 y123-H2O12+ 
1146.1067 1146.1119 -4.57 y616+ 
1146.9393 1146.9438 -3.95 y12312+ 
1152.6089 1152.6137 -4.19 y62-H2O6+ 
1154.1892 1154.1965 -6.35 y12412+ 
1155.4439 1155.4489 -4.30 y626+ 
1157.7714 1157.7731 -1.44 a626+ 
1160.1757 1160.1827 -6.03 y202+ 
1163.2052 1163.2109 -4.90 b515+ 
1165.4368 1165.4433 -5.61 b626+ 
1166.3439 1166.3497 -5.00 y11511+ 
1172.1232 1172.1269 -3.19 y636+ 
1174.5311 1174.5383 -6.10 y12612+ 
1179.2763 1179.2802 -3.28 b63-NH36+ 
1180.4031 1180.4104 -6.18 b10610+ 
1182.1116 1182.1180 -5.39 b636+ 
1184.3505 1184.3570 -5.53 y117-H2O11+ 
1185.7123 1185.7216 -7.86 y11711+ 
1188.9624 1188.9682 -4.91 y646+ 
1191.4998 1191.5063 -5.44 a969+ 
1191.6113 1191.6188 -6.29 b10710+ 
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1195.6208 1195.6249 -3.43 b646+ 
1197.6344 1197.6360 -1.37 y11811+ 
1198.0222 1198.0297 -6.26 b535+ 
1201.5233 1201.5246 -1.08 b108-NH310+ 
1203.9539 1203.9601 -5.12 a979+ 
1208.2932 1208.2996 -5.32 b656+ 
1212.6122 1212.6190 -5.61 b878+ 
1213.6416 1213.6463 -3.87 y656+ 
1216.4073 1216.4121 -3.93 a98-NH39+ 
1217.6884 1217.6962 -6.41 y212+ 
1225.8583 1225.8602 -1.51 a99-NH39+ 
1232.9330 1232.9384 -4.38 b111-NH310+ 
1234.8348 1234.8410 -5.02 b11110+ 
1246.1991 1246.2069 -6.26 y222+ 
1251.3071 1251.3138 -5.38 b673+ 
1252.0500 1252.0576 -6.07 b565+ 
1254.2829 1254.2887 -4.62 y565+ 
1260.3986 1260.4062 -6.03 b454+ 
1262.2935 1262.3012 -6.10 b333+ 
1271.8636 1271.8712 -5.98 b575+ 
1289.8163 1289.8225 -4.78 b696+ 
1294.4824 1294.4881 -4.40 b585+ 
1303.2203 1303.2283 -6.14 y232+ 
1320.0918 1320.0998 -6.06 b595+ 
1340.1905 1340.1927 -1.64 a968+ 
1343.1000 1343.1084 -6.25 b605+ 
1354.4481 1354.4542 -4.50 a978+ 
1359.7623 1359.7704 -5.96 y242+ 
1368.7094 1368.7169 -5.48 b615+ 
1382.9269 1382.9351 -5.93 y62-H2O5+ 
1386.3293 1386.3372 -5.70 y625+ 
1398.1219 1398.1306 -6.22 b625+ 
1414.7300 1414.7348 -3.39 b63-NH35+ 
1418.3321 1418.3401 -5.64 b635+ 
1434.5449 1434.5485 -2.51 b64-NH35+ 
1438.1508 1438.1538 -2.09 b645+ 
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Appendix 14 — Fragments observed following ETD of 
+16 ions with m/z 942.24 from NASH liver tissue 
(identified as FABP1). 
Measured (m/z) Calculated (m/z) Δppm Assignment  
566.2926 566.2933 -1.24 c51+ 
729.3557 729.3566 -1.23 c61+ 
806.7926 806.7936 -1.24 z213+ 
815.4995 815.4999 -0.49 z142+ 
823.5086 823.5092 -0.73 y142+ 
825.8002 825.8008 -0.73 z223+ 
857.4146 857.4152 -0.70 c71+ 
863.8144 863.8151 -0.81 z233+ 
881.0195 881.0201 -0.68 z152+ 
901.2601 901.2611 -1.11 z324+ 
901.8437 901.8457 -2.22 z243+. 
911.9820 911.9814 0.66 c486+ 
916.3101 916.3108 -0.76 z415+ 
916.9255 916.9261 -0.65 c152+ 
922.4772 922.4776 -0.43 c324+ 
926.4851 926.4881 -3.24 c415+ 
936.6598 936.6593 0.57 c496+ 
938.0276 938.0282 -0.64 z336+ 
944.5235 944.5240 -0.53 z253+ 
949.8633 949.8635 -0.21 y253+ 
951.4841 951.4844 -0.32 c334+ 
952.0999 952.0999 0.00 c525+ 
963.2893 963.2901 -0.83 z344+ 
967.2933 967.2948 -1.55 y344+ 
970.4984 970.4993 -0.93 c81+ 
974.9085 974.9085 0.00 c434+ 
979.5049 979.5054 -0.51 c344+ 
988.5514 988.5520 -0.61 z354+ 
1000.5260 1000.5238 2.20 a354+ 
1011.5287 1011.5291 -0.40 c354+ 
1016.5686 1016.5689 -0.30 y273+ 
1025.0371 1025.0378 -0.65 c556+ 
1039.1435 1039.1435 0.00 c465+ 
1040.2395 1040.2400 -0.48 z283+ 
1041.5887 1041.5901 -1.34 z374+ 
1045.5789 1045.5796 -0.67 y283+ 
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1050.5510 1050.5516 -0.57 c374+ 
1053.3880 1053.3885 -0.47 y475+ 
1068.5582 1068.5572 0.94 c475+ 
1072.3084 1072.3096 -1.12 c384+ 
1082.9377 1082.9383 -0.55 z293+ 
1094.1748 1094.1762 -1.28 c485+ 
1123.7902 1123.7899 0.27 c495+ 
1132.8388 1132.8393 -0.44 c404+ 
1145.1362 1145.1367 -0.44 z414+ 
1158.6471 1158.6473 -0.17 z313+ 
1159.6084 1159.6084 0.00 c414+ 
1164.3221 1164.3202 1.60 y313+ 
1166.6154 1166.6162 -0.69 c515+ 
1167.9287 1167.9289 -0.17 c303+ 
1187.2701 1187.2694 0.56 c313+ 
1189.6223 1189.6230 -0.59 c424+ 
1201.6800 1201.6816 -1.33 z323+. 
1214.9638 1214.9606 2.61 a323+ 
1218.1333 1218.1318 1.23 c414+. 
1229.8444 1229.8439 0.41 c555+ 
1229.9686 1229.9677 0.70 c322+ 
1232.3884 1232.3891 -0.57 c444+ 
1250.7035 1250.7018 1.33 z333+ 
1254.1108 1254.1072 2.87 a222+ 
1284.3857 1284.3870 -1.01 z343+. 
1298.9276 1298.9276 0.00 c464+ 
1305.6717 1305.6714 0.23 c343+ 
1316.7358 1316.7338 1.52 y474+ 
1323.7074 1323.7051 1.74 c595+ 
1324.9443 1324.9393 3.77 a474+ 
1333.6969 1333.6959 0.72 a353+ 
1335.6949 1335.6947 0.15 c474+ 
1348.3696 1348.3697 -0.07 c353+ 
1352.2643 1352.2649 -0.44 z242+. 
1367.4701 1367.4684 1.24 c484+ 
1388.7870 1388.7870 0.00 z373+ 
1404.7368 1404.7355 0.93 c494+ 
1408.0442 1408.0444 -0.14 y12610+ 
1412.5408 1412.5411 -0.21 a635+ 
1416.7877 1416.7864 0.92 z252+ 
1429.7476 1429.7437 2.70 c383+ 
1442.6015 1442.5994 1.46 z786+. 
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1458.2708 1458.2685 1.58 c514+ 
1526.8494 1526.8491 0.20 z413+. 
1537.0566 1537.0530 2.34 c554+ 
1558.8639 1558.8605 2.18 z282+ 
1564.4942 1564.4930 0.75 y1269+ 
1586.1657 1586.1616 2.56 c424+ 
1624.1791 1624.1759 1.95 c433+ 
1643.1858 1643.1830 1.70 c443+ 
1760.1848 1760.1787 3.47 y1268+ 
 
 253 
Appendix 15 — Fragments observed following CID of +15 
ions with m/z 1084.08 from non-diseased liver tissue 
(identified as FABPTA). 
Measured (m/z) Theoretical (m/z) Δppm Assignment 
477.2368 477.2400 -6.71 b82+ 
573.8734 573.8771 -6.45 y92+ 
584.7817 584.7853 -6.16 b102+ 
620.6969 620.7011 -6.77 y16-H2O3+ 
630.4150 630.4192 -6.66 y102+ 
687.9281 687.9326 -6.54 y112+ 
692.3934 692.3980 -6.64 y18-H2O3+ 
698.3968 698.4015 -6.73 y183+ 
712.3254 712.3301 -6.60 b61+ 
716.4387 716.4434 -6.56 y122+ 
730.0879 730.0927 -6.57 y193+ 
736.0911 736.0962 -6.93 y193+ 
772.9803 772.9854 -6.60 y132+ 
773.7861 773.7909 -6.20 y203+ 
823.5039 823.5092 -6.44 y142+ 
831.1341 831.1403 -7.46 y222+ 
840.3834 840.3886 -6.19 b71+ 
869.1488 869.1547 -6.79 y233+ 
879.0963 879.1028 -7.39 y385+ 
889.0237 889.0295 -6.52 y152+ 
930.5419 930.5480 -6.56 y16-H2O2+ 
939.5471 939.5533 -6.60 y162+ 
953.4668 953.4727 -6.19 y81+ 
985.2983 985.3040 -5.79 y354+ 
987.5631 987.5695 -6.48 y17-H2O2+ 
996.5684 996.5748 -6.42 y172+ 
1007.2651 1007.2725 -7.35 b354+ 
1009.8155 1009.8211 -5.55 y364+ 
1010.9526 1010.9555 -2.83 b63-NH37+ 
1018.8932 1018.8996 -6.25 y556+ 
1038.0865 1038.0933 -6.55 y18-H2O2+ 
1040.4000 1040.4067 -6.41 y566+ 
1045.5732 1045.5796 -6.12 y283+ 
1047.0918 1047.0986 -6.49 y182+ 
1059.2478 1059.2541 -5.92 y576+ 
1091.1647 1091.1709 -5.68 b485+ 
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1094.6284 1094.6354 -6.39 y19-H2O2+ 
1103.6335 1103.6406 -6.43 y192+ 
1118.3942 1118.3982 -3.61 b111-NH311+ 
1119.4195 1119.4248 -4.76 b606+ 
1119.5984 1119.6030 -4.14 y606+ 
1119.9413 1119.9461 -4.32 b11111+ 
1140.7582 1140.7653 -6.19 b616+ 
1143.1029 1143.1088 -5.16 y123-H2O12+ 
1144.5203 1144.5263 -5.21 y12312+ 
1150.2724 1150.2804 -6.95 y626+ 
1151.7724 1151.7790 -5.70 y12412+ 
1160.1750 1160.1827 -6.64 y202+ 
1163.6046 1163.6072 -2.23 a1055+ 
1165.6043 1165.6100 -4.89 b626+ 
1166.9515 1166.9585 -5.97 y636+ 
1177.4013 1177.4093 -6.79 b10610+ 
1179.1082 1179.1135 -4.49 b63-NH36+ 
1181.5303 1181.5379 -6.46 y117-H2O11+ 
1182.1109 1182.1180 -5.98 b636+ 
1183.1681 1183.1752 -6.03 y11711+ 
1183.9601 1183.9664 -5.35 y646+ 
1186.2120 1186.2183 -5.31 a10710+ 
1187.1088 1187.1151 -5.31 b107-NH310+ 
1188.9096 1188.9177 -6.81 b10710+ 
1193.2638 1193.2704 -5.57 y118-H2O11+ 
1194.9012 1194.9078 -5.56 y11811+ 
1195.7870 1195.7916 -3.82 b646+ 
1197.6204 1197.6279 -6.26 b535+ 
1212.6108 1212.6190 -6.76 b878+ 
1231.8308 1231.8400 -7.47 b11110+ 
1260.3979 1260.4062 -6.59 b454+ 
1262.2927 1262.3012 -6.73 b333+ 
1279.7738 1279.7830 -7.19 y11510+ 
1289.9810 1289.9891 -6.30 b696+ 
1294.6811 1294.6881 -5.41 b585+ 
1303.2194 1303.2283 -6.83 y232+ 
1308.3406 1308.3429 -1.79 b1069+ 
1320.2931 1320.2998 -5.07 b595+ 
1368.7149 1368.7169 -1.46 b615+ 
1380.3269 1380.3351 -5.94 y625+ 
1398.3225 1398.3306 -5.79 b625+ 
1414.9289 1414.9348 -4.17 b63-NH35+ 
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1418.5317 1418.5401 -5.92 b635+ 
1438.3462 1438.3538 -5.28 b645+ 
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Appendix 16 — Fragments observed following ETD of 
+16 ions with m/z 940.24 from NASH liver tissue 
(identified as FABPTA). 
Measured (m/z) Calculated (m/z) Δppm Assignment  
566.2923 566.2933 -1.77 c51+ 
729.3552 729.3566 -1.92 c61+ 
815.4987 815.4999 -1.47 z142+ 
826.1347 826.1367 -2.42 z223+. 
857.4141 857.4152 -1.28 c71+ 
863.8139 863.8151 -1.39 z233+ 
869.2355 869.2373 -2.07 z314+ 
901.2595 901.2611 -1.78 z324+ 
901.8432 901.8457 -2.77 z243+. 
910.3072 910.3087 -1.65 z415+ 
912.1470 912.1481 -1.17 c486+ 
916.9252 916.9261 -0.98 c152+ 
922.7268 922.7276 -0.87 c324+ 
939.5525 939.5533 -0.85 y162+ 
944.5225 944.5240 -1.59 z253+ 
952.0989 952.0999 -1.05 c525+ 
956.0359 956.0394 -3.66 z344+. 
970.4984 970.4993 -0.93 c81+ 
979.5044 979.5054 -1.02 c344+ 
1011.5285 1011.5291 -0.59 c354+ 
1025.0362 1025.0378 -1.53 c556+ 
1039.3439 1039.3435 0.38 c465+ 
1040.2394 1040.2400 -0.58 z283+ 
1044.3813 1044.3842 -2.78 z475+. 
1045.5785 1045.5796 -1.05 y283+ 
1050.5537 1050.5516 2.00 c374+ 
1068.5621 1068.5572 4.59 c475+ 
1072.3072 1072.3096 -2.24 c384+ 
1082.9376 1082.9383 -0.65 z293+ 
1094.3759 1094.3762 -0.27 c485+ 
1123.6280 1123.6306 -2.31 z404+. 
1123.7895 1123.7899 -0.36 c495+ 
1135.9464 1135.9447 1.50 c474+ 
1137.6325 1137.6340 -1.32 z414+ 
1158.6464 1158.6473 -0.78 z313+ 
1164.3209 1164.3202 0.57 y313+ 
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1166.6172 1166.6162 0.86 c515+ 
1189.6225 1189.6230 -0.42 c424+ 
1201.6801 1201.6816 -1.25 z323+. 
1218.1369 1218.1318 4.19 c414+. 
1229.8437 1229.8439 -0.16 c555+ 
1229.9682 1229.9677 0.38 c322+ 
1232.6393 1232.6391 0.16 c444+ 
1250.7030 1250.7018 0.93 z333+ 
1274.3844 1274.3834 0.78 z343+. 
1305.6709 1305.6714 -0.38 c343+ 
1348.3695 1348.3697 -0.15 c353+ 
1367.7199 1367.7184 1.10 c484+ 
1516.8444 1516.8443 0.07 z273+. 
1537.0569 1537.0530 2.54 c554+ 
1586.1619 1586.1616 0.19 c423+ 
1643.1868 1643.1830 2.31 c443+ 
1725.3199 1725.3158 2.38 z785+. 
1737.9724 1737.9674 2.88 z312+ 
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Appendix 17 — Bottom-up coverage of FABP in All 
extractions and replicates. 
Ammonium bicarbonate extraction, replicate1  Coverage 54.33%  
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS 
VTELNGDIIT NTMTLGDIVF KRISKRI 
Ammonium bicarbonate extraction, replicate 2  Coverage 57.48% 
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS 
VTELNGDIIT NTMTLGDIVF KRISKRI  
50% Methanol extraction, replicate 1   Coverage 54.33%  
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS   
VTELNGDIIT NTMTLGDIVF KRISKRI 
50% Methanol extraction, replicate 2   Coverage 53.54%  
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS   
VTELNGDIIT NTMTLGDIVF KRISKRI 
70% Methanol extraction, replicate 1   Coverage 53.54%  
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS   
VTELNGDIIT NTMTLGDIVF KRISKRI 
70% Methanol extraction, replicate 2   Coverage 54.33%  
MSFSGKYQLQ SQENFEAFMK AIGLPEELIQ KGKDIKGVSE IVQNGKHFKF 
TITAGSKVIQ NEFTVGEECE LETMTGEKVK TVVQLEGDNK LVTTFKNIKS   
VTELNGDIIT NTMTLGDIVF KRISKRI 
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Appendix 18 — Publication: Liquid Extraction Surface 
Analysis Mass Spectrometry Coupled with Field 
Asymmetric Waveform Ion Mobility Spectrometry for 
Analysis of Intact Proteins from Biological Substrates. 
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Appendix 19 — Illustration of the extra brackets required 
for the LESA to increase the gap between the instrument 
and the Triversa to allow for the longer cone used for the 
ultraFAIMS. 
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Appendix 20 — Relative molecule masses of proteins 
detected from mouse brain tissue using the ultra-FAIMS. 
Mouse	Brain	
With	Ultra-FAIMS	 Without	Ultra-FAIMS	
MW	 MW	
4895.6390	 8559.6696	
4933.5890	 12365.1983	
4960.5527	 14955.8663	
5439.8902	 14971.8789	
5455.9021	 15549.1450	
5703.1946	 15562.0597	
5751.0834	 15590.1511	
6246.3368	 15607.2468	
6568.4907	 15841.9500	
6584.5553	 16780.0867	
6693.6855	 	
7308.8543	 	
7350.8786	 	
7746.0861	 	
7850.1582	 	
7930.4376	 	
8099.5844	 	
8373.5721	 	
8501.6310	 	
8514.7185	 	
8542.6698	 	
8559.7427	 	
8581.7654	 	
8939.5860	 	
9320.9570	 	
9613.8989	 	
9905.2786	 	
9971.9289	 	
10254.2017	 	
10270.2129	 	
10711.2785	 	
12365.2972	 	
12428.5548	 	
14126.4726	 	
14971.8621	 	
14990.0092	 	
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15564.1857	 	
15607.4189	 	
15839.9454	 	
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Appendix 21 — Relative molecule masses of proteins 
detected from mouse liver tissue using the ultra-FAIMS. 
Mouse	liver	
With	Ultra-FAIMS	 Without	Ultra-FAIMS	
5184.7285	 5329.6470	
5569.1897	 14194.4401	
7159.2736	 14220.4481	
7159.7520	 14236.4717	
7455.7883	 14252.4361	
14160.5286	 14262.4559	
14195.4872	 14279.4967	
14200.5275	 14296.5258	
14204.4581	 14305.5173	
14220.4320	 14316.4938	
14234.4307	 14926.7514	
14260.5207	 14955.7170	
14279.5268	 14972.7901	
14295.5366	 15010.7615	
14315.4114	 15550.0201	
14343.3976	 15608.1105	
14406.4311	 15646.1398	
14548.3305	 18634.2003	
14928.6248	 18698.2250	
14972.7671	 23463.1848	
14973.8941	 	
14992.7933	 	
15011.6677	 	
15589.1740	 	
15607.1015	 	
15627.1558	 	
15644.0586	 	
22348.0711	 	
23467.3873	 	
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Appendix 22 —Fragments observed following MS/MS of 
+9 ions with m/z 1021.47. 
Fragments observed following CID, HCD and ETD of +14 ions with m/z 
1021.47 from mouse liver tissue using DF of 130 Td and a CF of 0.3 Td identified 
as liver fatty acid binding protein 
CID  HCD  ETD    
Measured 
Mass 
Δppm Measured 
Mass 
Δppm Measured 
Mass 
Δppm Calculated 
Mass 
Assignment 
  288.0998 -5.21   288.1013 b2+ 
  435.1675 -5.06   435.1697 b3+ 
    724.3412 -4.83 724.3447 c6+ 
870.3777 -4.37 870.3773 -4.83   870.3815 b7+ 
  981.4088 -4.79   981.4135 b8-NH3+ 
998.4358 -4.21 998.4352 -4.81   998.4400 b8+ 
1111.5191 -4.50 1111.5187 -4.86   1111.5241 b9+ 
  1148.7203 -5.14   1148.7262 y9+ 
1239.5769 -4.68     1239.5827 b10+ 
1261.8044 -4.68 1261.8040 -4.99   1261.8103 y10+ 
1308.5981 -4.59     1308.6041 b11-H2O+ 
1326.6088 -4.45     1326.6147 b11+ 
1433.8523 -4.46 1433.8516 -4.95   1433.8587 y12+ 
1546.9360 -4.40 1546.9352 -4.91   1546.9428 y13+ 
1583.7088 -4.48     1583.7159 b13+ 
    1631.9636 -4.96 1631.9717 z14+ 
1647.9831 -4.49 1647.9825 -4.85   1647.9905 y14+ 
1779.0232 -4.33 1779.0222 -4.89   1779.0309 y15+ 
1844.8193 -4.28     1844.8272 b15+ 
  1862.0589 -4.89   1862.0680 y16-H2O+ 
1880.0702 -4.47     1880.0786 y16+ 
  1977.0868 -4.15   1977.0950 y17-NH3+ 
2077.1497 -4.33     2077.1587 y18-H2O+ 
  2078.1324 -4.96   2078.1427 y18-NH3+ 
2095.1601 -4.34 2095.1587 -5.01   2095.1692 y18+ 
  2191.2312 1.96   2191.2269 y19-NH3+ 
2208.2427 -4.80 2208.2427 -4.80   2208.2533 y19+ 
2309.2907 -4.46 2309.2898 -4.85   2309.3010 y20+ 
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2481.3374 -4.84 2481.3377 -4.72   2481.3494 y22+ 
    2579.3607 -5.00 2579.3736 z23+ 
2595.3813 -4.24     2595.3923 y23+ 
    2821.4870 -4.68 2821.5002 z25+ 
    3037.6203 -4.84 3037.6350 y27+ 
    3124.6516 -4.96 3124.6671 y28+ 
    3236.7255 -5.50 3236.7433 z29+ 
    3406.8324 -4.81 3406.8488 z31+ 
    3534.9258 -5.09 3534.9438 z32+ 
    3856.9201 -5.19 3856.9401 c33+ 
    4085.0296 -5.26 4085.0511 c35+ 
    4114.1948 -5.27 4114.2165 z37+ 
    4213.1229 -5.48 4213.1460 c36+ 
4372.3538 -4.41     4372.3731 y39+ 
    4528.3784 -5.39 4528.4028 z41+ 
    4797.4379 -5.42 4797.4639 c42+ 
    4934.4959 -5.27 4934.5219 c43+ 
    5120.5602 -5.04 5120.5860 c45+ 
    5826.1535 -5.77 5826.1871 y53+ 
    6209.2513 -4.91 6209.2818 c54+ 
    6362.3184 -4.68 6362.3482 c55+. 
6627.5538 2.11     6627.5398 a59-NH3+ 
    6689.5524 -5.29 6689.5878 c59+ 
    6845.6525 -5.32 6845.6889 c60+ 
    7435.7881 -5.27 7435.8273 z67+ 
    8073.1933 -6.07 8073.2423 z73+. 
10307.4924 -6.31     10307.5574 y93-H2O+ 
10325.5666 -0.13     10325.5679 y93+ 
11027.8384 8.34     11027.7464 b98+ 
11562.1731 -5.73     11562.2393 y104+ 
11619.1968 -5.51     11619.2608 y105+ 
12372.5394 8.45     12372.4349 a111+ 
12435.5803 -8.11     12435.6812 y112+ 
12678.7254 -4.46     12678.7820 y114-H2O+ 
12808.7315 -6.02     12808.8086 y115-NH3+ + 
12825.8724 2.91     12825.8351 y115+ 
12936.8025 -5.00     12936.8672 y116-NH3+ 
12953.7884 -8.13     12953.8937 y116+ 
13023.8476 -3.96     13023.8992 y117-NH3+ 
13040.8588 -5.13     13040.9257 y117+ 
13151.9202 -2.86     13151.9578 y118-NH3+ 
13168.8767 -8.17     13168.9843 y118+ 
 272 
13281.9538 -8.63     13282.0684 y119+ 
13828.2412 -5.13     13828.3122 y124-NH3+ 
13845.2728 -4.76     13845.3387 y124+ 
13974.2810 -0.99     13974.2948 b125-H2O+ 
13974.2810 -8.27     13974.3966 y125-H2O+ + 
13992.3216 1.16     13992.3054 b125+ 
13992.3216 -6.11     13992.4071 y125+ 
14106.3499 -7.10     14106.4501 y126+ 
    14237.466
3 
-1.71 14237.4906 y127+ 
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Appendix 23 —Fragments observed following MS/MS of 
+9 ions with m/z 1021.47. 
Fragments observed following CID, HCD and ETD of +14 ions with m/z 
1021.47 from mouse liver tissue not using the ultraFAIMS 
CID  HCD  ETD    
Measured 
Mass 
Δppm Measured 
Mass 
Δppm Measured 
Mass 
Δppm  Calculated 
Mass 
Assignment 
  998.4347 -5.31   998.4400 b8+ 
1111.5194 -4.23     1111.5241 b9+ 
1239.5766 -4.92     1239.5827 b10+ 
  1261.8033 -5.55   1261.8103 y10+ 
1326.6085 -4.67     1326.6147 b11+ 
1433.8521 -4.60 1433.8510 -5.37   1433.8587 y12+ 
1546.9357 -4.59 1546.9345 -5.37   1546.9428 y13+ 
1583.7086 -4.61     1583.7159 b13+ 
    1631.9635 -5.02 1631.9717 z14+ 
1647.9829 -4.61 1647.9818 -5.28   1647.9905 y14+ 
1779.0227 -4.61 1779.0213 -5.40   1779.0309 y15+ 
1880.0703 -4.41 1880.0686 -5.32   1880.0786 y16+ 
  1977.0847 -5.21   1977.0950 y17-NH3+ 
  1994.1107 -5.42   1994.1215 y17+ 
  2077.1468 -5.73   2077.1587 y18-H2O+ 
  2078.1307 -5.77   2078.1427 y18-NH3+ 
2095.1593 -4.73 2095.1577 -5.49   2095.1692 y18+ 
      2191.2269 y19-NH3+ 
  2208.2415 -5.34   2208.2533 y19+ 
    3124.6482 -6.05 3124.6671 y28+ 
    3406.8299 -5.55 3406.8488 z31+ 
    4085.0231 -6.85 4085.0511 c35+ 
    4528.3755 -6.03 4528.4028 z41+ 
    4934.4932 -5.82 4934.5219 c43+ 
5029.5075 -0.80     5029.5115 b44-NH3+ 
    5826.1543 -5.63 5826.1871 y53+ 
    6209.2462 -5.73 6209.2818 c54+ 
6627.5346 -0.78     6627.5398 a59-NH3+ 
7208.7265 -4.72     7208.7605 y65+ 
8566.5067 1.26     8566.4959 y77+ 
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    9753.0577 -5.72 9753.1135 c86+ 
12696.6792 -8.92     12696.7925 y114+ 
12807.7429 -6.38     12807.8246 y115-H2O+ 
12936.8407 -2.05     12936.8672 y116-NH3+ 
13040.8635 -4.77     13040.9257 y117+ 
13151.9246 -2.52     13151.9578 y118-NH3+ 
13202.8466 -0.69     13202.8557 a119+ 
13741.2107 -5.06     13741.2802 y123-NH3+ 
13760.2329 5.89     13760.1518 b123-NH3+ 
13828.2515 -4.39     13828.3122 y124-NH3+ 
13845.2451 -6.76     13845.3387 y124+ 
13975.2685 -0.74     13975.2788 b125-NH3+ 
13992.4139 7.75     13992.3054 b125+ 
13992.4139 0.49     13992.4071 y125+ 
14088.4936 3.84     14088.4395 y126-H2O+ 
14089.3338 -6.37     14089.4235 y126-NH3+ 
    14219.383
5 
-6.79 14219.4800 y127-H2O+ 
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Appendix 24 —Fragments observed following MS/MS of 
+9 ions with m/z 952.63. 
Fragments observed following CID, HCD and ETD of +9 ions with m/z 952.63 
from mouse brain tissue using DF of 270 Td and a CF of 2.6 Td identified as 
unbiquitin. 
CID  HCD  ETD    
Measured 
Mass 
Δppm Measured 
Mass 
Δppm Measured 
Mass 
Δppm Calculated 
Mass 
Assignment 
  260.1057 -2.31   260.1063 b2+ 
  373.1895 -2.41   373.1904 b3+ 
  753.4712 -2.39   753.4730 y7-NH3+ 
  866.5551 -2.19   866.5570 y8-NH3+ 
  1003.6137 -2.29   1003.6160 y9-NH3+ 
1062.5993 -2.16     1062.6016 b9+ 
    1136.6468 -2.46 1136.6496 c10+ 
1247.7159 -1.68     1247.7180 b10+ 
  1304.7768 -2.22   1304.7797 y12-NH3+ 
  1321.8033 -2.27   1321.8063 y12+ 
1348.7635 -1.63     1348.7657 b12+ 
  1433.8198 -1.74   1433.8223 y13-NH3+ 
1443.8366 -1.80     1443.8392 b13-H2O+ 
1450.8459 -2.07 1450.8454 -2.41   1450.8489 y13+ 
1461.8469 -1.98     1461.8498 b13+ 
1562.8944 -1.98     1562.8975 b14+ 
1578.9406 -2.03 1578.9403 -2.22   1578.9438 y14+ 
1657.9679 -1.87     1657.9710 b15-H2O+ 
1675.9782 -1.97     1675.9815 b15+ 
1706.9992 -1.87 1706.9985 -2.28   1707.0024 y15+ 
1805.0209 -1.77     1805.0241 b16+ 
2033.1309 -2.07     2033.1351 b18+ 
2097.1884 -2.05 2097.1881 -2.19   2097.1927 y18+ 
    2081.1692 -2.31 2081.1740 z18+ 
    2513.3779 -2.19 2513.3834 y22+ 
    2692.4419 -2.15 2692.4477 c24+ 
2726.5013 -1.72 2726.4993 -2.46   2726.5060 y24+ 
    3104.6855 -1.84 3104.6912 c28+ 
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    3345.8626 -2.27 3345.8702 c30+ 
    3473.9228 -1.73 3473.9288 c31+ 
3571.9212 -2.24     3571.9292 b32+ 
3700.0168 -1.97     3700.0241 b33+ 
    4209.2909 -1.33 4209.2965 c38+. 
    4210.2886 -3.73 4210.3043 c38+ 
4253.3183 -1.93 4253.3149 -2.73   4253.3265 y37+ 
4308.2960 -2.02     4308.3047 b39+ 
    4352.3261 -2.00 4352.3348 z38+ 
  4465.3956 -2.40   4465.4063 y39+ 
  4545.4271 -1.19   4545.4325 y40-NH3+ 
4562.4495 -2.08 4562.4473 -2.56   4562.4590 y40+ 
  4732.5531 -2.41   4732.5645 y42+ 
4989.6898 -2.47 4989.6887 -2.69   4989.7021 y44+ 
5835.1125 -2.18     5835.1252 y52+ 
6015.2411 -1.93     6015.2527 b53+ 
6511.4608 -1.35     6511.4696 y58-NH3+ 
6528.4821 -2.14     6528.4961 y58+ 
6639.5150 -1.99     6639.5282 y59-H2O+ 
    6643.5147 -0.89 6643.5206 c59+. 
6657.5261 -1.89     6657.5387 y59+ 
6756.5900 -2.53     6756.6071 y60+ 
6867.6246 -2.13     6867.6392 y61-H2O+ 
6885.6379 -1.71     6885.6497 y61+ 
6982.6837 -0.53     6982.6874 b62+ 
6998.7206 -1.89     6998.7338 y62+ 
7099.7673 -2.00     7099.7815 y63+ 
7212.8508 -2.04     7212.8655 y64+ 
7295.8890 -1.88     7295.9027 y65-H2O+ 
7313.8963 -2.31     7313.9132 y65+ 
7814.1953 -1.77     7814.2091 y70+ 
7942.2869 -2.15     7942.3040 y71+ 
8188.4225 -2.25     8188.4409 y73+ 
8301.5071 -2.14     8301.5249 y74+ 
    8501.5787 -3.76 8501.6107 c75+. 
8560.6044 -2.29   8560.6080 -1.87 8560.6240 Precursor 
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Appendix 25 — MATLAB Code for Interpolation of 
FAIMS data.  
 
function  [vq]=multiInterpol(Ydata,Xdata,xq) 
[R,C]=size(Ydata); 
vq=zeros(R,length(xq)); 
    for j=1:R 
         v=1; 
        for k=1:length(xq) 
            True=0; 
            while True == 0 
  
            if Xdata(j,v)<=xq(k) && xq(k)<Xdata(j,(v+1))  
                    x1=Xdata(j,v); 
                    x2=Xdata(j,(v+1)); 
                    y1=Ydata(j,v); 
                    y2=Ydata(j,(v+1)); 
  
                    m=(y2-y1)/(x2-x1); 
                    c=y1-m*x1; 
  
                    vq(j,k)=(m*xq(k))+c; 
                     
                    True=1; 
  
            else 
                  
                v=v+1; 
                           
            end 
            end 
         end 
    end 
end 
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Appendix 26 – Fragments observed following CID of m/z 
792 using LESA extraction and an Orbitrap mass analyser.  
Fragmentation of m/z revealed fragments specific to three different lipid 
species. PC(18:1/18:1)+Li+, PC(18:0/18:2)+Li+ and PC(16:0/20:2)+Li+. With the 
possibility of a forth lipid as PC(16:1/20:1)+Li+. 
The fragments detected were. 
PC(36:2)+Li+	 792.6089	 792.6072 -2.14	
NL	Choline	 733.5349	 733.5334	 -2.04	
NL	PC	 609.5429	 609.5415	 -2.30	
NL	PC+Li	 603.5341	 603.5333	 -1.33	
NL	(16:1)	 538.3843	 538.3809	 -6.32	
NL	(16:0)	 536.3687	 536.3674	 -2.42	
NL	(18:2)	 512.3687	 512.3676	 -2.15	
NL	(18:1)	 510.353	 510.352	 -1.96	
NL	(18:0)	 508.3374	 508.3364	 -1.97	
NL	(18:2)	+Li	 506.3605	 506.3595	 -1.97	
NL	(18:1)+Li	 504.3449	 504.3438	 -2.18	
NL	(18:0)	+Li	 502.3292	 502.3281	 -2.19	
NL	(20:2)	+Li	 478.3292	 478.3284	 -1.67	
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Appendix 27 — All Identified Lipids via MS/MS analysis 
on the Orbitrap Velos. 
Table of all identified lipids. 
Measured 
(m/z) 
Calculated 
(m/z) 
Δppm Assignment 
502.3469 502.3479 -0.20 LysoPC(16:0)+Li+ 
545.4749 545.4752 -0.05 DG(12:0/18:1)+Li+ 
545.4749 545.4752 -0.05 DG(14:0/16:1)+Li+ 
545.4749 545.4752 -0.05 DG(14:1/16:0)+Li+ 
548.3530 548.3323 3.78 LysoPC(20:5)+Li+ 
571.4907 571.4908 -0.02 DG(14:0/18:2)+Li+ 
571.4907 571.4908 -0.02 DG(16:1/16:1)+Li+ 
573.5063 573.5065 -0.03 DG(14:0/18:1)+Li+ 
573.5063 573.5065 -0.03 DG(16:0/16:1)+Li+ 
575.5218 575.5221 -0.05 DG(16:0/16:0)+Li+ 
597.5064 597.5070 -0.09 DG(16:0/18:3)+Li+ 
597.5064 597.5070 -0.09 DG(16:1/18:2)+Li+ 
599.5221 599.5221 0.00 DG(16:0/18:2)+Li+ 
599.5221 599.5221 0.00 DG(16:1/18:1)+Li+ 
601.5378 601.5378 0.00 DG(18:1/16:0)+Li+ 
601.5378 601.5378 0.00 DG(18:1/16:0)+Li+ 
603.5446 603.5534 -1.46 DG(16:0/18:0)+Li+ 
623.5221 623.5221 0.00 DG(16:0/20:4)+Li+ 
623.5221 623.5221 0.00 DG(16:1/20:3)+Li+ 
623.5221 623.5221 0.00 DG(18:2/18:2)+Li+ 
623.5221 623.5221 0.00 DG(18:3/18:1)+Li+ 
625.5367 625.5378 -0.18 DG(18:2/18:1)+Li+ 
625.5367 625.5378 -0.18 DG(20:3/16:0)+Li+ 
627.5535 627.5534 0.02 DG(18:0/18:2)+Li+ 
627.5535 627.5534 0.02 DG(18:1/18:1)+Li+ 
629.5686 629.5671 0.24 DG(16:0/18:1)+Li+ 
629.5686 629.5671 0.24 DG(16:1/18:0)+Li+ 
644.4016 644.4262 -3.82 LysoPE(30:6)+Li+ 
709.5833 709.5830 0.04 SM(16:0)+Li+ 
722.5292 722.5307 -0.21 PE(18:2/16:0)+Li+ 
724.5471 744.5619 -2688.13 PE(18:1/16:0)+Li+ 
736.5468 736.5461 0.10 PC(14:0/18:2)+Li+ 
736.5468 736.5461 0.10 PC(16:1/16:1)+Li+ 
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738.5613 738.5620 -0.09 PC(16:0/16:1)+Li+ 
738.5624 738.5619 0.07 PC(16:0/16:1)+Li+ 
738.5624 738.5619 0.07 PC(18:1/14:0)+Li+ 
740.5789 740.5776 0.18 PC(16:0/16:0)+Li+ 
744.5100 744.5150 -0.67 PE(20:5/16:0)+Li+ 
746.5295 746.5307 -0.16 PE(20:4/16:0)+Li+ 
748.5481 748.5463 0.24 PE(18:2/18:1)+Li+ 
748.5481 748.5463 0.24 PE(20:3/16:0)+Li+ 
750.5612 750.5620 -0.11 PE(18:1/18:1)+Li+ 
750.5627 750.5620 0.09 PE(18:0/18:2)+Li+ 
762.5627 762.5612 0.20 PC(18:2/16:1)+Li+ 
762.5627 762.5612 0.20 PC(18:3/16:0)+Li+ 
764.5768 764.5776 -0.10 PC(18:2/16:0)+Li+ 
766.5938 766.5933 0.07 PC(18:1/16:0)+Li+ 
768.6000 768.6089 -1.16 PC(18:0/16:0)+Li+ 
770.5311 770.5307 0.05 PE(20:5/18:1)+Li+ 
770.5311 770.5307 0.05 PE(22:6/16:0)+Li+ 
772.5478 772.5463 0.19 PE(22:4/18:1)+Li+ 
774.5624 774.5620 0.05 PE(20:4/18:0)+Li+ 
776.5786 776.5776 0.13 PE(20:3/18:0)+Li+ 
786.5624 786.5620 0.05 PC(20:4/16:1)+Li+ 
786.5624 786.5620 0.05 PC(20:5/16:0)+Li+ 
788.5768 788.5776 -0.10 PC(18:2/18:2)+Li+ 
788.5768 788.5776 -0.10 PC(20:4/16:0)+Li+ 
790.5944 790.5933 0.14 PC(18:2/18:1)+Li+ 
790.5944 790.5933 0.14 PC(20:3/16:0)+Li+ 
792.6077 792.6089 -0.15 PC(18:1/18:1)+Li+ 
792.6077 792.6089 -0.15 PC(18:2/18:0)+Li+ 
792.6077 792.6089 -0.15 PC(20:2/16:0)+Li+ 
794.6270 794.6246 0.30 PC(18:1/18:0)+Li+ 
809.7209 809.7205 0.05 TAG(12:0/18:1/18:1)+Li+ 
809.7209 809.7205 0.05 TAG(14:0/16:0/18:2)+Li+ 
809.7209 809.7205 0.05 TAG(14:0/16:1/18:1)+Li+ 
809.7209 809.7205 0.05 TAG(14:1/16:0/18:1)+Li+ 
809.7209 809.7205 0.05 TAG(16:0/16:1/16:1)+Li+ 
811.7369 811.7362 0.09 TAG(14:0/16:0/18:1)+Li+ 
811.7369 811.7362 0.09 TAG(16:1/16:0/16:0)+Li+ 
812.5765 812.5776 -0.14 PC(20:4/18:2)+Li+ 
812.5765 812.5776 -0.14 PC(22:6/16:0)+Li+ 
814.5942 814.5933 0.11 PC(20:4/18:1)+Li+ 
814.5942 814.5933 0.11 PC(20:5/18:0)+Li+ 
814.5942 814.5933 0.11 PC(22:5/16:0)+Li+ 
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816.6083 816.6089 -0.07 PC(16:0/22:4)+Li+ 
816.6083 816.6089 -0.07 PC(20:3/18:1)+Li+ 
816.6083 816.6089 -0.07 PC(20:4/18:0)+Li+ 
816.6083 816.6089 -0.07 PC(20:4/18:0)+Li+ 
818.6273 818.6246 0.33 PC(18:2/20:1)+Li+ 
818.6273 818.6246 0.33 PC(20:3/18:0)+Li+ 
835.7366 835.7362 0.05 TAG(14:0/18:2/18:1)+Li+ 
835.7366 835.7362 0.05 TAG(16:0/16:0/18:3)+Li+ 
835.7366 835.7362 0.05 TAG(16:0/16:1/18:2)+Li+ 
835.7366 835.7362 0.05 TAG(16:1/16:1/18:1)+Li+ 
837.7522 837.7518 0.05 TAG(14:0/18:1/18:1)+Li+ 
837.7522 837.7518 0.05 TAG(16:0/16:0/18:1)+Li+ 
837.7522 837.7518 0.05 TAG(16:0/16:1/18:1)+Li+ 
840.6091 840.6088 0.04 PC(22:6/18:0)+Li+ 
846.5952 846.5984 -0.38 LysoPC(42:10)+Li+ 
861.7524 861.7518 0.07 TAG(16:0/16:0/20:4)+Li+ 
861.7524 861.7518 0.07 TAG(16:0/16:1/20:3)+Li+ 
861.7524 861.7518 0.07 TAG(16:0/18:1/18:3)+Li+ 
861.7524 861.7518 0.07 TAG(16:0/18:2/18:2)+Li+ 
861.7524 861.7518 0.07 TAG(16:1/18:0/18:3)+Li+ 
863.7675 863.7875 -2.32 TAG(18:1/18:1/16:1)+Li+ 
863.7675 863.7875 -2.32 TAG(18:2/18:1/16:0)+Li+ 
865.7831 865.7831 0.00 TAG(18:1/18:0/16:1)+Li+ 
865.7831 865.7831 0.00 TAG(18:1/18:1/16:0)+Li+ 
867.7881 867.7988 -1.23 TAG(16:0/18:0/18:1)+Li+ 
891.8000 891.7988 0.13 TAG(18:0/18:1/18:2)+Li+ 
891.8000 891.7988 0.13 TAG(18:1/18:1/18:1)+Li+ 
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